<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">HEJ</journal-id>
<journal-id journal-id-type="hwp">sphej</journal-id>
<journal-title>Health Education Journal</journal-title>
<issn pub-type="ppub">0017-8969</issn>
<issn pub-type="epub">1748-8176</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0017896911419346</article-id>
<article-id pub-id-type="publisher-id">10.1177_0017896911419346</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Ottawa Panel evidence-based clinical practice guidelines for patient education in the management of Rheumatoid Arthritis (RA)</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<collab>Ottawa Panel member: Ottawa methods group:</collab>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Brosseau</surname><given-names>Lucie</given-names></name>
<xref ref-type="aff" rid="aff1-0017896911419346">a</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wells</surname><given-names>George A</given-names></name>
<xref ref-type="aff" rid="aff2-0017896911419346">b</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Tugwell</surname><given-names>Peter</given-names></name>
<xref ref-type="aff" rid="aff3-0017896911419346">c</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Egan</surname><given-names>Mary</given-names></name>
<xref ref-type="aff" rid="aff1-0017896911419346">a</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Dubouloz</surname><given-names>Claire-Jehanne</given-names></name>
<xref ref-type="aff" rid="aff1-0017896911419346">a</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Welch</surname><given-names>Vivian A</given-names></name>
<xref ref-type="aff" rid="aff3-0017896911419346">c</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Trafford</surname><given-names>Laura</given-names></name>
<xref ref-type="aff" rid="aff4-0017896911419346">d</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Sredic</surname><given-names>Danjiel</given-names></name>
<xref ref-type="aff" rid="aff4-0017896911419346">d</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Pohran</surname><given-names>Kathryn</given-names></name>
<xref ref-type="aff" rid="aff4-0017896911419346">d</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Smoljanic</surname><given-names>Jovana</given-names></name>
<xref ref-type="aff" rid="aff4-0017896911419346">d</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Vukosavljevic</surname><given-names>Ivan</given-names></name>
<xref ref-type="aff" rid="aff4-0017896911419346">d</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>De Angelis</surname><given-names>Gino</given-names></name>
<xref ref-type="aff" rid="aff2-0017896911419346">b</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Loew</surname><given-names>Laurianne</given-names></name>
<xref ref-type="aff" rid="aff1-0017896911419346">a</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>McEwan</surname><given-names>Jessica</given-names></name>
<xref ref-type="aff" rid="aff5-0017896911419346">e</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Bell</surname><given-names>External experts: Mary</given-names></name>
<xref ref-type="aff" rid="aff6-0017896911419346">f</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Finestone</surname><given-names>Hillel M</given-names></name>
<xref ref-type="aff" rid="aff7-0017896911419346">g</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lineker</surname><given-names>Sydney</given-names></name>
<xref ref-type="aff" rid="aff8-0017896911419346">h</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>King</surname><given-names>Judy</given-names></name>
<xref ref-type="aff" rid="aff1-0017896911419346">a</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Jelly</surname><given-names>Wilma</given-names></name>
<xref ref-type="aff" rid="aff1-0017896911419346">a</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Casimiro</surname><given-names>Lynn</given-names></name>
<xref ref-type="aff" rid="aff1-0017896911419346">a</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Haines-Wangda</surname><given-names>Angela</given-names></name>
<xref ref-type="aff" rid="aff9-0017896911419346">i</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Russell-Doreleyers</surname><given-names>Marion</given-names></name>
<xref ref-type="aff" rid="aff10-0017896911419346">j</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Laferrière</surname><given-names>Lucie</given-names></name>
<xref ref-type="aff" rid="aff11-0017896911419346">k</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Lambert</surname><given-names>Kim</given-names></name>
<xref ref-type="aff" rid="aff12-0017896911419346">l</xref>
</contrib>
<contrib contrib-type="author">
<collab>a consumer with rheumatoid arthritis, Ottawa, Ontario, Canada</collab>
</contrib>
</contrib-group>
<aff id="aff1-0017896911419346"><label>a</label>School of Rehabilitation Sciences, Faculty of Health Sciences, University of Ottawa, Canada</aff>
<aff id="aff2-0017896911419346"><label>b</label>Department of Epidemiology and Community Medicine, University of Ottawa, Canada</aff>
<aff id="aff3-0017896911419346"><label>c</label>Centre for Global Health, Institute of Population Health, Canada</aff>
<aff id="aff4-0017896911419346"><label>d</label>School of Human Kinetics, Faculty of Health Sciences, University of Ottawa, Canada</aff>
<aff id="aff5-0017896911419346"><label>e</label>Berkman Library, University of Ottawa Heart Institute, Canada</aff>
<aff id="aff6-0017896911419346"><label>f</label>Sunnybrook and Women’s College Health Sciences Centre, Canada</aff>
<aff id="aff7-0017896911419346"><label>g</label>Sisters of Charity of Ottawa Health Service, Canada</aff>
<aff id="aff8-0017896911419346"><label>h</label>Research Co-ordinator, The Arthritis Society, Ontario Division, Canada</aff>
<aff id="aff9-0017896911419346"><label>i</label>Ottawa Hospital, General Campus, Canada</aff>
<aff id="aff10-0017896911419346"><label>j</label>Canadian Physiotherapy Association and Ottawa Arthritis Rehabilitation and Education Programme, Canada</aff>
<aff id="aff11-0017896911419346"><label>k</label>MHA Canadian forces, Department of Forces Health Services Group, National Defense, Canada</aff>
<aff id="aff12-0017896911419346"><label>l</label>The Arthritis Society Arthritis Rehabilitation and Education Programme (AREP) and member of Canadian Occupational Therapy Association, Canada</aff>
<author-notes>
<corresp id="corresp1-0017896911419346">Lucie Brosseau, School of Rehabilitation Sciences, University of Ottawa, Ottawa, ON, K1N 6N5, Canada Email: <email>Lucie.Brosseau@uottawa.ca</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>7</month>
<year>2012</year>
</pub-date>
<volume>71</volume>
<issue>4</issue>
<fpage>397</fpage>
<lpage>451</lpage>
<permissions>
<copyright-statement>© The Author(s) 2011</copyright-statement>
<copyright-year>2011</copyright-year>
<copyright-holder content-type="sage">Health Education Journal</copyright-holder>
</permissions>
<abstract>
<p><bold>Background and purpose:</bold> The objective of this article is to create guidelines for education interventions in the management of patients (&gt;18 years old) with rheumatoid arthritis (RA).</p>
<p><bold>Methods:</bold> The Ottawa Methods Group identified and synthesized evidence from comparative controlled trials using Cochrane Collaboration methods. The group then formed an expert panel, which developed a set of criteria for grading the strength of the evidence and the recommendation. Patient-important outcomes were determined through consensus, provided that these outcomes were assessed with validated and reliable scales.</p>
<p><bold>Results:</bold> Sixty-four positive recommendations of clinical benefit (35 of A level and 29 of C+ level) were developed for patient education in RA.</p>
<p><bold>Discussion and conclusion:</bold> For the management of rheumatoid arthritis, the use of patient education is recommended by the Ottawa Panel.</p>
</abstract>
<kwd-group>
<kwd>clinical practice guidelines</kwd>
<kwd>epidemiology</kwd>
<kwd>evidence-based practice</kwd>
<kwd>physical rehabilitation</kwd>
<kwd>rheumatology</kwd>
<kwd>rheumatoid arthritis</kwd>
<kwd>education</kwd>
<kwd>knowledge translation</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0017896911419346" sec-type="intro">
<title>Introduction</title>
<p>Rheumatoid arthritis (RA) is an autoimmune disease involving inflammation of the joints, leading to joint pain, swelling, stiffness and possible deformity. It is an extremely disabling disease that reduces physical function and health-related quality of life; even with appropriate drug therapy, 30–50% are too disabled to work five years after disease onset.<sup><xref ref-type="bibr" rid="bibr1-0017896911419346">1</xref></sup> As a result of its biological effects, RA incurs significant direct costs, such as health care expenses, indirect costs such as loss of productivity due to morbidity and costs due to decreased life expectancy.<sup><xref ref-type="bibr" rid="bibr2-0017896911419346">2</xref></sup> It is one of the most prevalent chronic conditions, found in approximately 1% of the adult population,<sup><xref ref-type="bibr" rid="bibr3-0017896911419346">3</xref></sup> and affects more women than men.<sup><xref ref-type="bibr" rid="bibr4-0017896911419346">4</xref></sup> The incidence of RA is greatest among those aged 40 to 60 years.</p>
<p>Despite the fact that significant progress has been made in the clinical management of RA over the last decade, there is an urgent need for rehabilitation specialists to provide the most efficient and effective treatments for their clients. Recent cutbacks in the health care system have magnified the need for appropriate and effective treatments. Although most of the clinical guidelines recommend patient education as part of the intervention in RA,<sup><xref ref-type="bibr" rid="bibr5-0017896911419346">5</xref>, <xref ref-type="bibr" rid="bibr6-0017896911419346">6</xref></sup> no details are given to the clinicians or patients as to how education should be given and what it should include. The goal of this article is to present evidence-based clinical practice guidelines (EBCPGs) which will allow RA patients to optimally benefit from their rehabilitation programmes.</p>
<p>The objective of this article is to develop clinical guidelines based on a systematic review for interventions in rehabilitative care with adult individuals suffering from rheumatoid arthritis (RA). These clinical guidelines will focus on the efficacy of patient education interventions currently used in the field of rehabilitation sciences. These interventions needed to be systematized to assist clinicians in physiotherapy and occupational therapy to guide optimal clinical decision-making when caring with individuals with rheumatoid arthritis.</p>
</sec>
<sec id="section2-0017896911419346" sec-type="methods">
<title>Methods</title>
<p>This study incorporated methods similar to those developed for the Philadelphia Panel for EBCPGs<sup><xref ref-type="bibr" rid="bibr7-0017896911419346">7</xref></sup> and those of the Ottawa Panel on therapeutic exercises and electrotherapy in RA.<sup><xref ref-type="bibr" rid="bibr8-0017896911419346">8</xref>, <xref ref-type="bibr" rid="bibr9-0017896911419346">9</xref></sup> The Ottawa Methods Group (OMG) consisted of nine methodologists experienced in the development of EBCPG guidelines. The OMG requested that professional associations caring for those with RA nominate panellists both familiar with EBCPGs and experienced in clinical RA management. Of those nominated, the OMG chose nine clinical specialty experts as panellists, included a rheumatologist, a physiatrist, a physician, a family physician, three physical therapists, an occupational therapist, and a patient with RA. These nine experts and the OMG comprised the Ottawa Panel. The OMG assembled a research and support staff that consisted of persons with expertise in meta-analysis, rheumatology rehabilitation interventions, research methods and the development and assessment of EBCPGs.</p>
<p>In order to systematically screen the studies, the OMG established a priori inclusion criteria (<xref ref-type="table" rid="table1-0017896911419346">Table 1</xref>) for the study designs, subject samples, interventions and outcomes. The inclusion criteria enabled research staff to identify the most relevant articles as evidence of the effectiveness of patient education on RA. The inclusion criteria were later reviewed by the OMG to ensure that the resulting study selection was reproducible and systematic. This a priori protocol guided separate systematic literature reviews for each intervention. Material was reviewed by the research staff and evidence tables were generated and distributed one month prior to the consensus meeting to the Ottawa Panel members to serve as the basis for making recommendations.</p>
<table-wrap id="table1-0017896911419346" position="float">
<label>Table 1.</label>
<caption>
<p>Inclusion and exclusion criteria</p>
</caption>
<graphic alternate-form-of="table1-0017896911419346" xlink:href="10.1177_0017896911419346-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Inclusion</th>
<th align="left">Exclusion</th>
</tr>
</thead>
<tbody>
<tr>
<td>Study designs<break/>Randomized controlled trial<break/>Controlled clinical trial<break/>Cohort study<break/>Case-control study<break/>*English and French articles only</td>
<td>Study designs<break/>Case-series / case report<break/>Uncontrolled cohort studies<break/>Data (graphic) without a mean and SD<break/>Sample size of less than 5 patients per treatment group<break/>Studies with more than 20% drop out rate</td>
</tr>
<tr>
<td>Population<break/>Out/inpatients<break/>Osteoarthritis of all human joints (incl. TMJ; except vertebral column)<break/>Chronic versus acute conditions?<break/>Age groups &gt; 18 yrs old<break/>Mixed population:<break/> - OA and RA only AND<break/> - only if RA is in majority</td>
<td>Population<break/>Cancer (and other Oncologic conditions)<break/>Cardiac conditions<break/>Dermatologic conditions<break/>Healthy normals<break/>Juvenile Arthritis<break/>Mixed population (other than OA and/or RA).<break/>Multiple conditions<break/>Neurologic conditions<break/>Pediatric conditions (no juvenile arthritis)<break/>Psychiatric conditions<break/>Pulmonary conditions<break/>Scoliosis</td>
</tr>
<tr>
<td>Intervention<break/><underline>Eligible control groups</underline>: placebo, untreated, sham, active physiotherapy treatments, educative pamphlets (not surgery, not drugs or injections)<break/>- Chiropractic interventions (manipulation, mobilization, manual therapy)<break/><underline>Eligible concurrent interventions</underline>:<break/> Acupuncture<break/> Assistive devices<break/> Balneotherapy<break/> Conservation of energy<break/> Electroanalgesia and other electrotherapy including electrical stimulation, TENS ultrasound, laser, diathermy<break/> Ice/heat (thermotherapy)<break/> Intensity of rehabilitation<break/> Manual therapy<break/> Neuromuscular re-education<break/> Patient education<break/> Splinting and orthoses<break/> Therapeutic exercises including post-surgery, and swimming pool exercise<break/> - Multiple concurrent interventions (‘physiotherapy’ including ice, heat, massage, TENS, ultrasound, combinations etc.)</td>
<td>Intervention<break/>- Bilateral interventions (if systemic effects)<break/>- Neck and back interventions<break/>- Multidisciplinary, functional restoration programmes<break/>- Surgery of shoulder, knee, neck and low back (i.e. not the effect of the surgery, but the effect of post-surgery physiotherapy intervention is eligible, e.g. CPM, exercises, thermotherapy, etc.)<break/>- Medication (e.g. phonophoresis with meds)<break/>- Thermal biofeedback</td>
</tr>
<tr>
<td>Outcomes<break/>Absenteeism, sick leave, return to work (if available)<break/>Balance status<break/>Cardio-pulmonary functions<break/>Coordination status<break/>Costs (economics)<break/>Disease activity<break/>Edema<break/>EMG activity<break/>Erythrocyte sedimentation rate (ESR)<break/>Flexibility<break/>Functional status, activities of daily living *(self-care activities)<break/>Gait status<break/>Girth, volume<break/>Inflammation<break/>Joint imaging<break/>Medication intake (if reported)<break/>Muscle strength, endurance and power<break/>Pain<break/>Patient satisfaction<break/>Postural assessment<break/>Quality of life<break/>Range of motion, flexibility, mobility<break/>Side effects (if reported)<break/>Swelling</td>
<td>Outcomes<break/>- Biochemical measures<break/>- Patient compliance to medication<break/>- Psychosocial measures (depression, home and community activities, leisure, social roles, sexual functions)<break/>- Serum markers (except ESR)</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="section3-0017896911419346">
<title>Literature search</title>
<p>A structured literature search was developed by the library scientist, based on the sensitive search strategy for randomized controlled trials (RCTs) recommended by the Cochrane Collaboration and modifications proposed by Haynes and colleagues.<sup><xref ref-type="bibr" rid="bibr10-0017896911419346">10</xref></sup> The Cochrane Collaboration method is used to minimize bias through a systematic approach to the literature search, study selection, and data extraction and synthesis. Being an a priori search, it was focused around the condition and interventions, rather than the outcomes (<xref ref-type="table" rid="table4-0017896911419346">Appendix 1</xref>). For this reason, we did not have control over the outcomes chosen by the authors.</p>
<p>The search strategy was expanded to identify other comparative controlled, case-control, cohort, and nonrandomized studies. The library scientist searched the electronic databases of MEDLINE, EMBASE, Current Contents, the Cumulative Index to Nursing and Allied Health (CINAHL), SUMSearch, and the Cochrane Controlled Trials Register up to June 2010. Additionally, the registries of the Cochrane Field of Rehabilitation and Related Therapies, the Cochrane Musculoskeletal Group, the Physiotherapy Evidence Database (PEDro), and the University of Ottawa EBCPGs Web site were searched. The reference lists of all of the included trials were searched for relevant studies and content experts were contacted for additional studies.</p>
<sec id="section4-0017896911419346">
<title>Study inclusion/exclusion criteria</title>
<sec id="section5-0017896911419346">
<title>Type of intervention</title>
<p>Patient education included different approaches such as cognitive-behaviour, behaviour modification and different strategies such as health education, social support techniques and combinations of these strategies. Teaching was home or health-centre based and was performed in groups or on a one-on-one basis. Group treatments were professionally led. Comparison interventions that were acceptable included traditional care, no education treatment (including waiting list and geographically-distant controls), reduced comprehensiveness of education (e.g. reduced number of sessions, lack of follow-up after educational sessions common to both controls and experimental groups, receipt of only educational summary), or use of educational literature for self-management. Concurrent therapies (such as exercise and treatments) were accepted only if they were provided to both the experimental and control groups. Studies in which patients served as their own controls were excluded. No limitations based on methodological quality were imposed a priori, though the quality of comparative controlled studies was considered when grading the recommendations resulting from our analysis. Head-to-head studies (comparison of two active interventions) were generally rejected because the goal was to make a recommendation about a specific intervention. Head-to-head comparisons of teaching versus didactic information and participatory versus didactic education studies were included as this was determined relevant to RA rehabilitation practice.</p>
</sec>
<sec id="section6-0017896911419346">
<title>Type of study designs</title>
<p>All original comparative controlled studies that evaluated specific educational interventions with patients with RA were included. This included RCTs, controlled clinical trials (CCTs), cohort studies, and case-control studies. Crossover studies were included, and to avoid potential confounders, data from only the first part of the study (pre-crossover) were included. Excluded studies were those with an uncontrolled cohort design (no comparison group), case series design, and eligible studies with dropout rates greater than 20% or a sample size less than five patients per group. Where full text articles were unavailable, even from the authors, abstracts were excluded because they were unable to furnish sufficient data for analysis. Trials published in languages other than English and French were excluded due to the time and cost involved in translation.</p>
</sec>
<sec id="section7-0017896911419346">
<title>Type of participants</title>
<p>The studies included were those with samples of adult patients (18 years of age and older) diagnosed with RA according to the criteria of the 1987 American Rheumatism Association (ARA). Acute and chronic RA were both included in the different clinical trials studied, sometimes appearing in the same trial. However, wherever possible, the recommendations specify whether the intervention is appropriate for chronic or acute conditions. The recommendations also include classification of functional capacity in patients with RA described as: (1) complete functional capacity with ability to carry out all usual duties without handicaps; (2) functional capacity adequate to conduct normal activities despite the handicap of discomfort or limited mobility of one or more joints; (3) functional capacity adequate to perform only a few or none of the duties of usual occupation of or of self-care; or (4) largely or completely incapacitated, with the patient bed-ridden or wheelchair-bound, permitting little or no self-care.<sup><xref ref-type="bibr" rid="bibr12-0017896911419346">12</xref></sup> In cases of recommendations where disease severity or functional severity are not mentioned, it is because the trial on which the recommendation was based did not indicate degree of severity (<xref ref-type="app" rid="app1-0017896911419346">Appendix 2</xref>).</p>
<p>Studies were excluded if they contained samples of patients with RA concurrently having back or neck problems, due to the numerous and varied associated signs and symptoms of these conditions. In addition, spine disorders were not considered for inclusion because the Philadelphia Panel had recently developed guidelines for back and neck pain.<sup><xref ref-type="bibr" rid="bibr13-0017896911419346">13</xref>, <xref ref-type="bibr" rid="bibr14-0017896911419346">14</xref></sup> Further exclusion criteria included studies of patients who had recently had surgery or who had one of the following conditions: (1) other rheumatologic or musculoskeletal problems, such as tendonitis, bursitis, or fractures; (2) major medical problems that could interfere with the rehabilitation process or incapacitate functional status; or (3) psychiatric conditions. Studies of subjects without known pathology or impairments were also excluded. Studies of patients with mixed arthritic conditions were excluded unless the mixed conditions were RA and osteoarthritis (OA) and only then if the case mix contained at least 75% patients with RA. Further inclusion and exclusion criteria are given in <xref ref-type="table" rid="table1-0017896911419346">Table 1</xref>.</p>
</sec>
<sec id="section8-0017896911419346">
<title>Type of outcomes</title>
<p>To measure effectiveness, validated and reliable outcomes were selected based on the recommendations of the conference on Outcome Measures for Rheumatoid Arthritis Clinical Trials (OMERACT)<sup><xref ref-type="bibr" rid="bibr15-0017896911419346">15</xref></sup> and by the theoretical framework for rehabilitation application.<sup><xref ref-type="bibr" rid="bibr16-0017896911419346">16</xref></sup> The a priori outcomes were selected according to the Philadelphia Panel recommendations,<sup><xref ref-type="bibr" rid="bibr7-0017896911419346">7</xref></sup> as well as from the Canadian Physiotherapy Association’s ‘Physical Rehabilitation Outcome Measures (PROM II)’<sup><xref ref-type="bibr" rid="bibr17-0017896911419346">17</xref></sup> and RIFSSSO’s ‘Répertoire des outils d’évaluation en français pour la réadaptation’.<sup><xref ref-type="bibr" rid="bibr18-0017896911419346">18</xref></sup> Outcomes that were psychosocial (e.g. depression) and physiological (e.g. cardiopulmonary capacity) were excluded. Further details are found in <xref ref-type="table" rid="table1-0017896911419346">Table 1</xref>.</p>
</sec>
<sec id="section9-0017896911419346">
<title>Study selection</title>
<p>Two independent reviewers appraised the studies of the literature search and created an individual list of all the articles in the database with a reason for their inclusion or exclusion. In cases of uncertainty about an article after reading the abstract, the reviewers read the article in full before making the determination. Where there were inconsistent findings, the two independent lists of articles were checked for inclusion/exclusion reasons by a senior reviewer who is an expert in RA. In the next stage of inclusion/exclusion determination, the pair of reviewers retrieved the articles initially screened for inclusion and assessed the full articles for final inclusion or exclusion from the study.</p>
</sec></sec>
<sec id="section10-0017896911419346">
<title>Data extraction and methodological quality assessment</title>
<p>Using pre-determined data extraction forms, each of the reviewers independently extracted data on the population characteristics, details of the interventions, trial design, allocation concealment, and outcomes. Methodological quality was assessed using the Jadad Scale, a five-point scale reported to be valid and reliable that assigns two points each for randomization and double-blinding and one point for description of withdrawals.<sup><xref ref-type="bibr" rid="bibr19-0017896911419346">19</xref></sup> A Jadad scale score below 3 (&lt; 3) will be considered as being of low methodological quality, while a Jadad score of 3 or more (≥ 3) will be classified as high quality study. The Ottawa Panel approved to the inclusion of CCSs that had a score of &lt; 3 if they met the inclusion and exclusion criteria. Consequently, the Ottawa Panel focused more on the randomization component of the Jadad scale. Quality scores from the Jadad scale were used to interpret the results and, if any discrepancies in the data extraction and scoring of methodological quality occurred, the leading methodologist was consulted to resolve such disparity. Studies that failed to successfully meet the methodological criteria illustrated in the inclusion and exclusion table (<xref ref-type="table" rid="table2-0017896911419346">Table 2</xref>) and that were categorized by the Ottawa Panel as poor methodological quality trials were reassigned to the list of excluded studies. The Cochrane Collaboration methodology was used to generate the figures.<sup><xref ref-type="bibr" rid="bibr20-0017896911419346">20</xref></sup></p>
<table-wrap id="table2-0017896911419346" position="float">
<label>Table 2.</label>
<caption>
<p>Grading recommendations<sup><xref ref-type="table-fn" rid="table-fn2-0017896911419346">a</xref></sup></p>
</caption>
<graphic alternate-form-of="table2-0017896911419346" xlink:href="10.1177_0017896911419346-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Grade</th>
<th align="left">Clinical importance</th>
<th align="left">Statistical importance</th>
<th align="left">Study design</th>
</tr>
</thead>
<tbody>
<tr>
<td>A</td>
<td>≥ 15%</td>
<td><italic>P</italic> &lt; .05</td>
<td>RCT (single or meta-analysis)</td>
</tr>
<tr>
<td>B</td>
<td>≥ 15%</td>
<td><italic>P</italic> &lt; .05</td>
<td>CCT or observational (single or meta-analysis)</td>
</tr>
<tr>
<td>C+</td>
<td>≥ 15%</td>
<td>Not significant</td>
<td>RCT/CCT or observational (single or meta-analysis)</td>
</tr>
<tr>
<td>C</td>
<td>&lt; 15%</td>
<td>Not significant</td>
<td>Any study design</td>
</tr>
<tr>
<td>D</td>
<td>&lt; 15% (favours control)</td>
<td>Not significant</td>
<td>Any study design</td>
</tr>
<tr>
<td>D+</td>
<td>&lt; 15% (favours control)</td>
<td>Not significant</td>
<td>RCT/CCT or observational (single or meta-analysis)</td>
</tr>
<tr>
<td>D−</td>
<td>≥ 15% (favours control)</td>
<td><italic>P</italic> &lt; .05 (favors control)</td>
<td>Well-designed RCT with &gt;100 patients (if &lt;100 patients, becomes grade D)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0017896911419346">
<p><italic>Notes</italic>: RCT = randomized controlled trial, CCT = controlled clinical trial.</p>
</fn>
<fn id="table-fn2-0017896911419346">
<label>a</label>
<p>Reprinted with permission of the American Physical Therapy Association from: Ottawa Panel Evidence-Based Clinical Practice</p>
</fn>
<fn id="table-fn3-0017896911419346">
<p>Guidelines for Aerobic Fitness Exercises in the Management of Fibromyalgia: Part 1. <italic>Phys Ther</italic>, 2008: <bold>88</bold>: 857–871.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>Clinical improvement was defined as 15% improvement compared to a control, based on previous work relating to musculoskeletal rehabilitation<sup><xref ref-type="bibr" rid="bibr21-0017896911419346">21</xref></sup> as well as consensus.<sup><xref ref-type="bibr" rid="bibr7-0017896911419346">7</xref></sup> For dichotomous data, the relative percentage of improvement was taken to be the difference in the percentage of improvement between the intervention and the control groups.<sup><xref ref-type="bibr" rid="bibr22-0017896911419346">22</xref></sup></p>
</sec>
<sec id="section11-0017896911419346">
<title>Reviewing the guidelines</title>
<p>The guidelines were externally reviewed by practitioners in order to assess clinical usefulness and ensure relevance of the findings.<sup><xref ref-type="bibr" rid="bibr23-0017896911419346">23</xref></sup> Feedback was solicited from five practitioners who were currently working with patients with RA. These practitioners, selected from clinical settings in Ottawa and Toronto regions, included a physical therapist, an occupational therapist, a physiatrist, a family physician and a rheumatologist. The practitioners were asked to comment on four questions for each guideline: whether the recommendation was clear, whether they agreed with the recommendation, whether they felt that the literature search on patient education was relevant and complete, and whether the results of the trials in the guidelines were interpreted according to their understanding of the data.</p>
</sec></sec>
<sec id="section12-0017896911419346" sec-type="results">
<title>Results</title>
<sec id="section13-0017896911419346">
<title>Literature search</title>
<p>The literature search identified 118 articles potentially relevant based on the selection criteria for RA only. Of these, 28 articles<sup><xref ref-type="bibr" rid="bibr24-0017896911419346">24</xref><xref ref-type="bibr" rid="bibr25-0017896911419346"/><xref ref-type="bibr" rid="bibr26-0017896911419346"/><xref ref-type="bibr" rid="bibr27-0017896911419346"/><xref ref-type="bibr" rid="bibr28-0017896911419346"/><xref ref-type="bibr" rid="bibr29-0017896911419346"/><xref ref-type="bibr" rid="bibr30-0017896911419346"/><xref ref-type="bibr" rid="bibr31-0017896911419346"/><xref ref-type="bibr" rid="bibr32-0017896911419346"/><xref ref-type="bibr" rid="bibr33-0017896911419346"/><xref ref-type="bibr" rid="bibr34-0017896911419346"/><xref ref-type="bibr" rid="bibr35-0017896911419346"/><xref ref-type="bibr" rid="bibr36-0017896911419346"/><xref ref-type="bibr" rid="bibr37-0017896911419346"/><xref ref-type="bibr" rid="bibr38-0017896911419346"/><xref ref-type="bibr" rid="bibr39-0017896911419346"/><xref ref-type="bibr" rid="bibr40-0017896911419346"/><xref ref-type="bibr" rid="bibr41-0017896911419346"/><xref ref-type="bibr" rid="bibr42-0017896911419346"/><xref ref-type="bibr" rid="bibr43-0017896911419346"/><xref ref-type="bibr" rid="bibr44-0017896911419346"/><xref ref-type="bibr" rid="bibr45-0017896911419346"/><xref ref-type="bibr" rid="bibr46-0017896911419346"/><xref ref-type="bibr" rid="bibr47-0017896911419346"/><xref ref-type="bibr" rid="bibr48-0017896911419346"/><xref ref-type="bibr" rid="bibr49-0017896911419346"/><xref ref-type="bibr" rid="bibr50-0017896911419346"/>–<xref ref-type="bibr" rid="bibr51-0017896911419346">51</xref></sup> met the selection criteria for patient education interventions and were included (<xref ref-type="table" rid="table3-0017896911419346">Table 3</xref>). The other 90 studies<sup><xref ref-type="bibr" rid="bibr52-0017896911419346">52</xref><xref ref-type="bibr" rid="bibr53-0017896911419346"/><xref ref-type="bibr" rid="bibr54-0017896911419346"/><xref ref-type="bibr" rid="bibr55-0017896911419346"/><xref ref-type="bibr" rid="bibr56-0017896911419346"/><xref ref-type="bibr" rid="bibr57-0017896911419346"/><xref ref-type="bibr" rid="bibr58-0017896911419346"/><xref ref-type="bibr" rid="bibr59-0017896911419346"/><xref ref-type="bibr" rid="bibr60-0017896911419346"/><xref ref-type="bibr" rid="bibr61-0017896911419346"/><xref ref-type="bibr" rid="bibr62-0017896911419346"/><xref ref-type="bibr" rid="bibr63-0017896911419346"/><xref ref-type="bibr" rid="bibr64-0017896911419346"/><xref ref-type="bibr" rid="bibr65-0017896911419346"/><xref ref-type="bibr" rid="bibr66-0017896911419346"/><xref ref-type="bibr" rid="bibr67-0017896911419346"/><xref ref-type="bibr" rid="bibr68-0017896911419346"/><xref ref-type="bibr" rid="bibr69-0017896911419346"/><xref ref-type="bibr" rid="bibr70-0017896911419346"/><xref ref-type="bibr" rid="bibr71-0017896911419346"/><xref ref-type="bibr" rid="bibr72-0017896911419346"/><xref ref-type="bibr" rid="bibr73-0017896911419346"/><xref ref-type="bibr" rid="bibr74-0017896911419346"/><xref ref-type="bibr" rid="bibr75-0017896911419346"/><xref ref-type="bibr" rid="bibr76-0017896911419346"/><xref ref-type="bibr" rid="bibr77-0017896911419346"/><xref ref-type="bibr" rid="bibr78-0017896911419346"/><xref ref-type="bibr" rid="bibr79-0017896911419346"/><xref ref-type="bibr" rid="bibr80-0017896911419346"/><xref ref-type="bibr" rid="bibr81-0017896911419346"/><xref ref-type="bibr" rid="bibr82-0017896911419346"/><xref ref-type="bibr" rid="bibr83-0017896911419346"/><xref ref-type="bibr" rid="bibr84-0017896911419346"/><xref ref-type="bibr" rid="bibr85-0017896911419346"/><xref ref-type="bibr" rid="bibr86-0017896911419346"/><xref ref-type="bibr" rid="bibr87-0017896911419346"/><xref ref-type="bibr" rid="bibr88-0017896911419346"/><xref ref-type="bibr" rid="bibr89-0017896911419346"/><xref ref-type="bibr" rid="bibr90-0017896911419346"/><xref ref-type="bibr" rid="bibr91-0017896911419346"/><xref ref-type="bibr" rid="bibr92-0017896911419346"/><xref ref-type="bibr" rid="bibr93-0017896911419346"/><xref ref-type="bibr" rid="bibr94-0017896911419346"/><xref ref-type="bibr" rid="bibr95-0017896911419346"/><xref ref-type="bibr" rid="bibr96-0017896911419346"/><xref ref-type="bibr" rid="bibr97-0017896911419346"/><xref ref-type="bibr" rid="bibr98-0017896911419346"/><xref ref-type="bibr" rid="bibr99-0017896911419346"/><xref ref-type="bibr" rid="bibr100-0017896911419346"/><xref ref-type="bibr" rid="bibr101-0017896911419346"/><xref ref-type="bibr" rid="bibr102-0017896911419346"/><xref ref-type="bibr" rid="bibr103-0017896911419346"/><xref ref-type="bibr" rid="bibr104-0017896911419346"/><xref ref-type="bibr" rid="bibr105-0017896911419346"/><xref ref-type="bibr" rid="bibr106-0017896911419346"/><xref ref-type="bibr" rid="bibr107-0017896911419346"/><xref ref-type="bibr" rid="bibr108-0017896911419346"/><xref ref-type="bibr" rid="bibr109-0017896911419346"/><xref ref-type="bibr" rid="bibr110-0017896911419346"/><xref ref-type="bibr" rid="bibr111-0017896911419346"/><xref ref-type="bibr" rid="bibr112-0017896911419346"/><xref ref-type="bibr" rid="bibr113-0017896911419346"/><xref ref-type="bibr" rid="bibr114-0017896911419346"/><xref ref-type="bibr" rid="bibr115-0017896911419346"/><xref ref-type="bibr" rid="bibr116-0017896911419346"/><xref ref-type="bibr" rid="bibr117-0017896911419346"/><xref ref-type="bibr" rid="bibr118-0017896911419346"/><xref ref-type="bibr" rid="bibr119-0017896911419346"/><xref ref-type="bibr" rid="bibr120-0017896911419346"/><xref ref-type="bibr" rid="bibr121-0017896911419346"/><xref ref-type="bibr" rid="bibr122-0017896911419346"/><xref ref-type="bibr" rid="bibr123-0017896911419346"/><xref ref-type="bibr" rid="bibr124-0017896911419346"/><xref ref-type="bibr" rid="bibr125-0017896911419346"/><xref ref-type="bibr" rid="bibr126-0017896911419346"/><xref ref-type="bibr" rid="bibr127-0017896911419346"/><xref ref-type="bibr" rid="bibr128-0017896911419346"/><xref ref-type="bibr" rid="bibr129-0017896911419346"/><xref ref-type="bibr" rid="bibr130-0017896911419346"/><xref ref-type="bibr" rid="bibr131-0017896911419346"/><xref ref-type="bibr" rid="bibr132-0017896911419346"/><xref ref-type="bibr" rid="bibr133-0017896911419346"/><xref ref-type="bibr" rid="bibr134-0017896911419346"/><xref ref-type="bibr" rid="bibr135-0017896911419346"/><xref ref-type="bibr" rid="bibr136-0017896911419346"/><xref ref-type="bibr" rid="bibr137-0017896911419346"/><xref ref-type="bibr" rid="bibr138-0017896911419346"/><xref ref-type="bibr" rid="bibr139-0017896911419346"/><xref ref-type="bibr" rid="bibr140-0017896911419346"/>–<xref ref-type="bibr" rid="bibr141-0017896911419346">141</xref></sup> were excluded (results not shown) for various reasons: 28 studies<sup><xref ref-type="bibr" rid="bibr53-0017896911419346">53</xref><xref ref-type="bibr" rid="bibr54-0017896911419346"/>–<xref ref-type="bibr" rid="bibr55-0017896911419346">55</xref>, <xref ref-type="bibr" rid="bibr57-0017896911419346">57</xref>, <xref ref-type="bibr" rid="bibr61-0017896911419346">61</xref>, <xref ref-type="bibr" rid="bibr74-0017896911419346">74</xref>, <xref ref-type="bibr" rid="bibr75-0017896911419346">75</xref>, <xref ref-type="bibr" rid="bibr78-0017896911419346">78</xref>, <xref ref-type="bibr" rid="bibr84-0017896911419346">84</xref>, <xref ref-type="bibr" rid="bibr89-0017896911419346">89</xref>, <xref ref-type="bibr" rid="bibr90-0017896911419346">90</xref>, <xref ref-type="bibr" rid="bibr109-0017896911419346">109</xref><xref ref-type="bibr" rid="bibr55-0017896911419346"/>–<xref ref-type="bibr" rid="bibr113-0017896911419346">113</xref>, <xref ref-type="bibr" rid="bibr115-0017896911419346">115</xref>, <xref ref-type="bibr" rid="bibr117-0017896911419346">117</xref>, <xref ref-type="bibr" rid="bibr118-0017896911419346">118</xref>, <xref ref-type="bibr" rid="bibr120-0017896911419346">120</xref><xref ref-type="bibr" rid="bibr121-0017896911419346"/>–<xref ref-type="bibr" rid="bibr122-0017896911419346">122</xref>, <xref ref-type="bibr" rid="bibr125-0017896911419346">125</xref>, <xref ref-type="bibr" rid="bibr127-0017896911419346">127</xref>, <xref ref-type="bibr" rid="bibr129-0017896911419346">129</xref>, <xref ref-type="bibr" rid="bibr133-0017896911419346">133</xref>, <xref ref-type="bibr" rid="bibr139-0017896911419346">139</xref>, <xref ref-type="bibr" rid="bibr141-0017896911419346">141</xref></sup> were not appropriate PE interventions; there was a &lt; 75% proportion of RA patients<sup><xref ref-type="bibr" rid="bibr56-0017896911419346">56</xref>, <xref ref-type="bibr" rid="bibr62-0017896911419346">62</xref>, <xref ref-type="bibr" rid="bibr66-0017896911419346">66</xref>, <xref ref-type="bibr" rid="bibr72-0017896911419346">72</xref>, <xref ref-type="bibr" rid="bibr76-0017896911419346">76</xref>, <xref ref-type="bibr" rid="bibr77-0017896911419346">77</xref>, <xref ref-type="bibr" rid="bibr80-0017896911419346">80</xref>, <xref ref-type="bibr" rid="bibr81-0017896911419346">81</xref>, <xref ref-type="bibr" rid="bibr83-0017896911419346">83</xref>, <xref ref-type="bibr" rid="bibr93-0017896911419346">93</xref>, <xref ref-type="bibr" rid="bibr95-0017896911419346">95</xref>, <xref ref-type="bibr" rid="bibr97-0017896911419346">97</xref>, <xref ref-type="bibr" rid="bibr100-0017896911419346">100</xref>, <xref ref-type="bibr" rid="bibr101-0017896911419346">101</xref>, <xref ref-type="bibr" rid="bibr104-0017896911419346">104</xref>, <xref ref-type="bibr" rid="bibr105-0017896911419346">105</xref>, <xref ref-type="bibr" rid="bibr107-0017896911419346">107</xref>, <xref ref-type="bibr" rid="bibr131-0017896911419346">131</xref></sup> or unconfirmed diagnosis<sup><xref ref-type="bibr" rid="bibr71-0017896911419346">71</xref></sup> in 19 studies; nine studies<sup><xref ref-type="bibr" rid="bibr60-0017896911419346">60</xref>, <xref ref-type="bibr" rid="bibr68-0017896911419346">68</xref>, <xref ref-type="bibr" rid="bibr70-0017896911419346">70</xref>, <xref ref-type="bibr" rid="bibr86-0017896911419346">86</xref>, <xref ref-type="bibr" rid="bibr87-0017896911419346">87</xref>, <xref ref-type="bibr" rid="bibr99-0017896911419346">99</xref>, <xref ref-type="bibr" rid="bibr103-0017896911419346">103</xref>, <xref ref-type="bibr" rid="bibr134-0017896911419346">134</xref>, <xref ref-type="bibr" rid="bibr135-0017896911419346">135</xref></sup> were literature review; 15 studies did not have sufficient data studies<sup><xref ref-type="bibr" rid="bibr52-0017896911419346">52</xref>, <xref ref-type="bibr" rid="bibr56-0017896911419346">56</xref>, <xref ref-type="bibr" rid="bibr69-0017896911419346">69</xref>, <xref ref-type="bibr" rid="bibr73-0017896911419346">73</xref>, <xref ref-type="bibr" rid="bibr79-0017896911419346">79</xref>, <xref ref-type="bibr" rid="bibr88-0017896911419346">88</xref>, <xref ref-type="bibr" rid="bibr106-0017896911419346">106</xref>, <xref ref-type="bibr" rid="bibr108-0017896911419346">108</xref>, <xref ref-type="bibr" rid="bibr126-0017896911419346">126</xref>, <xref ref-type="bibr" rid="bibr127-0017896911419346">127</xref>, <xref ref-type="bibr" rid="bibr130-0017896911419346">130</xref>, <xref ref-type="bibr" rid="bibr136-0017896911419346">136</xref>, <xref ref-type="bibr" rid="bibr138-0017896911419346">138</xref></sup> or a had a drop-out rate<sup><xref ref-type="bibr" rid="bibr94-0017896911419346">94</xref></sup> greater than 20%; seven<sup><xref ref-type="bibr" rid="bibr58-0017896911419346">58</xref>, <xref ref-type="bibr" rid="bibr82-0017896911419346">82</xref>, <xref ref-type="bibr" rid="bibr92-0017896911419346">92</xref>, <xref ref-type="bibr" rid="bibr96-0017896911419346">96</xref>, <xref ref-type="bibr" rid="bibr98-0017896911419346">98</xref>, <xref ref-type="bibr" rid="bibr132-0017896911419346">132</xref>, <xref ref-type="bibr" rid="bibr140-0017896911419346">140</xref></sup> studies had no control group; outcomes could not be used in five studies;<sup><xref ref-type="bibr" rid="bibr64-0017896911419346">64</xref>, <xref ref-type="bibr" rid="bibr85-0017896911419346">85</xref>, <xref ref-type="bibr" rid="bibr91-0017896911419346">91</xref>, <xref ref-type="bibr" rid="bibr102-0017896911419346">102</xref>, <xref ref-type="bibr" rid="bibr119-0017896911419346">119</xref></sup> six<sup><xref ref-type="bibr" rid="bibr63-0017896911419346">63</xref>, <xref ref-type="bibr" rid="bibr65-0017896911419346">65</xref>, <xref ref-type="bibr" rid="bibr114-0017896911419346">114</xref>, <xref ref-type="bibr" rid="bibr116-0017896911419346">116</xref>, <xref ref-type="bibr" rid="bibr124-0017896911419346">124</xref>, <xref ref-type="bibr" rid="bibr137-0017896911419346">137</xref></sup> were not clinical trials, and two<sup><xref ref-type="bibr" rid="bibr67-0017896911419346">67</xref>, <xref ref-type="bibr" rid="bibr123-0017896911419346">123</xref></sup> others were published in a language other than English or French.</p>
<table-wrap id="table3-0017896911419346" position="float">
<label>Table 3.</label>
<caption>
<p>Evidence based clinical practice guidelines for patient education in the management of rheumatoid arthritis</p>
</caption>
<graphic alternate-form-of="table3-0017896911419346" xlink:href="10.1177_0017896911419346-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th/>
<th/>
<th align="left">Description of trial</th>
<th align="left">Study design and <italic>N</italic></th>
<th align="left">Grade A</th>
<th align="left">Grade C+</th>
<th align="left">Grade C</th>
<th align="left">Grade D</th>
<th align="left">Grade D+</th>
</tr>
</thead>
<tbody>
<tr>
<td>Only education programme</td>
<td>Knudson et al.<sup><xref ref-type="bibr" rid="bibr33-0017896911419346">33</xref></sup><break/>Jadad score: 1</td>
<td>6 sessions of 1 hr group EP (on exercises, disease, medication, assistive devices) vs. no intervention</td>
<td>CCT<break/><italic>N</italic> = 12</td>
<td>N/A</td>
<td>Compliance (1 mth and FU 3 mths)</td>
<td>N/A</td>
<td>N/A</td>
<td>N/A</td>
</tr>
<tr>
<td/>
<td>Taal et al.<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup><break/>Jadad score: 2</td>
<td>5 sessions of 2 hr<break/>Group EP (Arthritis Self-Management Course) vs. no EP, only referred to a PT</td>
<td>RCT<break/><italic>N</italic> = 75</td>
<td>Compliance to exercise (FU 1 wk, 3 and 15 mths)<break/>Arthritis knowledge (FU 1 wk, 5 and 13 mths)<break/>Tender joint count (FU 5 and 13 mths)</td>
<td>Dexterity (FU 5 mths)</td>
<td>Endurance (FU 13 mths)<break/>Self-efficacy (FU 1 wk, 13 mths)<break/>HAQ Disability (FU 1 wk, 5 and 13 mths)<break/>Dexterity (FU 1 wk, 13 mths)<break/>Physical activity (FU 5 mths)<break/>Pain relief AIMS (FU 1 wk)<break/>Pain relief ASE (FU 1 wk, 5 and 13 mths)<break/>Function (FU 1 wk, 5 and 13 mths)<break/>Other symptoms (FU 1 kw, 13 mths)</td>
<td>Physical activity (FU1 1 wk, 13 mths)<break/>Pain relief AIMS (FU 5 mths, 13 mths)<break/>Endurance (FU 1 wk)<break/>Self-efficacy (FU 5 mths)<break/>Other symptoms (FU 5 mths)</td>
<td>Endurance (FU 5 mths)</td>
</tr>
<tr>
<td/>
<td>Potts et al.<sup><xref ref-type="bibr" rid="bibr46-0017896911419346">46</xref></sup><break/>Jadad score: 0</td>
<td>4 sessions of 90 min<break/>Group EP (discussion on topics that arose spontaneously) vs. no EP</td>
<td>CCT<break/><italic>N</italic> = 38</td>
<td>N/A</td>
<td>N/A</td>
<td>Arthritis knowledge (6 mth)</td>
<td>Compliance exercise (FU 1 and 6 mths) Arthritis knowledge (1 mth)</td>
<td>N/A</td>
</tr>
<tr>
<td/>
<td>Helliwell et al.<sup><xref ref-type="bibr" rid="bibr32-0017896911419346">32</xref></sup><break/>Jadad score: 2</td>
<td>4 sessions of 2 hr<break/>Group EP (group information on disease) vs. no intervention</td>
<td>RCT<break/><italic>N</italic> = 79</td>
<td>Arthritis knowledge (1 and 12 mths)</td>
<td>N/A</td>
<td>Functional status (12 mths)</td>
<td>Functional status (1 mth)<break/>Ritchie articular index (1 and 12 mths)</td>
<td>N/A</td>
</tr>
<tr>
<td/>
<td>Lindroth et a.l<sup><xref ref-type="bibr" rid="bibr35-0017896911419346">35</xref></sup><break/>Jadad score: 1</td>
<td>6 sessions of 150 min<break/>Group EP (information on medical aspects, pain management, exercise, available treatments, stress-managements, joint protection, nutrition, leisure) vs. no intervention</td>
<td>CCT<break/><italic>N</italic> = 200</td>
<td>N/A</td>
<td>Functional status HAQ (FU 12 mths)</td>
<td>Pain relief (FU 12 mths)</td>
<td>N/A</td>
<td>N/A</td>
</tr>
<tr>
<td/>
<td>McAuley<sup><xref ref-type="bibr" rid="bibr39-0017896911419346">39</xref></sup><break/>Jadad score: 0</td>
<td>1 session<break/>Participatory style leadership group teaching<break/>(joint protection, energy conservation, relaxation and exercise) vs. summary of participatory leadership teaching only</td>
<td>RCT<break/><italic>N</italic> = 22</td>
<td>N/A</td>
<td>N/A</td>
<td>Quality of life (5 wks)</td>
<td>Pain relief (5 wks)<break/>Patient global assessment (5 wks)</td>
<td>N/A</td>
</tr>
<tr>
<td/>
<td>Niedermann<sup><xref ref-type="bibr" rid="bibr41-0017896911419346">41</xref></sup><break/>Jadad score: 2</td>
<td>4 sessions/week for 3 months of joint protection education (PRISM tasks, theories of social learning and self-management., burden of illness, resources, set goals and homework tasks) vs. Conventional JP education</td>
<td>RCT<break/><italic>N</italic> = 54</td>
<td>Joint behaviour assessment (3 mths)</td>
<td>Arthritis self-efficacy scale (3 mths)<break/>Pain relief (3 mths)</td>
<td>Joint protection self-efficacy scale (3 mths)<break/>Hospital anxiety and depression scale (HADS-D) (3 mths),<break/>Hospital anxiety and depression scale (HADS-A) (3 mths)<break/>Disease activity (3 mths)</td>
<td>Grip strength (3 mths)</td>
<td>N/A</td>
</tr>
<tr>
<td>Educational behavioural programme</td>
<td>Kraaimaat et al.<sup><xref ref-type="bibr" rid="bibr34-0017896911419346">34</xref></sup><break/>Jadad score: 2</td>
<td>10 sessions of 2 hr group EP and booklet (biomedical concepts, energy conservation, joint protection, assistive devices, exercises with self-management of active coping behaviour) vs. no intervention</td>
<td>RCT<break/><italic>N</italic> = 77</td>
<td>N/A</td>
<td>N/A</td>
<td>Quality of life mobility (10 wks)<break/>Quality of life self-care (10 wks)</td>
<td>Mobility (6 mths)<break/>Self-care (6 mths)<break/>Pain (10 wks, 6 mths)</td>
<td>N/A</td>
</tr>
<tr>
<td/>
<td>Strauss et al.<sup><xref ref-type="bibr" rid="bibr49-0017896911419346">49</xref></sup><break/>Jadad<break/>score: 2</td>
<td>6 months group EP (behavioural approach with role-playing, relaxation) vs. no intervention</td>
<td>RCT<break/><italic>N</italic> = 37</td>
<td>N/A</td>
<td>N/A</td>
<td>Functional status (3 and 12 mths)</td>
<td>N/A</td>
<td>N/A</td>
</tr>
<tr>
<td/>
<td>Parker et al.<sup><xref ref-type="bibr" rid="bibr42-0017896911419346">42</xref></sup><break/>Jadad score: 2</td>
<td>7 hr<break/>Group EP (RA disease, basic therapies, medication, joint protection, energy conservation, coping with psychosocial<break/>stresses and quackery) vs. no EP, only OT and PT sessions.</td>
<td>RCT<break/><italic>N</italic> = 22</td>
<td>N/A</td>
<td>N/A</td>
<td>Quality of life AIMS Exercise (1 mth)</td>
<td>Quality of life<break/>Pain (1 and 3 mths)<break/>Exercise (3 mth)</td>
<td/>
</tr>
<tr>
<td/>
<td>Parker et al.<sup><xref ref-type="bibr" rid="bibr44-0017896911419346">44</xref></sup><break/>Jadad score: 3</td>
<td>10 sessions of 1.5 hr<break/>Individual EP (specific stressors, coping strategies, assessment of life goals, management of pain and emotional distress, life change, self-esteem, and optimization of social relationships) vs. no EP, only standard care</td>
<td>RCT<break/><italic>N</italic> = 149</td>
<td>N/A</td>
<td>N/A</td>
<td>Pain relief (15 mths)</td>
<td>N/A</td>
<td>Pain relief (6 wks and 3 mths)</td>
</tr>
<tr>
<td/>
<td>Hammond et al.<sup><xref ref-type="bibr" rid="bibr31-0017896911419346">31</xref></sup><break/>Jadad score: 3</td>
<td>5 2hr meetings per week for group EP with behavioural modification (self-management with educational strategies), 8 2.5 hr meetings for lifestyle<break/>education programme vs. lifestyle programme over 3–9 months</td>
<td>RCT<break/><italic>N</italic> = 167</td>
<td>N/A</td>
<td>Early morning stiffness (12 mths)</td>
<td>Pain relief (12 mths)<break/>Fatigue (12 mths)<break/>Perceived Health (12 mths)<break/>RA self-efficacy (12 mths)<break/>Self-efficacy (12 mths)<break/>Self-efficacy other symptoms (12 mths)<break/>Psychological distress<break/>arthritis helplessness (index and perceived control)</td>
<td>Psychological distress (12 mths)<break/>Helplessness (12 mths)</td>
<td>Functional Status 12 mths)</td>
</tr>
<tr>
<td/>
<td>Hammond et al.<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup><break/>Jadad score: 3</td>
<td>4 sessions of 2 hr<break/>group EP (joint protection arthritis education using educational behavioural teaching methods) vs. standard arthritis education</td>
<td>RCT<break/><italic>N</italic> = 127</td>
<td>Psychological well-being (6 and 12 mths)<break/>Pain relief (12 mths)<break/>Disease activity – stiffness (12 mths)<break/>Physician global assessment (6 and 12 mths)<break/>Patient global assessment (6 and 12 mths)<break/>Quality of life (12 mths)</td>
<td>Disease activity – stiffness (6 mths and 12 months)<break/>Tender joint count (6 and 12 mths)<break/>Swollen (6 mths)</td>
<td>Pain relief (6 mths)<break/>Grip Force (6 and 12 mths)<break/>Mobility (6 and 12 mths)<break/>Quality of life (6 and 12 mths)<break/>Stiffness (6 mths)<break/>Self-efficacy (6 and 12 mths)</td>
<td>Quality of life (6 mths)<break/>Self-efficacy (6 mths)</td>
<td>N/A</td>
</tr>
<tr>
<td/>
<td>Hammond et al.<sup><xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref></sup><break/>Jadad score: 3</td>
<td>4 sessions of 2 hr<break/>Group EP (Joint protection arthritis education using educational behavioural teaching methods) vs. standard arthritis education</td>
<td>RCT<break/><italic>N</italic> = 127</td>
<td>Psychological well-being (48 mths)<break/>Disease activity – stiffness (48 mths)</td>
<td>Quality of life (48 mths)<break/>Joint tender count (48 mths)</td>
<td>Disease activity – swollen (48 months)<break/>Patient global assessment (48 mths)<break/>Grip Force (48 mths)<break/>Self-efficacy<break/>Pain relief (48 mths)<break/>Swollen (48 mths)</td>
<td>Self-efficacy (48 mths)</td>
<td>Quality of life (48 mths)</td>
</tr>
<tr>
<td/>
<td>Mathieux<sup><xref ref-type="bibr" rid="bibr38-0017896911419346">38</xref></sup><break/>Jadad score: 2</td>
<td>3 months of educational strategies EP (one-to-one teaching and group teaching) vs no intervention</td>
<td>RCT<break/><italic>N</italic> = 60</td>
<td>Grip force of the dominant hand (3 mths)<break/>Grip force of the non-dominant hand (3 mths)</td>
<td>N/A</td>
<td>N/A</td>
<td>Health assessment questionnaire score (3 mths)</td>
<td>N/A</td>
</tr>
<tr>
<td><bold>Self-Instructional Education</bold></td>
<td>Riemsma et al.<sup><xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup><break/>Jadad score: 2</td>
<td>6 months<break/>Education material(on RA, conservation of energy, medical information, self-help programme and modeling) vs. traditional care</td>
<td>RCT<break/><italic>N</italic> = 216</td>
<td>Compliance (1 and 19 mths)<break/>Endurance (19 mths)<break/>Disease activity – Swollen (19 mth)</td>
<td>N/A</td>
<td>Mobility (1 mth)<break/>Physical activity (1 and 19 mths)<break/>Pain (1 mth)<break/>Dexterity (1 mth) Walking speed (1 mth)<break/>Grip Force (1 mth)<break/>Arthritis knowledge<break/>(19 mth)<break/>Ritchie Index (1 mth)<break/>Disease activity – Swollen (1 mth)<break/>Self-efficacy-ASE function and other symptoms (1 mth)</td>
<td>Functional status (1 and 19 mths)<break/>Walking speed (19 mths)<break/>Endurance (1 mth)<break/>Arthritis knowledge (1 mth)<break/>Pain relief (19 mths)<break/>Mobility (19 mth)<break/>Physical activity (1 mths)<break/>Dexterity (19 mths)<break/>Grip Force (19 mths)<break/>Pain - Ritchie Index (19 mths)<break/>Self-efficacy - ASE function and other symptoms (19 mths)</td>
<td>N/A</td>
</tr>
<tr>
<td/>
<td/>
<td>6 mth<break/>Coordinated educational material plus passport (on RA, conservation of energy, medical information, self-help programme and modeling) vs. traditional care</td>
<td/>
<td>N/A</td>
<td>Compliance (FU 19 mths)</td>
<td>Dexterity (FU 1 mth)<break/>Grip Force (FU 1 mth)<break/>Disease activity – swollen (FU 1 and 19 mths)<break/>ASE Pain (FU 1 mth)<break/>ASE other symptoms (FU 1 mth)</td>
<td>Functional status (FU 1 mth and 19 mths)<break/>Walking speed (FU 1 mth)<break/>Mobility (FU 1 mth and 19 mths)<break/>ASE Physical activity(FU 1 mth and 19 mths)<break/>Endurance (FU 19 mths)<break/>Force<break/>Arthritis knowledge (FU 1 mth and 19 mths)<break/>Pain relief Ritchie Index (FU 1 mth)<break/>ASE Pain (FU 19 mths)<break/>ASE function (FU 1 and 19 mths) and other symptoms (FU 19 mths)</td>
<td>Walking speed (FU 19 mth)<break/>Compliance (FU 1 mth)<break/>Dexterity (FU 19 mths)<break/>ASE Pain relief (FU 19 mths)<break/>Endurance (FU 1 mth)<break/>Grip Force (FU 19 mth)<break/>Pain - Ritchie Index (FU 19 mths)</td>
</tr>
<tr>
<td/>
<td>Barlow et al.<sup><xref ref-type="bibr" rid="bibr24-0017896911419346">24</xref></sup><break/>Jadad score: 2</td>
<td>1 mail-out leaflet for intervention group only (disease related information) vs no intervention</td>
<td>RCT<break/><italic>N</italic> = 84</td>
<td>Arthritis knowledge (3 wks and 6 mths)</td>
<td>ASE Pain (3 wks)</td>
<td>Pain intensity VAS (3 wks and 6 mths)<break/>Self-efficacy<break/>ASE Pain (6 mths)<break/>ASE other symptoms (3 wks and 6 mths)</td>
<td>N/A</td>
<td>N/A</td>
</tr>
<tr>
<td/>
<td>Bell et al.<sup><xref ref-type="bibr" rid="bibr25-0017896911419346">25</xref></sup><break/>Jadad score: 2</td>
<td>4 sessions of 1 hr Home-visits and brochures (teaching on educational strategies covering the RA disease process, general principles of RA disease management, medications, nutrition, exercise, and access to community resources vs. no intervention</td>
<td>RCT<break/><italic>N</italic> = 150</td>
<td>N/A</td>
<td>N/A</td>
<td>Tender joint count (6 wks and 3 mhs)<break/>Grip force (3 mths)<break/>Arthritis knowledge (6 wks and 3 mths)<break/>Disease activity – Morning stiffness (6 wks and 3 mths)<break/>ASE Pain (6 wks and 3 mths)<break/>ASE other symptoms (6 wks and 3 mths)</td>
<td>Pain relief (6 wks and 3 mths)<break/>Grip force (6 wks)</td>
<td>N/A</td>
</tr>
<tr>
<td/>
<td>Neuberger et al.<sup><xref ref-type="bibr" rid="bibr40-0017896911419346">40</xref></sup><break/>Jadad score: 2</td>
<td>4 sessions of 20 min Self-instruction only (completed LARA self-instructional programme – learning about RA) vs. no intervention</td>
<td>RCT<break/><italic>N</italic> = 53</td>
<td>Arthritis knowledge (4 mths)</td>
<td>Pain relief (4 mths)</td>
<td>N/A</td>
<td>N/A</td>
<td>N/A</td>
</tr>
<tr>
<td/>
<td/>
<td>4 sessions of 20 min Self-instruction plus practice (Completed LARA programme with ROM exercises and joint protection practices) vs. no intervention</td>
<td/>
<td>Arthritis knowledge (4 mths)</td>
<td>Pain relief (4 mths)</td>
<td>N/A</td>
<td>N/A</td>
<td>N/A</td>
</tr>
<tr>
<td/>
<td/>
<td>4 sessions of 20 min<break/>Self-instruction plus practice and contracting (Completed LARA programme with joint protection practices and nurse/patient contracts for target behaviours related to ROM exercises and joint protection practices) vs. no intervention</td>
<td/>
<td>Arthritis knowledge (4 mths)</td>
<td>N/A</td>
<td>Pain relief (4 mths)</td>
<td>N/A</td>
<td>N/A</td>
</tr>
<tr>
<td/>
<td/>
<td>4 sessions of 20 min<break/>Self-instruction only vs. self-instruction plus practice</td>
<td/>
<td>N/A</td>
<td>Arthritis knowledge (4 mths)</td>
<td>Pain relief (4 mths)</td>
<td>N/A</td>
<td>N/A</td>
</tr>
<tr>
<td/>
<td/>
<td>4 sessions of 20 min<break/>Self-instruction plus practice vs. self-instruction plus practice and contracting</td>
<td/>
<td>N/A</td>
<td>Arthritis knowledge (4 mths)<break/>Pain relief (4 mths)</td>
<td>N/A</td>
<td>N/A</td>
<td>N/A</td>
</tr>
<tr>
<td/>
<td>Wetstone et al.<sup><xref ref-type="bibr" rid="bibr51-0017896911419346">51</xref></sup><break/>Jadad score: 1</td>
<td>1 to 4 session(s) of computer based education (on pathophysiology information, medication, energy conservation, joint protection, exercise therapy, and diet) vs. no intervention</td>
<td>RCT<break/><italic>N</italic> = 36</td>
<td>Psychological well-being (1 mth)</td>
<td>N/A</td>
<td>N/A</td>
<td>N/A</td>
<td>N/A</td>
</tr>
<tr>
<td>Education programme combined with group support</td>
<td>Parker et al.<sup><xref ref-type="bibr" rid="bibr43-0017896911419346">43</xref></sup><break/>Jadad score: 3</td>
<td>12 months group EP (coping strategies, comprehensive pain management, overview of RA, theory of pain, medical management, with support group programme) vs. no EP, only routine care</td>
<td>RCT<break/><italic>N</italic> = 83</td>
<td>Pain relief (12 mths)</td>
<td>N/A</td>
<td>Helplessness (12 mths)</td>
<td>N/A</td>
<td>N/A</td>
</tr>
<tr>
<td>Education programme combined exercise</td>
<td>Hammond et al.<sup><xref ref-type="bibr" rid="bibr30-0017896911419346">30</xref></sup><break/>Jadad score: 2</td>
<td>4 of 1 hr individual and 1 of 2 hr group<break/>Occupational therapy plus (information about RA, treatments, management, ADL training, joint protection, energy conservation, posture and positioning advice) with range of motion hand exercises home programme with usual care vs. usual care</td>
<td>RCT<break/><italic>N</italic> = 326</td>
<td>N/A</td>
<td>N/A</td>
<td>Pain relief (6 mths)<break/>Tender joint count (6 mths)<break/>Grip force (12 mths)<break/>Satisfaction (6 and 12 mths)<break/>AIMS2: pain (6 and 12 mths)<break/>AIMS2: other symptoms (6 and 12 mths)<break/>Swollen (12 mths)<break/>Morning Stiffness (24 mths)<break/>Self-efficacy (6 and 12 mths)</td>
<td>Pain relief (12 and 24 mths)<break/>Swollen joint count (12 and 24 mths)<break/>Functional status (12 and 24 mths)<break/>Physical function (6, 12 and 24 mths)<break/>Grip Force (6 and 24 mths)<break/>Satisfaction (6 and 24 mths)<break/>AIMS2: pain (24 mths)<break/>AIMS2: other symptoms (24 mths)<break/>Swollen (6 and 24 mths)<break/>Morning Stiffness (6 and 12 mths)<break/>Self-efficacy (24 mths)</td>
<td>N/A</td>
</tr>
<tr>
<td/>
<td>Siu et al.<sup><xref ref-type="bibr" rid="bibr48-0017896911419346">48</xref></sup><break/>Jadad score: 0</td>
<td>3 months<break/>Group EP (3 phases interventions including (1) orientation - related information on community resources, (2) intervention - develop commitment and action towards self-management including stress management group, a self-management course and a water exercise class, (3) consolidation -translate commitment into coping and continue to maintain a supportive network) vs. no EP, only following orientation phase</td>
<td>CCT<break/><italic>N</italic> = 45</td>
<td>N/A</td>
<td>Psychological well-being (9 mths)<break/>Management of disease in general (9 mths)</td>
<td>Psychological well-being (9 mths)<break/>Pain relief (9 mths)</td>
<td>Functional status (9 mths)<break/>Psychological well-being (9 mths)<break/>Energy and fatigue (9 mths)</td>
<td>N/A</td>
</tr>
<tr>
<td>Education programme combined with self-instruction</td>
<td>Hammond<sup><xref ref-type="bibr" rid="bibr27-0017896911419346">27</xref></sup><break/>Jadad score: 2</td>
<td>4 sessions of 2 hr<break/>Group EP and workbook (joint protection programme with an home visit, using teaching manual and videotape) vs. no intervention</td>
<td>RCT<break/><italic>N</italic> = 35</td>
<td>N/A</td>
<td>Self-efficacy ASE (3 mth)</td>
<td>Grip force (3 mths)<break/>Hand mobility (3 mths)<break/>Functional status (FU 3 mths)<break/>Pain – Tender joint count (3 mths)</td>
<td>Functional status (3 mths)</td>
<td>Functional status (3 mths)</td>
</tr>
<tr>
<td/>
<td>Brus et al.<sup><xref ref-type="bibr" rid="bibr26-0017896911419346">26</xref></sup><break/>Jadad score: 1</td>
<td>6 sessions of 2 hr<break/>Group EP with brochure (on compliance, energy conservation and joint protection with feedback) vs. brochure only (no EP)</td>
<td>RCT<break/><italic>N</italic> = 60</td>
<td>Joint protection (3 mths)</td>
<td>Energy conservation (3, 6 and 12 mths)<break/>Endurance (3 and 12 mths)<break/>Joint protection (6 and 12 mths)<break/>Functional status (3 and 12 mths)</td>
<td>Endurance (6 mths)</td>
<td>Functional status<break/>(6 mths)</td>
<td>N/A</td>
</tr>
<tr>
<td/>
<td>Platt Furst et al.<sup><xref ref-type="bibr" rid="bibr45-0017896911419346">45</xref></sup><break/>Jadad score: 2</td>
<td>6 sessions of 1.5 hr over 6 wk<break/>Group PE (workbook describes body position, rest, activity analysis and joint protection and includes didactic information, illustrations, practice assignments and self-evaluation) vs. participatory education with didactic information</td>
<td>RCT<break/><italic>N</italic> = 28</td>
<td>N/A</td>
<td>Pain relief (3 mths)<break/>Quality of life (3 mths)<break/>Functional status (3 mths)</td>
<td>Functional status (3 mths)<break/>Pain relief (3 mths)</td>
<td>Arthritis knowledge<break/>(3 mths)</td>
<td>N/A</td>
</tr>
<tr>
<td/>
<td>Lindroth<sup><xref ref-type="bibr" rid="bibr36-0017896911419346">36</xref></sup><break/>Jadad score: 2</td>
<td>8 sessions of 2.5 hr group EP and handbook (on exercise, rest, diet, surgery) vs. no EP</td>
<td>RCT<break/><italic>N</italic> = 96</td>
<td>N/A</td>
<td>Functional status<break/>(12 mths)</td>
<td>Compliance (12 mths)<break/>Joint protection (3 and 12 mths)<break/>Pain relief (6 mths)</td>
<td>Pain relief (3 and 12 mths)<break/>Functional status (12 mths)<break/>Compliance (3 mths)</td>
<td>N/A</td>
</tr>
<tr>
<td/>
<td>Masiero et al.<sup><xref ref-type="bibr" rid="bibr37-0017896911419346">37</xref></sup><break/>Jadad score: 2</td>
<td>4 sessions of 3 hr<break/>Group EP (monthly telephone with group discussion, problem solving, guided practice, and lectures, illustrated brochures, home guide) vs. no EP, only usual drug treatment</td>
<td>RCT<break/><italic>N</italic> = 70</td>
<td>Quality of life (8 mths)<break/>Functional status (8 mths)<break/>Psychological status (8 mths)<break/>Disease progression (8months)<break/>Social status (8 mths)<break/>Physical function (8 mths)</td>
<td>N/A</td>
<td>N/A</td>
<td>Pain relief (8 m ths)</td>
<td>N/A</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-0017896911419346">
<p>EP = Education programme</p>
</fn>
<fn id="table-fn5-0017896911419346">
<p>JP = Joint protection</p>
</fn>
<fn id="table-fn6-0017896911419346">
<p><italic>Notes</italic>: To distinguish between interventions within the same study which have received different grades, please see <xref ref-type="app" rid="app1-0017896911419346">Appendix 2</xref> for more clarity.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section14-0017896911419346">
<title>Methodological quality</title>
<p>Out of the 24 included RCTs, there were five studies<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref>, <xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref>, <xref ref-type="bibr" rid="bibr31-0017896911419346">31</xref>, <xref ref-type="bibr" rid="bibr43-0017896911419346">43</xref>, <xref ref-type="bibr" rid="bibr44-0017896911419346">44</xref></sup> with a Jadad score of 3 which was of higher methodological quality (≥ 3). The remaining RCTs were of lower quality (&lt; 3): 16 RCTs <sup><xref ref-type="bibr" rid="bibr24-0017896911419346">24</xref>,<xref ref-type="bibr" rid="bibr25-0017896911419346">25</xref>,<xref ref-type="bibr" rid="bibr27-0017896911419346">27</xref>,<xref ref-type="bibr" rid="bibr30-0017896911419346">30</xref>,<xref ref-type="bibr" rid="bibr32-0017896911419346">32</xref>,<xref ref-type="bibr" rid="bibr34-0017896911419346">34</xref>,<xref ref-type="bibr" rid="bibr36-0017896911419346">36</xref><xref ref-type="bibr" rid="bibr37-0017896911419346"/>–<xref ref-type="bibr" rid="bibr38-0017896911419346">38</xref>, <xref ref-type="bibr" rid="bibr40-0017896911419346">40</xref><xref ref-type="bibr" rid="bibr41-0017896911419346"/>–<xref ref-type="bibr" rid="bibr42-0017896911419346">42</xref>, <xref ref-type="bibr" rid="bibr45-0017896911419346">45</xref>, <xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref>, <xref ref-type="bibr" rid="bibr49-0017896911419346">49</xref>, <xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> had a score of 2/5, two RCTs<sup><xref ref-type="bibr" rid="bibr26-0017896911419346">26</xref>, <xref ref-type="bibr" rid="bibr51-0017896911419346">51</xref></sup> had a score of 1/5, and one RCT<sup><xref ref-type="bibr" rid="bibr39-0017896911419346">39</xref></sup> had a score of 0/5. All four CCTs were of lower quality with two having a score of 1/5<sup><xref ref-type="bibr" rid="bibr33-0017896911419346">33</xref>, <xref ref-type="bibr" rid="bibr35-0017896911419346">35</xref></sup> while the other two CCTs<sup><xref ref-type="bibr" rid="bibr46-0017896911419346">46</xref>, <xref ref-type="bibr" rid="bibr48-0017896911419346">48</xref></sup> had a score of 0/5. No study received the point for ‘double-blind’.</p>
</sec>
<sec id="section15-0017896911419346">
<title>Summary of trials</title>
<p>Twenty four trials (<italic>N</italic> = 3,716)<sup><xref ref-type="bibr" rid="bibr24-0017896911419346">24</xref><xref ref-type="bibr" rid="bibr25-0017896911419346"/><xref ref-type="bibr" rid="bibr26-0017896911419346"/><xref ref-type="bibr" rid="bibr27-0017896911419346"/><xref ref-type="bibr" rid="bibr28-0017896911419346"/><xref ref-type="bibr" rid="bibr29-0017896911419346"/><xref ref-type="bibr" rid="bibr30-0017896911419346"/><xref ref-type="bibr" rid="bibr31-0017896911419346"/><xref ref-type="bibr" rid="bibr32-0017896911419346"/><xref ref-type="bibr" rid="bibr33-0017896911419346"/><xref ref-type="bibr" rid="bibr34-0017896911419346"/><xref ref-type="bibr" rid="bibr35-0017896911419346"/><xref ref-type="bibr" rid="bibr36-0017896911419346"/><xref ref-type="bibr" rid="bibr37-0017896911419346"/><xref ref-type="bibr" rid="bibr38-0017896911419346"/><xref ref-type="bibr" rid="bibr39-0017896911419346"/><xref ref-type="bibr" rid="bibr40-0017896911419346"/><xref ref-type="bibr" rid="bibr41-0017896911419346"/><xref ref-type="bibr" rid="bibr42-0017896911419346"/><xref ref-type="bibr" rid="bibr43-0017896911419346"/><xref ref-type="bibr" rid="bibr44-0017896911419346"/><xref ref-type="bibr" rid="bibr45-0017896911419346"/><xref ref-type="bibr" rid="bibr46-0017896911419346"/><xref ref-type="bibr" rid="bibr47-0017896911419346"/><xref ref-type="bibr" rid="bibr48-0017896911419346"/><xref ref-type="bibr" rid="bibr49-0017896911419346"/><xref ref-type="bibr" rid="bibr50-0017896911419346"/>–<xref ref-type="bibr" rid="bibr51-0017896911419346">51</xref></sup> measured the effectiveness of patient education for people diagnosed with RA. Eight trials examined the effectiveness of a cognitive behavioural programme.<sup><xref ref-type="bibr" rid="bibr31-0017896911419346">31</xref>, <xref ref-type="bibr" rid="bibr33-0017896911419346">33</xref>, <xref ref-type="bibr" rid="bibr35-0017896911419346">35</xref>, <xref ref-type="bibr" rid="bibr42-0017896911419346">42</xref><xref ref-type="bibr" rid="bibr43-0017896911419346"/>–<xref ref-type="bibr" rid="bibr44-0017896911419346">44</xref>, <xref ref-type="bibr" rid="bibr49-0017896911419346">49</xref>, <xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> Fourteen trials assessed the effectiveness of an educational-behavioural programme.<sup><xref ref-type="bibr" rid="bibr27-0017896911419346">27</xref><xref ref-type="bibr" rid="bibr28-0017896911419346"/><xref ref-type="bibr" rid="bibr29-0017896911419346"/>–<xref ref-type="bibr" rid="bibr30-0017896911419346">30</xref>, <xref ref-type="bibr" rid="bibr32-0017896911419346">32</xref>, <xref ref-type="bibr" rid="bibr35-0017896911419346">35</xref><xref ref-type="bibr" rid="bibr36-0017896911419346"/><xref ref-type="bibr" rid="bibr37-0017896911419346"/><xref ref-type="bibr" rid="bibr38-0017896911419346"/>–<xref ref-type="bibr" rid="bibr39-0017896911419346">39</xref>, <xref ref-type="bibr" rid="bibr41-0017896911419346">41</xref>, <xref ref-type="bibr" rid="bibr45-0017896911419346">45</xref>, <xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref>, <xref ref-type="bibr" rid="bibr48-0017896911419346">48</xref></sup> Four trials examined the effectiveness of a self-instructional education programme.<sup><xref ref-type="bibr" rid="bibr24-0017896911419346">24</xref>, <xref ref-type="bibr" rid="bibr25-0017896911419346">25</xref>, <xref ref-type="bibr" rid="bibr40-0017896911419346">40</xref>, <xref ref-type="bibr" rid="bibr51-0017896911419346">51</xref></sup> One study measured the effectiveness of educational support groups,<sup><xref ref-type="bibr" rid="bibr46-0017896911419346">46</xref></sup> while the remaining trial examined the effectiveness of an intervention involving the combination of education, exercise and medication<sup><xref ref-type="bibr" rid="bibr26-0017896911419346">26</xref></sup> (<xref ref-type="table" rid="table3-0017896911419346">Table 3</xref>; <xref ref-type="app" rid="app1-0017896911419346">Appendix 2</xref>).</p>
<p>In the trials of cognitive behavioural programmes,<sup><xref ref-type="bibr" rid="bibr31-0017896911419346">31</xref>, <xref ref-type="bibr" rid="bibr33-0017896911419346">33</xref>, <xref ref-type="bibr" rid="bibr35-0017896911419346">35</xref>, <xref ref-type="bibr" rid="bibr42-0017896911419346">42</xref><xref ref-type="bibr" rid="bibr43-0017896911419346"/>–<xref ref-type="bibr" rid="bibr44-0017896911419346">44</xref>, <xref ref-type="bibr" rid="bibr49-0017896911419346">49</xref>, <xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> a grade of A was demonstrated for pain relief (<xref ref-type="fig" rid="fig1-0017896911419346">Figure 1</xref>; see <xref ref-type="app" rid="app1-0017896911419346">Appendix 2</xref>),<sup><xref ref-type="bibr" rid="bibr43-0017896911419346">43</xref>, <xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> compliance<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> and arthritis knowledge.<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> A grade of C+ was demonstrated for early morning stiffness,<sup><xref ref-type="bibr" rid="bibr31-0017896911419346">31</xref></sup> compliance,<sup><xref ref-type="bibr" rid="bibr33-0017896911419346">33</xref></sup> quality of life,<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> and pain relief.<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> A grade of C was demonstrated for pain relief,<sup><xref ref-type="bibr" rid="bibr31-0017896911419346">31</xref>, <xref ref-type="bibr" rid="bibr44-0017896911419346">44</xref></sup> fatrigue,<sup><xref ref-type="bibr" rid="bibr31-0017896911419346">31</xref></sup> perceived health,<sup><xref ref-type="bibr" rid="bibr31-0017896911419346">31</xref></sup> RA self-effiacy,<sup><xref ref-type="bibr" rid="bibr31-0017896911419346">31</xref>, <xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> self-efficacy (end of treatment),<sup><xref ref-type="bibr" rid="bibr31-0017896911419346">31</xref></sup> psychological distress,<sup><xref ref-type="bibr" rid="bibr31-0017896911419346">31</xref></sup> arthritis helplessness,<sup><xref ref-type="bibr" rid="bibr31-0017896911419346">31</xref>, <xref ref-type="bibr" rid="bibr43-0017896911419346">43</xref></sup> quality of life,<sup><xref ref-type="bibr" rid="bibr35-0017896911419346">35</xref>, <xref ref-type="bibr" rid="bibr42-0017896911419346">42</xref>, <xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> functional status,<sup><xref ref-type="bibr" rid="bibr49-0017896911419346">49</xref></sup> and endurance.<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> A grade of D was demonstrated for quality of life.<sup><xref ref-type="bibr" rid="bibr35-0017896911419346">35</xref></sup> A grade of D+ was demonstrated for functional status,<sup><xref ref-type="bibr" rid="bibr31-0017896911419346">31</xref></sup> quality of life,<sup><xref ref-type="bibr" rid="bibr42-0017896911419346">42</xref></sup> and pain relief.<sup><xref ref-type="bibr" rid="bibr44-0017896911419346">44</xref></sup></p>
<fig id="fig1-0017896911419346" position="float">
<label>Figure 1.</label>
<caption>
<p>(WMD) Treatment vs. control: pain relief [vas pain (0–10cm)] at the end of a three week to 15 month patient education programmes (intervention period)</p>
</caption>
<graphic xlink:href="10.1177_0017896911419346-fig1.tif"/>
</fig>
<p>In the trials of educational-behavioural programmes,<sup><xref ref-type="bibr" rid="bibr27-0017896911419346">27</xref><xref ref-type="bibr" rid="bibr28-0017896911419346"/><xref ref-type="bibr" rid="bibr29-0017896911419346"/>–<xref ref-type="bibr" rid="bibr30-0017896911419346">30</xref>, <xref ref-type="bibr" rid="bibr32-0017896911419346">32</xref>, <xref ref-type="bibr" rid="bibr35-0017896911419346">35</xref><xref ref-type="bibr" rid="bibr36-0017896911419346"/><xref ref-type="bibr" rid="bibr37-0017896911419346"/><xref ref-type="bibr" rid="bibr38-0017896911419346"/>–<xref ref-type="bibr" rid="bibr39-0017896911419346">39</xref>, <xref ref-type="bibr" rid="bibr41-0017896911419346">41</xref>, <xref ref-type="bibr" rid="bibr45-0017896911419346">45</xref>, <xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref>, <xref ref-type="bibr" rid="bibr48-0017896911419346">48</xref></sup> a grade of A was demonstrated for psychological well-being,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref>, <xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref></sup> pain relief,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref>, <xref ref-type="bibr" rid="bibr39-0017896911419346">39</xref></sup> disease activity (<xref ref-type="fig" rid="fig2-0017896911419346">Figure 2</xref>; see <xref ref-type="app" rid="app1-0017896911419346">Appendix 2</xref>),<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref>, <xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref></sup> physician global assessment,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup> patient global assessment,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup> arthritis knowledge,<sup><xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref></sup> functional status,<sup><xref ref-type="bibr" rid="bibr37-0017896911419346">37</xref></sup> grip strength (dominant hand),<sup><xref ref-type="bibr" rid="bibr38-0017896911419346">38</xref></sup> grip strength (non-dominant hand),<sup><xref ref-type="bibr" rid="bibr38-0017896911419346">38</xref></sup> joint behaviour assessment,<sup><xref ref-type="bibr" rid="bibr41-0017896911419346">41</xref></sup> and quality of life.<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref>, <xref ref-type="bibr" rid="bibr37-0017896911419346">37</xref>, <xref ref-type="bibr" rid="bibr39-0017896911419346">39</xref></sup> A grade of C+ was demonstrated for self-efficacy,<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> pain relief,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref>, <xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref>, <xref ref-type="bibr" rid="bibr41-0017896911419346">41</xref>, <xref ref-type="bibr" rid="bibr45-0017896911419346">45</xref></sup> disease activity,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref>, <xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup> quality of life,<sup><xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref>, <xref ref-type="bibr" rid="bibr45-0017896911419346">45</xref>, <xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup> functional status,<sup><xref ref-type="bibr" rid="bibr35-0017896911419346">35</xref>, <xref ref-type="bibr" rid="bibr45-0017896911419346">45</xref></sup> arthritis self efficacy scale,<sup><xref ref-type="bibr" rid="bibr41-0017896911419346">41</xref></sup> compliance,<sup><xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup> endurance,<sup><xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup> psychological well-being,<sup><xref ref-type="bibr" rid="bibr48-0017896911419346">48</xref></sup> and management of disease.<sup><xref ref-type="bibr" rid="bibr48-0017896911419346">48</xref></sup> A grade of C was demonstrated for pain relief,<sup><xref ref-type="bibr" rid="bibr27-0017896911419346">27</xref><xref ref-type="bibr" rid="bibr28-0017896911419346"/><xref ref-type="bibr" rid="bibr29-0017896911419346"/>–<xref ref-type="bibr" rid="bibr30-0017896911419346">30</xref>, <xref ref-type="bibr" rid="bibr35-0017896911419346">35</xref>, <xref ref-type="bibr" rid="bibr45-0017896911419346">45</xref>, <xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref>, <xref ref-type="bibr" rid="bibr48-0017896911419346">48</xref></sup> disease activity,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref><xref ref-type="bibr" rid="bibr29-0017896911419346"/>–<xref ref-type="bibr" rid="bibr30-0017896911419346">30</xref>, <xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup> grip force,<sup><xref ref-type="bibr" rid="bibr27-0017896911419346">27</xref><xref ref-type="bibr" rid="bibr28-0017896911419346"/><xref ref-type="bibr" rid="bibr29-0017896911419346"/>–<xref ref-type="bibr" rid="bibr30-0017896911419346">30</xref>, <xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup> hand mobility,<sup><xref ref-type="bibr" rid="bibr27-0017896911419346">27</xref>, <xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup>, quality of life,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref>, <xref ref-type="bibr" rid="bibr30-0017896911419346">30</xref>, <xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup> self-efficacy,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref><xref ref-type="bibr" rid="bibr29-0017896911419346"/>–<xref ref-type="bibr" rid="bibr30-0017896911419346">30</xref>, <xref ref-type="bibr" rid="bibr41-0017896911419346">41</xref>, <xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup> patient global assessment,<sup><xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref>, <xref ref-type="bibr" rid="bibr39-0017896911419346">39</xref></sup> functional status,<sup><xref ref-type="bibr" rid="bibr27-0017896911419346">27</xref>, <xref ref-type="bibr" rid="bibr32-0017896911419346">32</xref>, <xref ref-type="bibr" rid="bibr36-0017896911419346">36</xref>, <xref ref-type="bibr" rid="bibr45-0017896911419346">45</xref></sup> joint protection,<sup><xref ref-type="bibr" rid="bibr36-0017896911419346">36</xref>, <xref ref-type="bibr" rid="bibr41-0017896911419346">41</xref></sup> hospital anxiety and depression scale (HADS-D),<sup><xref ref-type="bibr" rid="bibr41-0017896911419346">41</xref></sup> hospital anxiety and depression scale (HADS-A),<sup><xref ref-type="bibr" rid="bibr41-0017896911419346">41</xref></sup> arthritis knowledge,<sup><xref ref-type="bibr" rid="bibr45-0017896911419346">45</xref>, <xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup> mobility,<sup><xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup> and psychological well being.<sup><xref ref-type="bibr" rid="bibr48-0017896911419346">48</xref></sup> A grade of D was demonstrated for psychological well being,<sup><xref ref-type="bibr" rid="bibr48-0017896911419346">48</xref></sup> quality of life,<sup><xref ref-type="bibr" rid="bibr30-0017896911419346">30</xref>, <xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref>, <xref ref-type="bibr" rid="bibr48-0017896911419346">48</xref></sup> self-efficacy,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref>, <xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref>, <xref ref-type="bibr" rid="bibr30-0017896911419346">30</xref>, <xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup> pain relief,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref><xref ref-type="bibr" rid="bibr29-0017896911419346"/>–<xref ref-type="bibr" rid="bibr30-0017896911419346">30</xref>, <xref ref-type="bibr" rid="bibr32-0017896911419346">32</xref>, <xref ref-type="bibr" rid="bibr36-0017896911419346">36</xref>, <xref ref-type="bibr" rid="bibr37-0017896911419346">37</xref>, <xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup> arthritis knowledge,<sup><xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup> grip force,<sup><xref ref-type="bibr" rid="bibr30-0017896911419346">30</xref>, <xref ref-type="bibr" rid="bibr41-0017896911419346">41</xref>, <xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup>endurance,<sup><xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup> mobility,<sup><xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup> functional status,<sup><xref ref-type="bibr" rid="bibr30-0017896911419346">30</xref>, <xref ref-type="bibr" rid="bibr32-0017896911419346">32</xref>, <xref ref-type="bibr" rid="bibr36-0017896911419346">36</xref>, <xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup>and disease activity.<sup><xref ref-type="bibr" rid="bibr30-0017896911419346">30</xref>, <xref ref-type="bibr" rid="bibr41-0017896911419346">41</xref></sup> A grade of D+ was demonstrated for functional status,<sup><xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref>, <xref ref-type="bibr" rid="bibr48-0017896911419346">48</xref></sup> self-efficacy,<sup><xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup> pain relief,<sup><xref ref-type="bibr" rid="bibr27-0017896911419346">27</xref>, <xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup>grip force,<sup><xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup> endurance,<sup><xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup> mobility,<sup><xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup> compliance,<sup><xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup> and quality of life.<sup><xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref>, <xref ref-type="bibr" rid="bibr30-0017896911419346">30</xref>, <xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup></p>
<fig id="fig2-0017896911419346" position="float">
<label>Figure 2.</label>
<caption>
<p>(WMD)Joint protection education vs. standard education: disease activity [early morning stiffness (minutes)] at six to 48 month follow-up of a patient education programmes</p>
</caption>
<graphic xlink:href="10.1177_0017896911419346-fig2.tif"/>
</fig>
<p>In the trials of self-instructional education programmes,<sup><xref ref-type="bibr" rid="bibr24-0017896911419346">24</xref>, <xref ref-type="bibr" rid="bibr25-0017896911419346">25</xref>, <xref ref-type="bibr" rid="bibr40-0017896911419346">40</xref>, <xref ref-type="bibr" rid="bibr51-0017896911419346">51</xref></sup> a grade of A was demonstrated for arthritis knowledge<sup><xref ref-type="bibr" rid="bibr24-0017896911419346">24</xref>, <xref ref-type="bibr" rid="bibr40-0017896911419346">40</xref></sup> and psychological well-being.<sup><xref ref-type="bibr" rid="bibr51-0017896911419346">51</xref></sup> A grade of C+ was demonstrated for self efficacy,<sup><xref ref-type="bibr" rid="bibr24-0017896911419346">24</xref></sup> disease activity,<sup><xref ref-type="bibr" rid="bibr25-0017896911419346">25</xref></sup> pain relief,<sup><xref ref-type="bibr" rid="bibr40-0017896911419346">40</xref></sup> and arthritis knowledge.<sup><xref ref-type="bibr" rid="bibr40-0017896911419346">40</xref></sup> A grade of C was demonstrated for pain relief,<sup><xref ref-type="bibr" rid="bibr24-0017896911419346">24</xref>, <xref ref-type="bibr" rid="bibr25-0017896911419346">25</xref>, <xref ref-type="bibr" rid="bibr40-0017896911419346">40</xref></sup> self efficacy,<sup><xref ref-type="bibr" rid="bibr24-0017896911419346">24</xref>, <xref ref-type="bibr" rid="bibr25-0017896911419346">25</xref></sup> disease activity,<sup><xref ref-type="bibr" rid="bibr24-0017896911419346">24</xref>, <xref ref-type="bibr" rid="bibr25-0017896911419346">25</xref></sup> and arthritis knowledge.<sup><xref ref-type="bibr" rid="bibr25-0017896911419346">25</xref></sup> A grade of D was demonstrated for both pain relief<sup><xref ref-type="bibr" rid="bibr25-0017896911419346">25</xref></sup> and grip force.<sup><xref ref-type="bibr" rid="bibr25-0017896911419346">25</xref></sup></p>
<p>The single trial which consisted of education and support groups<sup><xref ref-type="bibr" rid="bibr46-0017896911419346">46</xref></sup> demonstrated a grade of C+ for compliance, a C for arthritis knowledge, a D for compliance and a D+ for arthritis knowledge. The other single trial which included education, exercise and medications<sup><xref ref-type="bibr" rid="bibr26-0017896911419346">26</xref></sup> demonstrated a grade of A for joint protection, a C+ for energy conservation, endurance and joint protection, a grade of C for functional status and endurance and finally a grade of D for functional status.</p>
</sec></sec>
<sec id="section16-0017896911419346" sec-type="discussion">
<title>Discussion</title>
<p>The Ottawa Panel brought to light a significant number of EBCPGs on patient education for rheumatoid arthritis. Five different education programmes were identified: cognitive-behavioural programme, educational-behavioural programme, self-instructional education, combined educational programme and support group as well as combined education programme, exercise and medication intake.</p>
<p>Strong evidence (Grades A: <italic>n</italic> = 35 and C+: <italic>n</italic> = 29) revealed that each of the five patient education programmes identified is an appropriate intervention to treat RA patients, especially to reduce disease activity, morning stiffness, pain intensity, and to increase grip force, endurance, exercise compliance, to develop knowledge on the illness, to improve functional status, joint protection, energy conversation, self-efficacy, patient as well as physician global assessment, to enhance psychological well-being and quality of life (QOL). These recommendations (Grades A and C+) had both clinical importance and statistical significance or clinical importance only (Grade C+). Among the remaining recommendations, 96 were graded C, 73 were graded D, and 12 were graded D+.</p>
<p>The results of this paper show that a wide variety of educational programmes can be adopted by health care professionals. Among the articles that lead to EBCPGs recommendations, most of the studies were group educational programmes which include a handout, workbook, or leaflet given to participants.<sup><xref ref-type="bibr" rid="bibr27-0017896911419346">27</xref><xref ref-type="bibr" rid="bibr28-0017896911419346"/>–<xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref>, <xref ref-type="bibr" rid="bibr32-0017896911419346">32</xref>, <xref ref-type="bibr" rid="bibr33-0017896911419346">33</xref>, <xref ref-type="bibr" rid="bibr35-0017896911419346">35</xref>, <xref ref-type="bibr" rid="bibr37-0017896911419346">37</xref>, <xref ref-type="bibr" rid="bibr39-0017896911419346">39</xref>, <xref ref-type="bibr" rid="bibr43-0017896911419346">43</xref>, <xref ref-type="bibr" rid="bibr46-0017896911419346">46</xref>, <xref ref-type="bibr" rid="bibr48-0017896911419346">48</xref></sup> Content of the interventions usually covered the pathophysiology of RA, joint protection, rest and positioning, pain management, energy conservation, exercises and medication. An example of the content and handout given to participants is the leaflet produced by the Arthritis and Rheumatism Council (ARC) used in Barlow et al.<sup><xref ref-type="bibr" rid="bibr24-0017896911419346">24</xref></sup> and Hammond et al.<sup><xref ref-type="bibr" rid="bibr27-0017896911419346">27</xref></sup></p>
<p>The sessions were generally given by a combination of health care professionals and other hospital staff such as physicians (e.g. rheumatologist or generalist), occupational therapists, physiotherapists, nurses, clinician psychologists, and social workers.<sup><xref ref-type="bibr" rid="bibr25-0017896911419346">25</xref><xref ref-type="bibr" rid="bibr26-0017896911419346"/><xref ref-type="bibr" rid="bibr27-0017896911419346"/><xref ref-type="bibr" rid="bibr28-0017896911419346"/>–<xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref>, <xref ref-type="bibr" rid="bibr33-0017896911419346">33</xref>, <xref ref-type="bibr" rid="bibr34-0017896911419346">34</xref>, <xref ref-type="bibr" rid="bibr44-0017896911419346">44</xref><xref ref-type="bibr" rid="bibr45-0017896911419346"/>–<xref ref-type="bibr" rid="bibr46-0017896911419346">46</xref></sup> There was less variability for the number of sessions as well as for the duration of the education programmes. On average, the studies that lead to recommendations were given about four sessions, for a total of length of eight hours.</p>
<p>However, there is a trend to be explored in future studies. The outcomes obtained seem to be in relation to the nature of the educational programme and its specific components. For instance, educational programmes which involved exercises and joint protection instructions seems to have a positive impact on joint protection as well as those which involved self-instructional programmes seem to produce a positive impact on self-efficacy, etcetera. The clinical goal setting seemed to be a key element and a prerequisite to implement a successful patient education programme.<sup><xref ref-type="bibr" rid="bibr142-0017896911419346">142</xref></sup></p>
<p>Using systematic review procedures, we were able to extend the findings of Riemsma et al.<sup><xref ref-type="bibr" rid="bibr143-0017896911419346">143</xref>, <xref ref-type="bibr" rid="bibr144-0017896911419346">144</xref></sup> to include studies up to 2010, and we were able to identify the demonstrated impact of these programmes exclusively on patients with RA. Both systematic reviews revealed that educational programmes lead to a significant effect on pain relief when applied during three to 12 weeks, especially when it is measured using a 10cm visual analogue scale (VAS). However, this effect seems to have no retention effect at longer term.</p>
<p>Additionally, the Ottawa Panel recommendations are in concordance with other clinical practice guidelines;<sup><xref ref-type="bibr" rid="bibr145-0017896911419346">145</xref></sup> related to the efficacy of patient education for the management of RA, especially to improve pain, physical activity level, self-efficacy and quality of life, joint protection, and conservation of energy.</p>
</sec>
<sec id="section17-0017896911419346">
<title>Limitations</title>
<p>The primary limitation to this study was the lack of correlation among included programmes. While we were able to generally group studies according to the broad objectives of treatment, the studies within each category varied in regards to length of programme, primary and secondary outcomes, method of delivery, and timing of follow-up. In addition, the majority of included RCTs were of low methodological quality. Since some of the studies are not recent, updated research using better methodology is necessary. Although several of the studies had a description of methods and interventions, more details would be needed to replicate the education programmes.</p>
</sec>
<sec id="section18-0017896911419346">
<title>Implications for practice</title>
<p>Evidence was found by the Ottawa Panel that patient education is an effective intervention to improve the quality of life and significantly change behaviour to have an impact on the different challenges among the population with RA. Since EBCPGs recommendations were based on a wide variety of education programmes, clinicians and multidisciplinary teams have the flexibility to develop their own programmes related to a specific clinical goal setting and still expect to have significant improvement on outcomes. Furthermore, this systematic review supports group education, which could help maximize the time spent by health care professionals to educate RA patients and overcome barriers (e.g. limited staffing and clinical time, funding for programme costs) to implement these programmes in clinical settings.<sup><xref ref-type="bibr" rid="bibr142-0017896911419346">142</xref></sup></p>
</sec>
</body>
<back>
<app-group>
<table-wrap id="table4-0017896911419346" position="float">
<label>Appendix 1</label>
<caption>
<p>Characteristics of included studies</p>
</caption>
<graphic alternate-form-of="table4-0017896911419346" xlink:href="10.1177_0017896911419346-table4.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Author/year</th>
<th align="left">Sample size</th>
<th align="left">Population details</th>
<th align="left">Symptom duration (years)</th>
<th align="left">Age (years) (mean, <italic>SD</italic>)</th>
<th align="left">Treatment</th>
<th align="left">Comparison group</th>
<th align="left">Concurrent therapy</th>
<th align="left">Treatment duration</th>
<th align="left">Follow-up</th>
<th align="left">Quality R, B, W</th>
</tr>
</thead>
<tbody>
<tr>
<td>Barlow<sup><xref ref-type="bibr" rid="bibr24-0017896911419346">24</xref></sup></td>
<td>RCT<break/>Total: 84<break/>Gr1: 42<break/>Gr2: 42</td>
<td>RA</td>
<td>Group 1: mean disease duration: 16.0<break/><italic>SD</italic> = 11.7 Range: 0.47<break/>Group 2: mean disease duration: 18.6<break/><italic>SD</italic> = 12.5 Range: 1–52</td>
<td>Group 1: mean age: 58.3<break/><italic>SD</italic> = 11.3<break/>Group 2: mean age: 58.3<break/><italic>SD</italic> = 10.7</td>
<td>Intervention group received a leaflet through the mail (containing disease-related information)</td>
<td>Control group did not receive leaflet</td>
<td>N/A</td>
<td>1 mail-out of leaflets</td>
<td>6 months</td>
<td>1,0,1</td>
</tr>
<tr>
<td>Bell<sup><xref ref-type="bibr" rid="bibr25-0017896911419346">25</xref></sup></td>
<td>RCT<break/>Total: 150<break/>Gr1: 76<break/>Gr2: 74</td>
<td>RA (referral for a physical therapy intervention, diagnosis of RA confirmed by a physician, disease onset after age 18, first referral to consultation therapy service for the client, ability to read, write and speak English, ability to understand the purpose of the study and provide informed consent, consent 4 or more visits of 3 hours or more from a CTS physical therapist, available for follow-up for the full length of the study, at least 3 of 12 potential</td>
<td>Group 1: mean disease duration: 7.6<break/><italic>SD</italic> = 11.0<break/>Group 2: mean disease duration: 7.4<break/><italic>SD</italic> = 10.0</td>
<td>Group 1: mean age: 57.6<break/><italic>SD</italic> = 11.1<break/>Group 2: mean age: 54.3<break/><italic>SD</italic> = 15.1</td>
<td>Home-based teaching on educational strategies.<break/>The distribution and review of a set of 5 educational brochures covering the RA disease process, general principles of RA disease management, medications, nutrition and exercise, and access to community resources. There was also individual goal setting.</td>
<td>Controls did not receive the same home-based therapy</td>
<td>N/A</td>
<td>Approx. 4 visits</td>
<td>12 weeks</td>
<td>1,0,1</td>
</tr>
<tr>
<td>Brus<sup><xref ref-type="bibr" rid="bibr26-0017896911419346">26</xref></sup></td>
<td>RCT<break/>Total: 60<break/>Gr1: 29<break/>Gr2: 31</td>
<td>RA (suffering from RA – American College of Rheumatology (ACR) criteria – for less than 3 years, 6 or more painful joints and 3 or more swollen joints)</td>
<td>3 or less</td>
<td>Group 1: mean age: 59.7 <italic>SD</italic> = 15.0<break/>Group 2: mean age: 58.7 <italic>SD</italic> = 9.2</td>
<td>Programme focused on compliance, energy conservation and joint protection. Individuals were helped with their problems; feedback was given on eventual implementation.</td>
<td>Control group received a brochure only – not the educational programme.</td>
<td>N/A</td>
<td>6 sessions of 2 hrs</td>
<td>1 yr</td>
<td>0,0,1</td>
</tr>
<tr>
<td>Hammond<sup><xref ref-type="bibr" rid="bibr27-0017896911419346">27</xref></sup></td>
<td>RCT<break/>Total: 35<break/>Gr1: 17<break/>Gr2: 18</td>
<td>Patients with RA, with wrist and/or Meta Carpophalangeal (MCP) involvement, no other medical condition affecting hand function, some restriction in ability to perform daily activities and recreational activities.</td>
<td>Disease duration: 9.83</td>
<td>Total mean age: 55.17</td>
<td>Gr1: Joint protection programme with an optional home visit within two weeks of the end of the programme. (Use of teaching manual and videotape). Self-efficacy group.</td>
<td>Control group receiving no treatment</td>
<td>N/A</td>
<td>4 sessions over a period of 4 weeks. Each session lasting 2 hours.</td>
<td>6 months</td>
<td>1,0,1</td>
</tr>
<tr>
<td>Hammond<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup></td>
<td>RCT<break/>Total: 127<break/>Gr1: 62<break/>Gr2: 65</td>
<td>Aged 18–65 yrs, had been diagnosed with RA within the last 5 yrs, were experiencing hand pain on activity, had no other medical condition affecting hand function and had a history of wrist and or MCP joint pain and inflammation</td>
<td>Group 1: mean of duration 17.52<break/>Group 2 : mean of duration 21.34</td>
<td>Group 1: mean age: range: 49.49<break/>Group 2: mean age: range:<break/>51.56</td>
<td>Joint protection arthritis education programme – using educational- behavioural teaching methods: applied educational, behavioural, motor learning and self-efficacy enhancing strategies.</td>
<td>Standard arthritis education group included joint protection education based on typical UK practice</td>
<td>N/A</td>
<td>4 sessions per week, 2 hours each</td>
<td>6 and 12 months</td>
<td>2,0,1</td>
</tr>
<tr>
<td>Hammond<sup><xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref></sup></td>
<td>RCT<break/>Total: 127<break/>Gr1: 62<break/>Gr2: 65</td>
<td>Aged 18–65 yrs, had been diagnosed with RA within the last 5 yrs, were experiencing hand pain on activity, had no other medical condition affecting hand function and had a history of wrist and or MCP joint pain and inflammation</td>
<td>Group 1: mean of duration<break/>12<break/>Group 2 : mean of duration 14.5</td>
<td>Group 1: mean age: range: 52<break/>Group 2: mean age: range: 51</td>
<td>Joint protection arthritis education programme – using educational- behavioural teaching methods: applied educational, behavioural, motor learning and self-efficacy enhancing strategies.</td>
<td>Standard arthritis education group included joint protection education based on typical UK practice</td>
<td>N/A</td>
<td>4 sessions per week, 2 hrs each</td>
<td>48 months</td>
<td>2,0,1</td>
</tr>
<tr>
<td>Hammond<sup><xref ref-type="bibr" rid="bibr30-0017896911419346">30</xref></sup></td>
<td>RCT<break/>Total: 326<break/>Gr1: 162<break/>Gr2: 164</td>
<td>People with RA were recruited from 11 hospitals in the former North Thames Regional Health Authority. People were eligible to participate if aged over 18 yrs; diagnosed with RA by a consultant rheumatologist within the past 2.5 yrs; required active medical treatment; had had no or minimal OT previously; and could speak and read English adequately to complete assessments.</td>
<td>Group 1: mean of duration 9.0 <italic>SD</italic>: 7.7<break/>Group 2 : mean of duration 9.9 <italic>SD</italic> = 8.8</td>
<td>Group 1: mean age: range: 53.9 <italic>SD</italic>: 13.5<break/>Group 2: mean age: range: 57.1 <italic>SD</italic> = 13.5</td>
<td>Information about RA, its treatment and management; relevant ADL training; joint protection and energy conservation; posture and positioning advice; and a range of movement hand exercise home programme. The group AEP included information on RA, its effects on joints and emphasized self managing symptoms through exercise, joint protection, and energy conservation. Optional programme components to meet an individual’s needs included provision/ recommendation of assistive devices, referral to social services for house adaptations and large equipment, splints (resting and wrist working, thumb, finger or neck as appropriate); upper and lower limb exercises, referring to physiotherapy if needed; basic gait analysis and foot advice, referring to podiatry as necessary; advice on leisure and work; work assessment; advice on benefits, and referral to a social worker as necessary; relaxation training and coping with stress; discussing the effect of RA on relationships and mood; and sexual advice.</td>
<td>Control group did not receive OT</td>
<td>N/A</td>
<td>5 sessions: 4 of 1 hr individual treatment and a 2 hrs group session. The intervention lasted over 1yr</td>
<td>At 6, 12 and 24 months</td>
<td>2, 0, 0</td>
</tr>
<tr>
<td>Hammond<sup><xref ref-type="bibr" rid="bibr31-0017896911419346">31</xref></sup></td>
<td>RCT<break/>Total: 167<break/>Gr1: 81<break/>Gr2: 86</td>
<td>Inclusion: 18 years or older, diagnose RA, early IA, and PSA.<break/>Exclusion: psychological difficulties, mental health care, if they can’t do any physical activity, and finally if they attended previous programmes</td>
<td>Gr1: 7.2 <italic>SD</italic> = 6.68<break/>Gr2: 7.56 <italic>SD</italic> = 7.09</td>
<td>Gr1: 55.56, <italic>SD</italic> = 13.10<break/>55.29, <italic>SD</italic> = 11.84 (mean in years, <italic>SD</italic>)</td>
<td>Educational programme of type self-management, group information, group teaching, with educational strategies. Also, It is a behavioural modification programme. The programme consists of 5–2hr meetings per week. The lifestyle programme consisted of 2 modules each with 4–2.5 hr meetings (this during a 3–9 month period on their own time.) These programmes were established and directed by rehabilitation professionals.</td>
<td>Gr1(standard programme) compared with Gr2( lifestyle programme)</td>
<td>N/A</td>
<td>Standard programme had 5, 2 hr meeting/ week. For the lifestyle programme it consists of 2 modules and review meeting in 3–9 months</td>
<td>N/A</td>
<td>2, 0, 1</td>
</tr>
<tr>
<td>Helliwell<sup><xref ref-type="bibr" rid="bibr32-0017896911419346">32</xref></sup></td>
<td>RCT<break/>Total: 79<break/>Completing study<break/>Gr1: 34<break/>Gr2: 43</td>
<td>RA (received diagnosis less than 5 yrs prior to study, able to read and speak English)</td>
<td>Group 1: mean disease duration: 3.0<break/>Group 2: mean disease duration: 3.5</td>
<td>Group 1: mean age: 55 range: 23–71<break/>Group 2: mean age: 56.5 range: 28–78</td>
<td>Received group information on disease by a non-medical health professional</td>
<td>Control group did not receive educational information</td>
<td>N/A</td>
<td>4 2-hr sessions</td>
<td>1 yr after study</td>
<td>2,0,0</td>
</tr>
<tr>
<td>Knudson<sup><xref ref-type="bibr" rid="bibr33-0017896911419346">33</xref></sup></td>
<td>CCT<break/>Total: 12<break/>Gr1: 6<break/>Gr2: 6</td>
<td>RA (women)</td>
<td>N/A</td>
<td>Group 1 mean age: 52.5<break/>Group 2 mean age: 54.6</td>
<td>Treatment group: 6 one-hr sessions on exercise, disease, meds, assistive devices.</td>
<td>Control group: no education</td>
<td>N/A</td>
<td>6 weekly sessions of one hr</td>
<td>3 months</td>
<td>0,0,1</td>
</tr>
<tr>
<td>Kraaimaat<sup><xref ref-type="bibr" rid="bibr34-0017896911419346">34</xref></sup></td>
<td>RCT<break/>Total: 77</td>
<td>RA (a minimum of 20 yrs of age, duration of illness of at least 1 yr)</td>
<td>15.6 <italic>SD</italic> = 12.4</td>
<td>Mean age: 57 <italic>SD</italic> = 12.7</td>
<td>(1) OT group: info on biomedical concepts, energy conservation, joint protection, use of devices and exercises.<break/>(2) Cognitive-behavioural group: info on biomedical concepts, assessment of patients’ coping repertoire, self-management of active coping behaviour.</td>
<td>Waiting list control group</td>
<td>Current medical treatment was continued</td>
<td>10 sessions, 2 hrs weekly</td>
<td>6 months</td>
<td>1,0,1</td>
</tr>
<tr>
<td>Lindroth<sup><xref ref-type="bibr" rid="bibr35-0017896911419346">35</xref></sup></td>
<td>CCT<break/>Total: 200<break/>Gr1: 100<break/>Gr2: 100</td>
<td>RA</td>
<td>Intervention group: disease duration: 11.6 <italic>SD</italic> = 1.2<break/>Control group: disease duration: 12.3 <italic>SD</italic> = 1.3</td>
<td>Mean age Intervention group: 63 <italic>SD</italic> = 14<break/>Mean age control group: 57 <italic>SD</italic> = 13</td>
<td>Intervention group: 6 sessions of 150 minutes; information on medical aspects, pain management, exercise, available treatments, stress-managements, joint protection, nutrition, leisure etc.</td>
<td>Control group: no education was given</td>
<td>Regular visits to doctor and routine arthritis treatment</td>
<td>6 weeks</td>
<td>none</td>
<td>0,0,1</td>
</tr>
<tr>
<td>Lindroth<sup><xref ref-type="bibr" rid="bibr36-0017896911419346">36</xref></sup></td>
<td>RCT<break/>Total: 96<break/>Gr1: 49<break/>Gr2: 47</td>
<td>RA</td>
<td>Intervention group: mean disease duration: 11 <italic>SD</italic> = 8<break/>Control group: mean disease duration: 13 <italic>SD</italic> = 12</td>
<td>Intervention group: mean age: 54 yrs <italic>SD</italic> = 15<break/>Control group: Mean age: 56 <italic>SD</italic> = 12</td>
<td>An educational programme given by a doctor, nurse, physiotherapist, occupational therapist, social worker and dietician. Education on exercise, rest, diet, surgery – all individual problems.</td>
<td>Control group: did not take the educational programme</td>
<td>None</td>
<td>8 sessions of 2.5 hrs each (weekly)</td>
<td>None</td>
<td>1,0,1</td>
</tr>
<tr>
<td>Masiero<sup><xref ref-type="bibr" rid="bibr37-0017896911419346">37</xref></sup></td>
<td>Total: 70<break/>Gr1: 36<break/>Gr2: 34</td>
<td>Inclusion criteria : aged 18–65 yrs old; presented no variations in drug therapy in the 6 months before trial; did not present severe disability that seriously compromised independence in activities of daily living<break/>Exclusion criteria: previous participation in educational training<break/>variations in drug therapy at any time during the trial</td>
<td>Gr1:14.8 <italic>SD</italic> = 8.8<break/>Gr2: 16.1 <italic>SD</italic> = 8.3</td>
<td>Gr1: 54.2 <italic>SD</italic> = 9.8<break/>Gr2: 52.2 <italic>SD</italic> = 11.9</td>
<td>Gr1: experimental group: education<break/>4 meetings, 3hr sessions every 3 weeks with groups of 4–6 patients + monthly telephone check up programme developed by interdisciplinary team: physiatrist, rheumatologist, physiotherapist, occupational therapist. Group discussion, problem solving, guided practice, and lectures, illustrated brochures, home guide<break/>+usual drug</td>
<td>Gr 2:only usual drug treatment</td>
<td>Anti-tumour necrosis factor alpha (TNF α) drugs (infliximab)</td>
<td>4 session/ week (3 hrs per session)<break/>For 3 weeks</td>
<td>No follow-up</td>
<td>1,0,1</td>
</tr>
<tr>
<td>Mathieux<sup><xref ref-type="bibr" rid="bibr38-0017896911419346">38</xref></sup></td>
<td>Total:60<break/>Gr1: 30<break/>Gr2: 30</td>
<td>Inclusion:<break/>patients with early RA<break/>Exclusion: diagnosis greater than 2 yrs, depression, if they had lack of contribution, or had followed a previous programme.</td>
<td>Gr1:14.3 months <italic>SD</italic> = 7.6<break/>Gr2: 15.4 <italic>SD</italic> = 6.9</td>
<td>Gr1: 48.3 <italic>SD</italic> = 13.0<break/>Gr2: 47.0 <italic>SD</italic> = 13.2</td>
<td>Educational programme with educational strategies, one-to-one teaching, gave out individual information as well with audio visual information. There was also group teaching. All of this done by rehabilitation professionals. Sessions elaborated over a 3 month phase.</td>
<td>Gr 2:only<break/>Without the OT programme</td>
<td>N/A</td>
<td>3 months</td>
<td>No follow-up</td>
<td>1,0,1</td>
</tr>
<tr>
<td>McAuley<sup><xref ref-type="bibr" rid="bibr39-0017896911419346">39</xref></sup></td>
<td>Total: 22<break/>Gr1: 11<break/>Gr2: 11</td>
<td>RA patients</td>
<td>N/A</td>
<td>N/A</td>
<td>Participatory style leadership.<break/>Group teaching<break/>(teaching was on joint protection, energy conservation, relaxation and exercise)</td>
<td>Control group received only a summary of the class.</td>
<td>N/A</td>
<td>1</td>
<td>1 session</td>
<td>0,0,0</td>
</tr>
<tr>
<td>Neuberger<sup><xref ref-type="bibr" rid="bibr40-0017896911419346">40</xref></sup></td>
<td>RCT<break/>Total: 53<break/>Gr1: 13<break/>Gr2: 14<break/>Gr3: 15<break/>Gr4: 11</td>
<td>RA</td>
<td>N/A</td>
<td>Mean age of sample: 52.6 <italic>SD</italic> = 14.3 range: 25–81</td>
<td>Gr1: completed Learning About Rheumatoid Arthritis<break/>(LARA) self-instructional programme (learning about rheumatoid arthritis)<break/>Gr2: Completed LARA + Range of motion (ROM) exercises + joint protection practices<break/>Gr3: Completed LARA +joint protection practices +nurse/patient contracts for target behaviours related to ROM exercises and joint protection practices</td>
<td>Gr4: Control group did not follow programme but received same time for professional</td>
<td>N/A</td>
<td>Programme consisted of 4 individual units of 20–25 minutes each</td>
<td>None</td>
<td>1,0,1</td>
</tr>
<tr>
<td>Niederman<sup><xref ref-type="bibr" rid="bibr41-0017896911419346">41</xref></sup></td>
<td>RCT<break/>Total: 54<break/>Gr1: 27<break/>Gr2: 26</td>
<td>RA patients. Inclusion: RA according to ACR (ACR functional class 2,3,4) whom were associated with difficulties and/or pain in hands.<break/>Exclusion: if patients have severe finger, hand, and shoulder joint deformities.</td>
<td>Gr1: 8.3 <italic>SD</italic> = 9.75<break/>Gr2: 10.23 <italic>SD</italic> = 7.64</td>
<td>Group control: 53.4 <italic>SD</italic> = 15.71<break/>Group treatment: 62,08 <italic>SD</italic> = 12.61</td>
<td>The Pictorial Representation of Illness and Self Measure (PRISM)-based JP education is a programme of standardized joint protection programme that is individualized and based on PRISM tasks, the theories of social learning and self-management. Two researchers trained occupational therapists, who provided the PRISM-JP programmes, to assess the perceived burden of illness, to figure out the resources, and to set goals (therapeutic) by means of PRISM and to understand the applied theories of social learning and self-management. 4 sessions + homework tasks were necessary for patients for the PRISM-JP programme. The programme was based on joint protection and consisted of oral presentations, written literature, and written documents and based on educational strategies, group information, self management, and individual information.</td>
<td>Gr2: Conventional joint protection programme.</td>
<td>N/A</td>
<td>4 sessions/week for 3 months + homework assignments</td>
<td>3 month/end of study</td>
<td>2,0,0</td>
</tr>
<tr>
<td>Parker<sup><xref ref-type="bibr" rid="bibr42-0017896911419346">42</xref></sup></td>
<td>RCT<break/>Total: 22<break/>Gr1: 11<break/>Gr2: 11</td>
<td>RA (excluding previous patient education, history of organic brain syndrome, presence of major psychotic or uncontrolled medical or major communication disorder, illiteracy and American Rheumatism Association (ARA)-class 4)</td>
<td>Disease duration: Gr1: 7.1 <italic>SD</italic> = 6.5<break/>Gr2: 9.2 <italic>SD</italic> = 9.9</td>
<td>Gr1: 55.3 <italic>SD</italic> = 10.8<break/>Gr2: 55.8 <italic>SD</italic> = 10.2</td>
<td>Inpatient rheumatology care plus 7 hr education programme delivered by 2 experienced educators. Including: RA disease process, basic therapies and medication, joint protection and energy conservation, coping with psychosocial stresses and quackery.</td>
<td>Controls: only inpatient rheumatology care, including occupational therapy and physical therapy.</td>
<td>N/A</td>
<td>7 hours of education programme session</td>
<td>3 month/end of study</td>
<td>2, 0, 0</td>
</tr>
<tr>
<td>Parker<sup><xref ref-type="bibr" rid="bibr43-0017896911419346">43</xref></sup></td>
<td>RCT<break/>Total: 83<break/>Gr1: 29<break/>Gr2: 26<break/>Gr3: 28</td>
<td>Classic or definite RA (ARA criteria).<break/>Patients excluded if: uncontrolled medical problems, organic brain syndrome, major psychiatric disturbances, major communicative disorders, history of severe noncompliance, less than 7 yrs of formal education, illiteracy, functional class IV.</td>
<td>Mean disease duration of sample: 11.4</td>
<td>Mean age of sample: 60.6 <italic>SD</italic> = 7.5</td>
<td>Cognitive-behavioural<break/>Specific coping strategies and comprehensive pain management programme (educational overview of RA, presentation of the gate control theory of pain, information about acute vs. chronic pain and medical management of RA (inpatient phase)<break/>Extensive support group programme to maintain treatment gains.</td>
<td>Routine care provided by rheumatology team.</td>
<td>None</td>
<td>12 months</td>
<td>None</td>
<td>2, 0, 1</td>
</tr>
<tr>
<td>Parker<sup><xref ref-type="bibr" rid="bibr44-0017896911419346">44</xref></sup></td>
<td>RCT<break/>Total: 149<break/>Gr1: 50<break/>Gr2:53<break/>Gr3:46</td>
<td>RA (excluding a history of organic brain syndrome, presence of a psychotic disorder, presence of other uncontrolled medical disorders, presence of a major communication disorder and illiteracy and functional class 4)</td>
<td>Gr 1: mean disease duration: 118.0 months<break/>Gr 2: mean disease duration: 109.0 months<break/>Gr 3: mean disease duration: 119.0 months</td>
<td>Gr 1: mean age: 60.0<break/>Gr 2: mean age: 59.0<break/>Gr 3: mean age: 60.0</td>
<td>Stress-management group (SM): 3 counsellors covered topics such as identification of specific stressors, development of effective coping strategies, assessment of life goals, management of pain, managements of emotional distress, adaptation to life change, enhancement of self-esteem, and optimization of social relationships.</td>
<td>Control group (CG): Received standard care</td>
<td>Ongoing rheumatology care</td>
<td>10 session of 1.5 hours each</td>
<td/>
<td>2,0,1</td>
</tr>
<tr>
<td>Platt<sup><xref ref-type="bibr" rid="bibr45-0017896911419346">45</xref></sup></td>
<td>RCT<break/>28<break/>Gr1: 18<break/>Gr2: 10</td>
<td>Patients18 yrs old or older with a diagnosis of adult RA, probable as defined by the American Rheumatism Association criteria or classical RA for at least 1 yr, not hospitalized, participating voluntarily with permission from primary physician.</td>
<td>Gr1:7.8<break/>Range: 1–28<break/>Gr2:7.0<break/>Range: 1–12</td>
<td>Gr1:57.4<break/>Range: 33–84<break/>Gr2:50.8<break/>Range: 33–73</td>
<td>Gr1: experimental, 6-week National Institutes Health (NIH) programme based on the workbook (6 sessions of 1.5 hr). Workbook describes body position, rest, activity analysis and joint protection and includes didactic information, illustrations, practice assignments and self-evaluation</td>
<td>Gr2: control, didactic information from slides/tapes (1 to 3 sessions, 50 min to 2 hrs)</td>
<td>N/m</td>
<td>6 weeks</td>
<td>N/m</td>
<td>1,0,1</td>
</tr>
<tr>
<td>Potts<sup><xref ref-type="bibr" rid="bibr46-0017896911419346">46</xref></sup></td>
<td>CCT<break/>Total: 38<break/>Gr1: 19<break/>Gr2: 19</td>
<td>RA (patients living within 1 hr drive, treated regularly by a rheumatologist at the Indiana University Multipurpose Arthritis Centre)</td>
<td>Group 1: mean disease duration: 9 <italic>SD</italic> = 11<break/>Group 2: mean disease duration: 10 <italic>SD</italic> = 9</td>
<td>Group 1: mean age: 56 <italic>SD</italic> = 14<break/>Group 2: mean age: 50 <italic>SD</italic> = 14</td>
<td>Group sessions where leaders served as facilitators to discuss the topics that arose spontaneously. Personal issues were not shared for they vary from patient to patient.</td>
<td>The control group are those that lived to far to conveniently attend the sessions.</td>
<td>Joint exercise 4 times daily and application of moist heat to affected joints before each exercise session was continued</td>
<td>4 meetings weekly, 90 minutes each</td>
<td>6 months</td>
<td>0,0,0</td>
</tr>
<tr>
<td>Riemsma<sup><xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup></td>
<td>RCT<break/>1st exp: 69<break/>2nd exp: 75<break/>Control: 72</td>
<td>RA (between ages of 20 and 70, consulted providers of health care from 2 or more disciplines during the previous 6 months and whose RA diagnoses met the revised ARA criteria)</td>
<td>1st exp: 14.24 <italic>SD</italic> = 10.72<break/>2nd exp: 12.89<break/><italic>SD</italic> = 9.82<break/>Control:12.99<break/><italic>SD</italic> = 10.94</td>
<td>1st exp: 56.70yrs <italic>SD</italic> = 10.4<break/>2<sup>nd</sup> exp: 59.09 <italic>SD</italic> = 9.63<break/>Control: 57.72 <italic>SD</italic> = 9.22</td>
<td>Videotape on RA, conservation of energy and medical information. Self-help programme and modeling.</td>
<td>Control group of 72 receiving only traditional care.</td>
<td>N/A</td>
<td>During a 6 month period</td>
<td>none</td>
<td>1,0,1</td>
</tr>
<tr>
<td>Siu<sup><xref ref-type="bibr" rid="bibr48-0017896911419346">48</xref></sup></td>
<td>CCT<break/>Total: 45<break/>Gr1: 29<break/>Gr2: 16</td>
<td>All the participants of this study had RA and were new to the service of the community rehabilitation network</td>
<td>Gr1: mean history illness: 95.34 months <italic>SD</italic>: 107.44 months<break/>Gr2: mean history illness: 68.31 months <italic>SD</italic>: 101.99 months</td>
<td>Gr1 mean age: 51.4 <italic>SD</italic>: 13.29<break/>Gr2 mean age: 51.3 <italic>SD</italic>: 13.60</td>
<td>Treatment group (Gr1): took part in a 3 phases interventions including orientation (disease-related info and info on community resources, to encourage them to mobilize or re-mobilize etc.), intervention (assist clients to develop commitment and action towards self-management, the clients are encouraged to participate in the 3 standardized intervention programmes including stress management group, a self-management course and a water exercise class) and consolidation (assist clients to translate commitment into coping and continue to maintain a supportive network).</td>
<td>Control group (Gr2): took part only in the orientation phase</td>
<td>N/A</td>
<td>3 months</td>
<td>9 months</td>
<td>0,0,0</td>
</tr>
<tr>
<td>Strauss<sup><xref ref-type="bibr" rid="bibr49-0017896911419346">49</xref></sup></td>
<td>RCT<break/>Total: 37<break/>Gr1: 17<break/>Gr2: 20</td>
<td>RA (classic or definite RA by ARA criteria, ability to speak English, outpatient status, sufficient ambulatory function – including wheelchair – to attend a weekly group at the medical centre)</td>
<td>N/A</td>
<td>Group 1 mean age: 56 <italic>SD</italic> = 9.7<break/>Group 2 mean age: 53 <italic>SD</italic> = 13.0</td>
<td>Treatment group: behavioural approach with role-playing, relaxation. Structured sessions.</td>
<td>Control group: no education</td>
<td>N/A</td>
<td>Weekly visits for 6 months</td>
<td>1 yr</td>
<td>1,0,1</td>
</tr>
<tr>
<td>Taal<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup></td>
<td>RCT<break/>Total: 75<break/>Gr1: 38<break/>Gr2: 37</td>
<td>Patients with a diagnosis of RA, between 21 and 65 yrs of age, and with a maximum use of 8 yrs of second-line medication, functional class 1, 2, 3.</td>
<td>Gr1 mean disease duration: 3.9yrs, Range: 1-20,<break/>Gr2: mean disease duration: 4.7yrs, Range: 1-29</td>
<td>Gr1 mean age: 49.7<break/>Gr2 mean age: 49.5</td>
<td>Gr1: Patients in experimental group participated in an arthritis self-management course.</td>
<td>Gr2: Control group with RA patients who were only referred to a PT and did not attend the group programme.</td>
<td>None</td>
<td>5 sessions weekly of 2 hrs each.</td>
<td>14 months</td>
<td>1,0,1</td>
</tr>
<tr>
<td>Wetstone<sup><xref ref-type="bibr" rid="bibr51-0017896911419346">51</xref></sup></td>
<td>RCT<break/>Total: 36<break/>Gr1: 18<break/>Gr2: 18</td>
<td>RA</td>
<td>Gr1: 57.9 months <italic>SD</italic>: 47.7 months<break/>Gr2: 52.2 months<break/><italic>SD</italic>: 58.7 months</td>
<td>Gr1: 51.6<break/><italic>SD</italic>: 12.8<break/>Gr2: 50.2<break/><italic>SD</italic>: 13.2</td>
<td>Gr2: Computer-based education lesson on pathophysiology information, medication, energy conservation, joint protection, exercise therapy, diet, etc.)</td>
<td>Gr1: Control group of 14 women and 3 men with RA did not took the computer-based lesson.</td>
<td>None</td>
<td>1 to 4 session (s) Mean duration: 107 min.<break/>Range: 81–204min. <italic>SD</italic>: 24min.</td>
<td>N/A</td>
<td>1,0,0</td>
</tr>
</tbody>
</table>
</table-wrap>
<app id="app1-0017896911419346">
<title>Appendix 2</title>
<p>Evidence-based clinical practice guidelines (EBCPGs) related to patient education in the management of rheumatoid arthritis (RA)</p>
<sec id="section19-0017896911419346">
<title>Education only programme</title>
<p>Group education in support groups versus control (no education), level II (1 CCT, <italic>n</italic> = 38, low quality<sup><xref ref-type="bibr" rid="bibr46-0017896911419346">46</xref></sup>): grade C+ (clinically-important benefit demonstrated without statistical significance) for improved compliance (number of patients with improved heat compliance) at end of treatment one month; grade C (no benefit demonstrated) for improved arthritis knowledge (number of patients with improved knowledge score) at end of treatment six months; grade D (no benefit demonstrated) for improved compliance (number of patients with improved heat compliance) at end of treatment six months, and for improved compliance (number of patients with improved exercise compliance) at end of treatment one month and at end of treatment six months and for improved arthritis knowledge (number of patients with improved knowledge score) at end of treatment one month. Patients diagnosed with RA.</p>
<p>Didactic lecture versus participatory leadership, level I (1 RCT, <italic>n</italic> = 22, low quality<sup><xref ref-type="bibr" rid="bibr39-0017896911419346">39</xref></sup>): grade C (no benefit demonstrated) for improved quality of life (AIMS: global impact [0–10]) at end of treatment five weeks (RD: 45%); grade D (no benefit demonstrated) for improved patient global assessment (satisfaction with leadership style [VAS 0–10]) at end of treatment five weeks and for pain relief (HAQ: pain [0–3]) at end of treatment five weeks (RD: 68%). Patients with RA, unspecified disease duration.</p>
<p>PRISM-based joint protection education versus conventional joint protection education, level I (1 RCT, <italic>n</italic> = 54, low quality<sup><xref ref-type="bibr" rid="bibr41-0017896911419346">41</xref></sup>): grade A (clinically-important benefits demonstrated) for joint behaviour assessment (D-JPBA-S) at end of treatment three months; grade C+ (clinically-important benefit demonstrated without statistical significance) for arthritis self-efficacy scale (ASES-D [0–8]) at end of treatment three months and for pain relief (VAS [0–10]); grade C (no benefit demonstrated) for joint protection self efficacy scale (JP-SES [0–10]) at end of treatment three months, for the hospital anxiety and depression scale, German version (HADS-D, at end of treatment three months, and for the hospital anxiety and depression scale, German version (HADS-A) at end of treatment three months and for disease activity score (DAS 28) at end of treatment three months; grade D (no benefit demonstrated but favouring control) for grip force (VAS [0–10]) at end of treatment three months. RA patients according to ACR (ACR functional class 2, 3, 4) who were associated with difficulties and/or pain in hands.</p>
<p>Group education (cognitive-behavioural) and booklet versus control (no education programme), level I (1 RCT, <italic>n</italic> = 87, low quality <sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup>) and level II (1 CCT, low quality<sup><xref ref-type="bibr" rid="bibr33-0017896911419346">33</xref></sup>): grade A (clinically-important benefits) for pain relief (tender joint count) at follow-up five months and 13 months,<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> improved compliance (exercise [times/week]) at follow-up one week,<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> at follow-up five months,<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> at follow-up 13 months,<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> and for improved arthritis knowledge [0–1]) at follow-up one week,<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> at follow-up five months,<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> at follow-up 13 months<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> ; grade C+ (clinically-important benefit demonstrated without statistical significance) for improved compliance (performance health care activity) at end of treatment one month<sup><xref ref-type="bibr" rid="bibr33-0017896911419346">33</xref></sup> and at follow-up three months<sup><xref ref-type="bibr" rid="bibr33-0017896911419346">33</xref></sup>, for improved quality of life (Dutch AIMS: dexterity [0–10]) at follow-up five months,<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup>; grade C (no benefit demonstrated) for improved quality of life (Dutch AIMS: physical activity [0–10]) at follow-up five months,<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> improved quality of life (Dutch AIMS: dexterity [0–10]) at follow-ups one week and 13 months,<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> improved quality of life (Dutch AIMS: pain [0–10]) at follow-up one week,<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> improved quality of life (M-HAQ: disability [1–4]) at follow-ups one week, five months, and 13 months,<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> improved endurance (endurance exercise) at follow-up 13 months,<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> improved self-efficacy (self-management activities [1–5]) at follow-up one week and follow-up 13 months,<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> improved self-efficacy (ASE: pain [1–5], ASE: function [1–5]) at follow-ups one week and 13 months,<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> improved self-efficacy (ASE: other symptoms [1–5]) at follow-ups one week and 13 months,<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup> for improved quality of life (Dutch AIMS: function [0–10]) at follow-up one week, five months and 13 months; grade D (no benefit demonstrated) for quality of life (Dutch AIMS: physical activity [0–10]) at follow-up one week and 13 months, for improved quality of life (Dutch AIMS: pain [0–10]) at follow-up five months and 13 months, for improved endurance (endurance exercise) at follow-up one week, for improved self-efficacy (ASE: pain [1–5], ASE: function [1–5]) at follow-ups 13 months and self-efficacy (ASE: other symptoms [1–5]) at follow-ups five months; grade D+ (clinically-important benefit demonstrated favouring control (no education programme) without statistical significance) for improved endurance (endurance exercise) at follow-up five months. Patients diagnosed with RA,<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref>, <xref ref-type="bibr" rid="bibr33-0017896911419346">33</xref></sup> between 21 and 65 years of age, and with a maximum use of eight years of second-line medication<sup><xref ref-type="bibr" rid="bibr50-0017896911419346">50</xref></sup>.</p>
<p>Group education (educational-behavioural) versus control (no education programme), <italic>n</italic> = 70, level I (1 RCT, low quality<sup><xref ref-type="bibr" rid="bibr32-0017896911419346">32</xref></sup>) and level II (1 CCT, low quality<sup><xref ref-type="bibr" rid="bibr35-0017896911419346">35</xref></sup>): grade A (clinically-important benefits) for improved arthritis knowledge (patient knowledge questionnaire) at end of treatment one month<sup><xref ref-type="bibr" rid="bibr32-0017896911419346">32</xref></sup> and at follow-up 12 months;<sup><xref ref-type="bibr" rid="bibr32-0017896911419346">32</xref></sup> grade C+ (clinically-important benefit demonstrated without statistical significance) for improved functional status (M-HAQ: disability) at follow-up 12 months;<sup><xref ref-type="bibr" rid="bibr35-0017896911419346">35</xref></sup> grade C (no benefit demonstrated) for improved functional status (HAQ [0–3]) at follow-up 12 months,<sup><xref ref-type="bibr" rid="bibr32-0017896911419346">32</xref></sup> and for pain relief (VAS [0–100mm]) at follow-up 12 months;<sup><xref ref-type="bibr" rid="bibr35-0017896911419346">35</xref></sup> grade D (no benefit demonstrated but favouring control [no education programme]) for improved pain relief (Ritchie articular index) at end of treatment one month<sup><xref ref-type="bibr" rid="bibr32-0017896911419346">32</xref></sup> and at follow-up 12 months,<sup><xref ref-type="bibr" rid="bibr32-0017896911419346">32</xref></sup> for improved functional status (HA) at end of treatment one month.<sup><xref ref-type="bibr" rid="bibr32-0017896911419346">32</xref></sup> Patients diagnosed with RA.<sup><xref ref-type="bibr" rid="bibr32-0017896911419346">32</xref>, <xref ref-type="bibr" rid="bibr35-0017896911419346">35</xref></sup></p>
</sec>
<sec id="section20-0017896911419346">
<title>Educational behavioural programme</title>
<p>Group education (cognitive-behavioural) and booklet versus control (no education programme), level I (2 RCTs, <italic>n</italic> = 114, low quality<sup><xref ref-type="bibr" rid="bibr34-0017896911419346">34</xref>, <xref ref-type="bibr" rid="bibr49-0017896911419346">49</xref></sup>): grade C (no benefit demonstrated) for improved quality of life (IRDHL: mobility) at end of treatment 10 weeks,<sup><xref ref-type="bibr" rid="bibr34-0017896911419346">34</xref></sup> for improved quality of life (IRDHL self-care) at end of treatment 10 weeks<sup><xref ref-type="bibr" rid="bibr34-0017896911419346">34</xref></sup> and for improved functional status (0–4 scale) at end of treatment three months<sup><xref ref-type="bibr" rid="bibr49-0017896911419346">49</xref></sup> and at follow-up 12 months;<sup><xref ref-type="bibr" rid="bibr49-0017896911419346">49</xref></sup> Grade D (no benefit demonstrated but favouring control [no education programme]) for improved quality of life (IRDHL: mobility) at follow-up six months,<sup><xref ref-type="bibr" rid="bibr34-0017896911419346">34</xref></sup> for improved quality of life (IRDHL self-care) at follow-up six months,<sup><xref ref-type="bibr" rid="bibr34-0017896911419346">34</xref></sup> and for improved quality of life (IRDHL: pain) at end of treatment 10 weeks<sup><xref ref-type="bibr" rid="bibr34-0017896911419346">34</xref></sup> and at follow-up six months.<sup><xref ref-type="bibr" rid="bibr34-0017896911419346">34</xref></sup> Patients diagnosed with RA<sup><xref ref-type="bibr" rid="bibr34-0017896911419346">34</xref>, <xref ref-type="bibr" rid="bibr49-0017896911419346">49</xref></sup> for at least one year and aged 20 years old or older,<sup><xref ref-type="bibr" rid="bibr34-0017896911419346">34</xref></sup> with the ability to speak English, outpatient status and sufficient ambulatory function.<sup><xref ref-type="bibr" rid="bibr49-0017896911419346">49</xref></sup></p>
<p>Education (cognitive-behavioural) versus control (no education programme), level I (1 RCT, <italic>n</italic> = 22, low quality<sup><xref ref-type="bibr" rid="bibr42-0017896911419346">42</xref></sup>): grade C (no benefit demonstrated) for improved quality of life (AIMS: Exercise) at end of treatment one month; grade D (no benefit demonstrated but favouring control (no education programme)) for improved quality of life (AIMS: Exercise) at follow-up three months, and for improved quality of life (AIMS: Pain) at end of treatment one month and at follow-up three months. Patients diagnosed with RA.</p>
<p>Individual education (cognitive-behavioural) versus control (no education programme), level I (1 RCT, <italic>n</italic> = 149, high quality<sup><xref ref-type="bibr" rid="bibr44-0017896911419346">44</xref></sup>): grade C (no benefit demonstrated) for pain relief (VAS [0–10cm]) at follow-up 15 months; grade D+ (clinically-important benefit demonstrated favouring control without statistical significance) for pain relief (VAS [0–10cm]) at end of treatment six weeks, and follow-up three months. Patients with RA.</p>
<p>Education and lifestyle education programme versus lifestyle education programme, level I (1 RCT, <italic>n</italic> = 167, high quality<sup><xref ref-type="bibr" rid="bibr31-0017896911419346">31</xref></sup>): grade C+ (clinically-important benefit demonstrated without statistical significance) for early morning stiffness (min) at end of treatment 12 months; Grade C (no benefit demonstrated) for pain (VAS [0–100]) at end of treatment 12 months, for fatigue (VAS [0–100]), for perceived health [0–100] at end of treatment 12 months, for RA self-efficacy [28–140] at end of treatment 12 months, for self efficacy with other system at end of treatment 12 months, for psychological distress [1–4] at end of treatment 12 months, for Arthritis Helplessness Index (AHI,5-30) at end of treatment 12 months, for arthritis helplessness perceived control (AHI [6–36]) at end of treatment 12 month; grade D (no benefit demonstrated but favouring control) for psychological distress and for helplessness at end of treatment 12 months; grade D+ (clinically-important benefit demonstrated favouring control without statistical significance) for functional status (modified HAQ [0–3]) at end of treatment 12 months. Patients who met the following criteria: (1) 18 years or older; (2) diagnosis of RA; (3) early IA; (4) PSA.</p>
<p>Joint protection versus standard education, level I (2 RCTs, <italic>n</italic> = 254, both high quality<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref>, <xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref></sup>): grade A (clinically-important benefits) for improved psychological well-being (JPBA (0-40)) at follow-up six months,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup> at follow-up 12 months,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup> and at follow-up 48 months,<sup><xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref></sup> for pain relief<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup> (hand pain [VAS 0–100]) at follow-up 12 months, for improved disease activity (morning stiffness [min]) at follow-up 12 months (<xref ref-type="fig" rid="fig2-0017896911419346">Figure 2</xref>) <sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup> and at follow-up 48 months,<sup><xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref></sup> for improved physician global assessment (assessor’s global disease status [0–5]) at follow-up six months<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup> and at follow-up 12 months,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup> for improved patient global assessment (patient’s global disease status [0–5]) at follow-up six months<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup> and at follow-up 12 months,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup> for improved quality of life (AIMS2 ADL [0–10]) at follow-up 12 months<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup>; grade C+ (clinically-important benefit demonstrated without statistical significance) for pain relief (tender joint count [0–28]) at follow-up six months,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup> at follow-up 12 months,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup> and 48 months <sup><xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref></sup>, for improved disease activity (swollen joint count [0–28]) at follow-up six months <sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup> and at follow-up 12 months,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup> and for improved quality of life (AIMS2 ADL [0–10]) at follow-up 48 months <sup><xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref></sup>; grade C (no benefit demonstrated) for pain relief (overall pain [VAS 0–100], at follow-up six months,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup> for improved disease activity (morning stiffness [mins]), at follow-up six months, <sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup>for increased force (grip force [kg]) at follow-up six months<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup>, for improved disease activity (swollen joint count [0–28]), at follow-up 48 months, <sup><xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref></sup> for improved mobility (hand JAM [0–80]), at follow-up six months and at follow-up 12 months, <sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup>for improved quality of life (AIMS2 upper limb [0–10] and lower limb [0–10]), at follow-up 12 months, <sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup>for improved quality of life (AIMS2 current health status [0–10]), at follow-up six months and at follow-up 12 months, <sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup>for improved quality of life (AIMS2 satisfaction with health [0–10]), at follow-up 12 months, <sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup>for improved self-efficacy (ASE: pain [10–100]) at follow-up six months, at follow-up 12 months, <sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup> for improved self-efficacy (ASE: other symptoms [10–100], at follow-up 12 months, <sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup> for improved patient global assessment (patient’s global disease status [0–5], at follow-up 48 months, <sup><xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref></sup> for increased force (grip force [kg]) at follow-up 48 months, <sup><xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref></sup>and for improved self-efficacy (ASE: pain [10–100]) at follow-up 48 months.<sup><xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref></sup> For pain relief (overall pain [VAS 0–100]) at follow-up 48 months <sup><xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref></sup>; grade D (no benefit demonstrated but favouring standard education) for pain for improved quality of life (AIMS2 ADL [0–10]) at follow-up six months,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup>for improved quality of life (AIMS2 upper limb [0–10]) at follow-up six months,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup> for improved quality of life (AIMS2 lower limb [0–10]) at follow-up six months,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup>for improved quality of life (AIMS2 satisfaction with health [0–10]) at follow-up six months,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup> for improved self-efficacy (ASE: other symptoms [10–100]) at follow-up six months,<sup><xref ref-type="bibr" rid="bibr28-0017896911419346">28</xref></sup> and at follow-up 48 months;<sup><xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref></sup> grade D+ (clinically-important benefit demonstrated favouring standard education without statistical significance) for improved quality of life (AIMS2 upper limb [0–10]) at follow-up 48 months (RD: 20%),<sup><xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref></sup> for improved quality of life (AIMS2 lower limb [0–10]) at follow-up 48 months (RD: 23%).<sup><xref ref-type="bibr" rid="bibr29-0017896911419346">29</xref></sup> Patients diagnosed with RA within the last five years, aged 18–65 years, were experiencing hand pain on activity, had no other medical condition affecting hand function and had a history of wrist and or MCP joint pain and inflammation.</p>
<p>Education versus control (no intervention), level I (1 RCT, <italic>n</italic> = 60, low quality<sup><xref ref-type="bibr" rid="bibr38-0017896911419346">38</xref></sup>): grade A (clinically-important benefits demonstrated) for improved grip force of the dominant hand (KPA) at the end of treatment three months (RD: 39%), grip force of the non-dominant hand (KPA) at the end of treatment three months (RD: 43%); grade D (no benefit demonstrated but favouring control (no intervention) for improved health assessment questionnaire score (RD: −39%) at end of treatment three months. Patients with early RA.</p>
</sec>
<sec id="section21-0017896911419346">
<title>Self-instructional education</title>
<p>Education material versus control (traditional care), level I (1 RCT, <italic>n</italic> = 216, low quality<sup><xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup>): grade A (clinically important) for improved compliance (physical exercises [min/week]) at follow-up one month and at follow-up 19 months, for improved endurance (endurance exercises [min]) at follow-up 19 months, and for improved disease activity (swollen joint count [0–46]) at follow-up 19 months; grade C (no benefit demonstrated) for improved quality of life (Dutch AIMS: mobility, dexterity [0–10], pain [0–10]) at follow-up one month, for improved quality of life (Dutch AIMS: physical activity [0–10]) at follow-ups one month and 19 months, for improved walking speed (10m walking time [min]) at follow-up one month, for increased force (grip force [mm Hg]) at follow-up one month, for improved arthritis knowledge [10–100]) at follow-up 19 months, for improved disease activity (swollen joint count [0–46]) at follow-up one month, for pain relief (Ritchie articular index [0–75]) at follow-up one month, and for improved self-efficacy (ASE: function [10–100], other symptoms [10–100]) at follow-up one month, grade D (no benefit demonstrated but favouring control [traditional care]) for improved quality of life (Dutch AIMS: mobility, dexterity [0–10], pain [0–10]) at follow-up 19 months, for improved functional status (M-HAQ: disability [0–3]) at follow-ups one month and 19 months, for improved mobility (walking speed, 10m walking time [min]) at follow-up 19 months, for improved endurance (endurance exercises [min]) at follow-up one month, for increased force (grip force [mm Hg]) at follow-up 19 months, for improved arthritis knowledge (10–100) at follow-up one month, for pain relief (Ritchie articular index [0–75]) at follow-up 19 months, for improved self-efficacy (ASE: pain [10–100]) at follow-up one month, and for improved self-efficacy (ASE: function [10–100], other symptoms [10–100]) at follow-up 19 months. Patients with RA, unspecified disease duration.</p>
<p>Coordinated educational material plus passport versus control (traditional care), level I (1 RCT, <italic>n</italic> = 216, low quality<sup><xref ref-type="bibr" rid="bibr47-0017896911419346">47</xref></sup>): grade C+ (clinically-important benefit without statistical significance) for improved compliance (physical exercises [min/week]) at follow-up 19 months; grade C (no benefit demonstrated) for improved quality of life (Dutch AIMS: dexterity [0–10]) at follow-up one month, for increased force (grip force [mm Hg]) at follow-up one month, for improved disease activity (swollen joint count [0–46]) at follow-ups one month and 19 months, for improved self-efficacy (ASE: pain [10–100]) at follow-up one month, and for improved self-efficacy (ASE: other symptoms [10–100]) at follow-up one month; grade D (no benefit demonstrated but favouring control (traditional care)) for improved quality of life (Dutch AIMS: physical activity [0–10]) at follow-ups one month and 19 months, for improved quality of life (Dutch AIMS: pain [0–10]) at follow-up nine months, for improved functional status (M-HAQ: disability [0–3]) at follow-up one month and 19 months, for improved walking speed (10m walking time [min]) at follow-up one month, for improved endurance (endurance exercises [min]) at follow-up 19 months, for improved arthritis knowledge [0–100] at follow-ups one month and 19 months, for pain relief (Ritchie articular index [0–75]) at follow-up one month, for improved self-efficacy (ASE: function [10–100]) at follow-ups one month and 19 months, and for improved self-efficacy (ASE: other symptoms [10–100]) at follow-up 19 months; grade D+ (clinically-important benefit demonstrated favouring control [traditional care] without statistical significance) for improved quality of life (Dutch AIMS: dexterity [0–10]) at follow-up 19 months, for improved compliance (physical exercises [min/week]) at follow-up one month, for improved walking speed (10m walking time [min]) at follow-up 19 months, for improved endurance (endurance exercises [min]) at follow-up one month, for increased force (grip force [mm Hg]) at follow-up 19 months, for pain relief (Ritchie articular index [0–75]) at follow-up 19 months, and for improved self-efficacy (ASE: pain [10–100] at follow-up 19 months. Patients with RA, whose RA diagnoses met the revised ARA criteria, between ages of 20 and 70, consulted providers of health care from two or more disciplines during the previous six months.</p>
<p>Self-instructional education versus control (not received leaflet), level I (1 RCT, <italic>n</italic> = 84, low quality<sup><xref ref-type="bibr" rid="bibr24-0017896911419346">24</xref></sup>): grade A (clinically-important benefits) for improved arthritis knowledge (knowledge score) at end of treatment three weeks and at follow-up six months; grade C+ (clinically-important benefit demonstrated without statistical significance) for improved self-efficacy (ASE: pain) at end of treatment three weeks; grade C (no benefit demonstrated) for pain relief (VAS [0–10cm]) at end of treatment three weeks, at follow-up six months, for improved self-efficacy (ASE: pain) at follow-up six months, and for improved self-efficacy (ASE: other symptoms) at end of treatment three weeks and at follow-up six months. Patients diagnosed with RA.</p>
<p>Self-instruction only versus control (no intervention), level I (1 RCT, <italic>n</italic> = 53, low quality<sup><xref ref-type="bibr" rid="bibr40-0017896911419346">40</xref></sup>): grade A (clinically-important benefit) for improved arthritis knowledge (knowledge score [0–40]) at follow-up four months; grade C+ (clinically-important benefit demonstrated without statistical significance) for pain relief (VAS [0–10cm]) at follow-up four months. Patients diagnosed with RA.</p>
<p>Self-instruction plus practice versus control (no intervention), level I (1 RCT, <italic>n</italic> = 53, low quality<sup><xref ref-type="bibr" rid="bibr40-0017896911419346">40</xref></sup>): grade A (clinically-important benefit) for improved arthritis knowledge (knowledge score [0–40]) at follow-up four months; grade C+ (clinically-important benefit demonstrated without statistical significance) for pain relief (VAS [0–10cm]) at follow-up four months. Patients diagnosed with RA.</p>
<p>Self-instruction plus practice and contracting versus control (no intervention), level I (1 RCT, <italic>n</italic> = 53, low quality<sup><xref ref-type="bibr" rid="bibr40-0017896911419346">40</xref></sup>): grade A (clinically-important benefit of self-instruction plus practice and contracting versus control [no intervention]) for improved arthritis knowledge (knowledge score [0–40]) at follow-up four months; grade C (no benefit demonstrated) for pain relief (VAS [0–10]) at follow-up four months. Patients diagnosed with RA.</p>
<p>Self-instruction only versus self-instruction plus practice, level I (1 RCT, <italic>n</italic> = 53, low quality<sup><xref ref-type="bibr" rid="bibr40-0017896911419346">40</xref></sup>): grade C+ (clinically-important benefit without statistical significance) for improved arthritis knowledge (knowledge score [0–40]) at follow-up four months; grade C (no benefit demonstrated) for pain relief (VAS [0–10]) at follow-up four months. Patients diagnosed with RA.</p>
<p>Self-instruction plus practice versus self-instruction plus practice and contracting, Level I (1 RCT, <italic>n</italic> = 53, low quality<sup><xref ref-type="bibr" rid="bibr40-0017896911419346">40</xref></sup>): grade C+ (clinically-important benefit without statistical significance) for improved arthritis knowledge (knowledge score [0–40]) at follow-up four months and for pain relief (VAS [0–10cm]) at follow-up four months. Patients diagnosed with RA.</p>
<p>Community-based education versus control (no education), level I (1 RCT, <italic>n</italic> = 150, low quality<sup><xref ref-type="bibr" rid="bibr25-0017896911419346">25</xref></sup>): grade C (no benefit demonstrated) for improved disease activity (morning stiffness) at end of treatment six weeks; for pain relief (VAS [0–100mm]) at end of treatment six weeks, for pain relief (tender joint count) at end of treatment six weeks and at follow-up three months, for improved self-efficacy (ASE: pain and other symptoms) at end of treatment six weeks and at follow-up three months, for improved arthritis knowledge (knowledge score [0–31]) at end of treatment six weeks and at follow-up three months, and for improved disease activity (morning stiffness) at follow-up three months; grade D (no benefit demonstrated but favouring control (no education) for pain relief (VAS [0–100mm]) at end of treatment six weeks and Follow-up (FU) three months, and for increased force (grip force [mm Hg]) at end of treatment six weeks. Patients with RA (referral for a physical therapy intervention, diagnosis confirmed by a physician), disease onset after age 18, first referral to consultation, ability to read, write and speak English, ability to understand the purpose of the study and provide informed consent, consent four or more visits of three hours or more from a CTS physical therapist, available for follow-up for the full length of the study, at least three of 12 potential.</p>
<p>Computer based education versus control (no intervention), level I (1 RCT, <italic>n</italic> = 36, low quality<sup><xref ref-type="bibr" rid="bibr51-0017896911419346">51</xref></sup>): grade A (clinically-important benefit) for improved psychological well-being (number of patients with improved joint protection) at end of treatment one month.</p>
</sec>
<sec id="section22-0017896911419346">
<title>Education programme combined with group support</title>
<p>Group education (cognitive-behavioural) and booklet versus control (no education programme), level I (1 RCTs, <italic>n</italic> = 83, high quality<sup><xref ref-type="bibr" rid="bibr43-0017896911419346">43</xref></sup>): grade A (clinically-important benefits) for pain relief (<xref ref-type="fig" rid="fig1-0017896911419346">Figure 1</xref>) (VAS [0–100]) at end of treatment 12 months;<sup><xref ref-type="bibr" rid="bibr43-0017896911419346">43</xref></sup> grade C (no benefit demonstrated) for improved helplessness (arthritis helplessness index [AHI]) at end of treatment 12 months.<sup><xref ref-type="bibr" rid="bibr43-0017896911419346">43</xref></sup> Patients diagnosed with RA.<sup><xref ref-type="bibr" rid="bibr43-0017896911419346">43</xref></sup></p>
</sec>
<sec id="section23-0017896911419346">
<title>Education programme combined with exercise</title>
<p>OT plus usual rheumatology care versus contro (usual care), level I (1 RCT, <italic>n</italic> = 326, low quality<sup><xref ref-type="bibr" rid="bibr30-0017896911419346">30</xref></sup>): grade C (no benefit demonstrated) for pain relief (VAS [0–100mm]) at follow-up six months, for improved quality of life (AIMS2: satisfaction with health [0–10]) at follow-up six and12 months, for improved disease activity (swollen joint count [0–28]) at follow-up 12 months, for improved disease activity (morning stiffness [min]) at follow-up 24 months, for increased force (grip force [kg]) at follow-up 12 months, and for improved self-efficacy (total self-efficacy) at follow-up six months and follow-up 12 months; grade D (no benefit demonstrated but favouring contro [usual care]) for pain relief (VAS [0–100], tender joint count [0–28]) at follow-up 12 months and follow-up 24 months, for improved quality of life (AIMS2: physical function [0–10]) at follow-up six months, follow-up 12 months, and follow-up 24 months, for improved quality of life (AIMS2: satisfaction with health [0–28]) at follow-up six months and 24 months, for improved disease activity (swollen joint count [0–28]) at follow-up 12 months and follow-up 24 months, for improved disease activity (morning stiffness [min]) at follow-up six and 12 months, for improved functional status (HAQ [0–3]) at follow-up 12 months and follow-up 24 months, for improved physical function (Jensen hand function test [sec]) at follow-up six months, follow-up 12 months, and follow-up 24 months, for increased force (grip force [kg]) at follow-up six months and follow-up 24 months, and for improved self-efficacy (total self-efficacy) at follow-up 24 months. Patients with RA by a consultant rheumatologist within the past 2.5 years, recruited from hospitals in the former North Thames Regional Health Authority, aged over 18 years, required active medical treatment, had no or minimal OT previously; and could speak and read English adequately to complete assessments.</p>
<p>Group education (educational-behavioural) versus control (no education), level II (1 CCT, <italic>n</italic> = 45, low quality<sup><xref ref-type="bibr" rid="bibr48-0017896911419346">48</xref></sup>): grade C+ (clinically-important benefit demonstrated without statistical significance) for improved psychological well-being (achieve health outcomes [1–10]; Siu, 2004) and management of disease in general (1–10; Siu, 2004) at follow-up nine months; grade C (no benefit demonstrated) for improved psychological well-being (self-rated health [0–5]; Siu, 2004)) at follow-up nine months, for pain relief (pain and physical discomfort [0–100]; Siu, 2004) at follow-up nine months; grade D (no benefit demonstrated) for improved quality of life (energy and fatigue [0–5]; Siu, 2004) at follow-up nine months, for improved psychological well-being (health care utilization [0–5]; Siu, 2004) at follow-up nine months; grade D+ clinically-important benefit demonstrated favouring control (no education) without statistical significance for improved functional status (performance self-management behaviours [1–10]; Siu, 2004) at follow-up nine months. All the participants of this study had RA and were new to the service of the community rehabilitation network.</p>
</sec>
<sec id="section24-0017896911419346">
<title>Education programme combined with self-instruction</title>
<p>Group education and workbook (educational-behavioural) versus control (no intervention), level I (1 RCT, <italic>n</italic> = 135, low quality<sup><xref ref-type="bibr" rid="bibr27-0017896911419346">27</xref></sup>): grade C+ (clinically-important benefit demonstrated without statistical significance) for improved self-efficacy (ASE) at end of treatment three months; grade C (no benefit demonstrated) for pain relief (VAS [0–100mm]) at end of treatment three months, for pain relief (tender joint count) at end of treatment three months, for increased force (grip force [mm Hg]) at end of treatment three months, for improved mobility (Hand JAM [Hammond, Lincoln et al., 1999]) at end of treatment three months, and for improved functional status (HAQ [0–3]) at follow-up three months; grade D (no benefit demonstrated but favouring control [no education]) for improved functional status (HAQ [0–3]) at end of treatment three months; grade D+ (clinically-important benefit demonstrated favouring control [no intervention] without statistical significance) for functional status (HAQ [0–3]) at end of treatment three months. Patients with RA and wrist and/or MCP involvement, no other medical condition affecting hand function, some restriction in ability to perform daily activities and recreational activities.</p>
<p>Education with exercise and medication versus control (brochure only, no education), level I (1 RCT, <italic>n</italic> = 60, low quality<sup><xref ref-type="bibr" rid="bibr26-0017896911419346">26</xref></sup>) (Brus, 1998): grade A (clinically-important benefits) for improved joint protection at follow-up three months; grade C+ (clinically-important benefit demonstrated without statistical significance) for improved energy conservation at follow-up three months, at follow-up six months, and at follow-up 12 months, for improved endurance (endurance activities) at follow-up three months and at follow-up 12 months, and for improved joint protection at follow-up six months and at follow-up 12 months, for improved functional status (exercise) at follow-up three and 12 months; grade C (no benefit demonstrated) for improved endurance (endurance activities) at follow-up six months; grade D (no benefit demonstrated but favouring control [brochure only, no education]) for improved functional status (exercise) at follow-up six months. Patients suffering from RA, following the ACR criteria, for less than three years, six or more painful joints and three or more swollen joints.</p>
<p>Teaching versus participatory education, level I (1 RCT, <italic>n</italic> = 28, low quality<sup><xref ref-type="bibr" rid="bibr45-0017896911419346">45</xref></sup>): grade C+ (clinically-important benefit without statistical significance) for pain relief (Richey-camp articular index) at end of treatment three months, for improved quality of life (number of patients with improved rest during activity) at end of treatment three months, for improved quality of life (number of patients with improved HAQ fatigue) at end of treatment three months, for improved functional status (number of patients improved in physical activity) at end of treatment three months, and for improved functional status (number of patients improved index of physical activity) at end of treatment three months; grade C (no benefit demonstrated) for improved functional status (HAQ [0–3]) at end of treatment three months, and for pain relief (number of patients with improved HAQ: pain) at end of treatment three months; grade D (no benefit demonstrated but favouring control [participatory education] for improved arthritis knowledge (knowledge score [0–34]) at end of treatment three months. Patients 18 years old or older with a diagnosis of adult RA, probable as defined by the American Rheumatism Association criteria or classical RA for at least one year, not hospitalized, participating voluntarily with permission from primary physician.</p>
<p>Group education (educational-behavioural) and handbook versus control (no education programme), level I (1 RCT, <italic>n</italic> = 96, low quality<sup><xref ref-type="bibr" rid="bibr36-0017896911419346">36</xref></sup>): grade C+ (clinically-important benefit without statistical significance) for improved functional status (HAQ: impairment) at follow-up 12 months; grade C (no benefit demonstrated) for improved joint protection at follow-up three months and at follow-up 12 months, for pain relief (VAS [0–100mm]) at follow-up six months and improved functional status (compliance to exercise) at follow-up 12 months; grade D (no benefit demonstrated but favouring control [no education programme] for pain relief (VAS [0–100mm]) at follow-up three months and at follow-up 12 months, and for improved functional status [compliance to exercise] at follow-up three months, for improved functional status (HAQ: impairment [Lindroth, 1997]) at follow-up 12 months. Patients diagnosed with RA.</p>
<p>Group education (educational-behavioural) versus control (no education programme), <italic>n</italic> = , level I (1 RCT, low quality<sup><xref ref-type="bibr" rid="bibr37-0017896911419346">37</xref></sup>): grade A (clinically-important benefits) for improved quality of life (AIMS physical function [0–10]) at the end of treatment eight months,<sup><xref ref-type="bibr" rid="bibr37-0017896911419346">37</xref></sup> for psychological status (AIMS psychological [0–10]) at the end of treatment eight months,<sup><xref ref-type="bibr" rid="bibr37-0017896911419346">37</xref></sup> disease progression (AIMS symptoms [0–10]) at the end of treatment eight months,<sup><xref ref-type="bibr" rid="bibr37-0017896911419346">37</xref></sup> for social status (AIMS social interaction [1–10]) at the end of the treatment eight months,<sup><xref ref-type="bibr" rid="bibr37-0017896911419346">37</xref></sup> for physical ability (AIMS work [0–10]) at the end of treatment eight months,<sup><xref ref-type="bibr" rid="bibr37-0017896911419346">37</xref></sup> and for improved functional status (HAQ [0–3]) at the end of treatment eight months;<sup><xref ref-type="bibr" rid="bibr37-0017896911419346">37</xref></sup> grade D (no benefit demonstrated but favouring control [no education programme] for pain relief (VAS [0–100]) at the end of treatment eight months.<sup><xref ref-type="bibr" rid="bibr37-0017896911419346">37</xref></sup> Patients diagnosed with RA, aged 18–65 years old, presented no variations in drug therapy in the six months before trial, did not present severe disability that seriously compromised independence in activities of daily living.<sup><xref ref-type="bibr" rid="bibr37-0017896911419346">37</xref></sup></p>
<sec id="section25-0017896911419346">
<title>Abbreviations</title>
<p>ADL = activities of daily living, AHI = Arthritis Helplessness Index, AIMS = Arthritis Impact Measurement Scales, AIMS2 = Arthritis Impact Measurement Scales 2, ASE = Arthritis Self-efficacy Scale, CCT = controlled clinical trials, Hand JAM = Hand Joint Alignment and Motion Scale, HAQ = Health Assessment Questionnaire, IRDHL = Impact of Rheumatic Diseases on Health and Lifestyle, JPBA = Joint Protection Behaviour Assessment, M-HAQ = Modified Health Assessment Questionnaire, OT = occupational therapy, RA = rheumatoid arthritis, RCT = randomized controlled trial, RD = relative difference, VAS = visual analogue scale.</p>
</sec>
</sec>
</app>
</app-group>
<ack><p>Assistant manuscript writers were Courtney Cohoon, Louis-Philippe Bergeron, and Linda S. Greene-Finestone of the School of Rehabilitation Sciences, Faculty of Health Sciences, University of Ottawa, Canada. The Ottawa Panel is indebted to Ms. Rachel Goard, Ms. Catherine Lamothe, Ms. Alison Marshall, Mr. George Gray, Ms. Shannon Rees, Mr. Shaun Cleaver, Ms. Lucie Lavigne, Mr. Guillaume Léonard, Ms. Marie-Andrée Ouimet, Mr. Martin Campbell, Ms. Isabelle Blais, Mr. Simon Barsoum, Ms. Judith Robitaille, and Ms. Karin Phillips for their technical support and help in data extraction.</p></ack>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This study was financially supported by The Ontario Arthritis Society (CANADA) (Research Grant No. TAS02/0079), the Ontario Ministry of Health and Long-Term Care (Canada) for salary support (HRPD-05225), University Research Chair (salary support for research staff) and the Ministry of Human Resources (summer student programme) (Canada).</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0017896911419346">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Young</surname><given-names>A</given-names></name>
<name><surname>Dixey</surname><given-names>J</given-names></name>
<name><surname>Kulinskaya</surname><given-names>E</given-names></name>
<name><surname>Cox</surname><given-names>N</given-names></name>
<name><surname>Davies</surname><given-names>P</given-names></name>
<name><surname>Devlin</surname><given-names>J</given-names></name>
<name><surname>Emery</surname><given-names>P</given-names></name>
<name><surname>Gough</surname><given-names>A</given-names></name>
<name><surname>James</surname><given-names>D</given-names></name>
<name><surname>Prouse</surname><given-names>P</given-names></name>
<name><surname>Williams</surname><given-names>P</given-names></name>
<name><surname>Winfield</surname><given-names>J</given-names></name>
</person-group>. <article-title>Which patients stop working because of rheumatoid arthritis? Results of five years’ follow up in 732 patients from the Early RA Study (ERAS)</article-title>. <source>Ann Rheum Dis</source>, <year>2002</year>: <volume>61</volume>(<issue>4</issue>): <fpage>335</fpage>–<lpage>340</lpage>.</citation>
</ref>
<ref id="bibr2-0017896911419346">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kobelt</surname><given-names>G</given-names></name>
<name><surname>Eberhardt</surname><given-names>K</given-names></name>
<name><surname>Jönsson</surname><given-names>L</given-names></name>
<name><surname>Jönsson</surname><given-names>B</given-names></name>
</person-group>. <article-title>Economic consequences of the progression of rheumatoid arthritis in Sweden</article-title>. <source>Arthritis Rheum</source>, <year>1999</year>: <volume>42</volume>(<issue>2</issue>): <fpage>347</fpage>–<lpage>356</lpage>.</citation>
</ref>
<ref id="bibr3-0017896911419346">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Villeneuve</surname><given-names>E</given-names></name>
<name><surname>Emery</surname><given-names>P</given-names></name>
</person-group>. <article-title>Rheumatoid arthritis: What has changed?</article-title> <source>Skeletal Radiol</source>, <year>2009</year>: <volume>38</volume>(<issue>2</issue>): <fpage>109</fpage>–<lpage>112</lpage>.</citation>
</ref>
<ref id="bibr4-0017896911419346">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Symmons</surname><given-names>DP</given-names></name>
</person-group>. <article-title>Epidemiology of rheumatoid arthritis: Determinants of onset, persistence and outcome</article-title>. <source>Best Pract Res Clin Rheumatol</source>, <year>2002</year>: <volume>16</volume>(<issue>5</issue>): <fpage>707</fpage>–<lpage>722</lpage>.</citation>
</ref>
<ref id="bibr5-0017896911419346">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Combe</surname><given-names>B</given-names></name>
<name><surname>Landewe</surname><given-names>R</given-names></name>
<name><surname>Lukas</surname><given-names>C</given-names></name>
<name><surname>Bolosiu</surname><given-names>HD</given-names></name>
<name><surname>Breedveld</surname><given-names>F</given-names></name>
<name><surname>Dougados</surname><given-names>M</given-names></name>
<name><surname>Emery</surname><given-names>P</given-names></name>
<name><surname>Ferraccioli</surname><given-names>G</given-names></name>
<name><surname>Hazes</surname><given-names>JM</given-names></name>
<name><surname>Klareskog</surname><given-names>L</given-names></name>
<name><surname>Machold</surname><given-names>K</given-names></name>
<name><surname>Martin-Mola</surname><given-names>E</given-names></name>
<name><surname>Nielsen</surname><given-names>H</given-names></name>
<name><surname>Silman</surname><given-names>A</given-names></name>
<name><surname>Smolen</surname><given-names>J</given-names></name>
<name><surname>Yazici</surname><given-names>H</given-names></name>
</person-group>. <article-title>EULAR recommendations for the management of early arthritis: Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)</article-title>. <source>Ann Rheum Dis</source>, <year>2007</year>: <volume>66</volume>(<issue>1</issue>): <fpage>34</fpage>–<lpage>45</lpage>.</citation>
</ref>
<ref id="bibr6-0017896911419346">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Deighton</surname><given-names>C</given-names></name>
<name><surname>O’Mahony</surname><given-names>R</given-names></name>
<name><surname>Tosh</surname><given-names>J</given-names></name>
<name><surname>Turner</surname><given-names>C</given-names></name>
<name><surname>Rudolf</surname><given-names>M</given-names></name>
</person-group>
<collab>Guideline Development Group</collab>. <article-title>Management of rheumatoid arthritis: Summary of NICE guidance</article-title>. <source>BMJ</source>, <year>2009</year>: <volume>16</volume>: <comment>338: b702</comment>.</citation>
</ref>
<ref id="bibr7-0017896911419346">
<label>7.</label>
<citation citation-type="journal">
<collab>The Philadelphia Panel</collab> (<collab>Ottawa Methods Group</collab>: <person-group person-group-type="author">
<name><surname>Wells</surname><given-names>G</given-names></name>
<name><surname>Tugwell</surname><given-names>P</given-names></name>
<name><surname>Brosseau</surname><given-names>L</given-names></name>
<etal/></person-group>.), <article-title>Philadelphia Panel evidence-based clinical practice guidelines on selected rehabilitation interventions: Overview and methodology</article-title>. <source>Phys Ther</source>, <year>2001</year>: <volume>81</volume>: <fpage>1629</fpage>–<lpage>1640</lpage>.</citation>
</ref>
<ref id="bibr8-0017896911419346">
<label>8.</label>
<citation citation-type="journal">
<collab>The Ottawa Panel</collab> (<collab>Ottawa Methods Group</collab>: <person-group person-group-type="author">
<name><surname>Brosseau</surname><given-names>L</given-names></name>
<name><surname>Wells</surname><given-names>G</given-names></name>
<name><surname>Tugwell</surname><given-names>P</given-names></name>
<name><surname>Egan</surname><given-names>M</given-names></name>
<name><surname>Dubouloz</surname><given-names>CJ</given-names></name>
<name><surname>Casimiro</surname><given-names>L</given-names></name>
<name><surname>Robinson</surname><given-names>V</given-names></name>
<name><surname>Pelland</surname><given-names>L</given-names></name>
<name><surname>McGowan</surname><given-names>J</given-names></name>
<name><surname>Lamb</surname><given-names>M</given-names></name>
</person-group>). <article-title>Ottawa Panel evidence clinical practice guidelines for therapeutic exercises and manual therapy in the treatment of rheumatoid arthritis</article-title>. <source>Phys Ther</source>, <year>2004</year>: <volume>84</volume>: <fpage>934</fpage>–<lpage>981</lpage>.</citation>
</ref>
<ref id="bibr9-0017896911419346">
<label>9.</label>
<citation citation-type="journal">
<collab>The Ottawa Panel</collab> (<collab>Ottawa Methods Group</collab>: <person-group person-group-type="author">
<name><surname>Brosseau</surname><given-names>L</given-names></name>
<name><surname>Wells</surname><given-names>G</given-names></name>
<name><surname>Tugwell</surname><given-names>P</given-names></name>
<name><surname>Egan</surname><given-names>M</given-names></name>
<name><surname>Dubouloz</surname><given-names>CJ</given-names></name>
<name><surname>Casimiro</surname><given-names>L</given-names></name>
<name><surname>Robinson</surname><given-names>V</given-names></name>
<name><surname>Pelland</surname><given-names>L</given-names></name>
<name><surname>McGowan</surname><given-names>J</given-names></name>
<name><surname>Lamb</surname><given-names>M</given-names></name>
</person-group>). <article-title>Ottawa Panel evidence clinical practice guidelines for electrotherapy and thermotherapy interventions in the treatment of rheumatoid arthritis</article-title>. <source>Phys Ther</source>, <year>2004</year>: <volume>84</volume>: <fpage>1016</fpage>–<lpage>1043</lpage>.</citation>
</ref>
<ref id="bibr10-0017896911419346">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Haynes</surname><given-names>R</given-names></name>
<name><surname>Wilcznski</surname><given-names>N</given-names></name>
<name><surname>McKibbon</surname><given-names>KA</given-names></name>
<name><surname>Walker</surname><given-names>CJ</given-names></name>
</person-group>. <article-title>Developing optimal search strategies for detecting clinically sound studies in MEDLINE</article-title>. <source>J Am Med Inform Assoc</source>, <year>1994</year>: <volume>1</volume>: <fpage>447</fpage>–<lpage>458</lpage>.</citation>
</ref>
<ref id="bibr11-0017896911419346">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Arnett</surname><given-names>FC</given-names></name>
<name><surname>Edworthy</surname><given-names>SM</given-names></name>
<name><surname>Bloch</surname><given-names>DA</given-names></name>
<etal/>
</person-group>. <article-title>The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis</article-title>. <source>Arthritis Rheum</source>, <year>1988</year>: <volume>31</volume>: <fpage>315</fpage>–<lpage>324</lpage>.</citation>
</ref>
<ref id="bibr12-0017896911419346">
<label>12.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Helewa</surname><given-names>A</given-names></name>
<name><surname>Walker</surname><given-names>JM</given-names></name>
</person-group>. <article-title>Epidemiology and economics of arthritis</article-title>. In: <person-group person-group-type="editor">
<name><surname>Walker</surname><given-names>JM</given-names></name>
<name><surname>Helewa</surname><given-names>A</given-names></name>
</person-group> (eds), <source>Physical Therapy in Rheumatoid Arthritis</source> (pp. <fpage>9</fpage>–<lpage>18</lpage>). <publisher-loc>Toronto</publisher-loc>: <publisher-name>WB Saunders Co.</publisher-name>, <year>2004</year>.</citation>
</ref>
<ref id="bibr13-0017896911419346">
<label>13.</label>
<citation citation-type="journal">
<collab>The Philadelphia Panel</collab>. <article-title>Philadelphia panel evidence-based clinical practice guidelines on selected rehabilitation interventions for neck pain</article-title>. <source>Physical Therapy</source>, <year>2001</year>: <volume>81</volume>: <fpage>1701</fpage>–<lpage>1717</lpage>.</citation>
</ref>
<ref id="bibr14-0017896911419346">
<label>14.</label>
<citation citation-type="journal">
<collab>The Philadelphia Panel</collab>. <article-title>Philadelphia panel evidence-based clinical practice guidelines on selected rehabilitation interventions for low back pain</article-title>. <source>Physical Therapy</source>, <year>2001</year>: <volume>81</volume>: <fpage>1641</fpage>–<lpage>1674</lpage>.</citation>
</ref>
<ref id="bibr15-0017896911419346">
<label>15.</label>
<citation citation-type="journal">
<collab>Outcome Measures for Rheumatoid Arthritis Clinical Trials (OMERACT)</collab>. <article-title>Conference on Outcome measures in Rheumatoid Arthritis Clinical Trials</article-title>. <source>J Rheumatol</source>, <year>1993</year>: <volume>20</volume>: <fpage>526</fpage>–<lpage>591</lpage>.</citation>
</ref>
<ref id="bibr16-0017896911419346">
<label>16.</label>
<citation citation-type="confproc">
<person-group person-group-type="author">
<name><surname>Morin</surname><given-names>M</given-names></name>
<name><surname>Brosseau</surname><given-names>L</given-names></name>
<name><surname>Quirion-DeGrardi</surname><given-names>C</given-names></name>
</person-group>. <article-title>A theoretical framework on low-level laser therapy (classes I, II, and III) application for the treatment of OA and RA (abstract)</article-title>. In: <conf-name>Proceedings of the Canadian Physiotherapy Association Annual Congress</conf-name>; <conf-date>May 31, 1986</conf-date>; <conf-name>Victoria, British Columbia, Canada</conf-name> (p. <fpage>1</fpage>). <publisher-loc>Victoria</publisher-loc>: <publisher-name>Canadian Physiotherapy Association</publisher-name>, <year>1996</year>.</citation>
</ref>
<ref id="bibr17-0017896911419346">
<label>17.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Finch</surname><given-names>E</given-names></name>
<name><surname>Brooks</surname><given-names>D</given-names></name>
<name><surname>Stratford</surname><given-names>P</given-names></name>
<name><surname>Mayo</surname><given-names>N</given-names></name>
</person-group>. <source>Physical Rehabilitation Outcome Measures</source> (<edition>2nd edition</edition>). <publisher-loc>Hamilton</publisher-loc>: <publisher-name>Canadian Physiotherapy Association</publisher-name>, <year>2002</year>.</citation>
</ref>
<ref id="bibr18-0017896911419346">
<label>18.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Tremblay</surname><given-names>LE</given-names></name>
<name><surname>Savard</surname><given-names>J</given-names></name>
<name><surname>Casimiro</surname><given-names>L</given-names></name>
<name><surname>Tremblay</surname><given-names>M</given-names></name>
</person-group>. <source>Répertoire des outils d’évaluation en français pour la réadaptation</source>. <publisher-loc>Ottawa</publisher-loc>: <publisher-name>RIFSSSO</publisher-name>, <year>2004</year>.</citation>
</ref>
<ref id="bibr19-0017896911419346">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jadad</surname><given-names>AR</given-names></name>
<name><surname>Moore</surname><given-names>RA</given-names></name>
<name><surname>Carroll</surname><given-names>D</given-names></name>
<name><surname>Jenkinson</surname><given-names>C</given-names></name>
<name><surname>Reynolds</surname><given-names>DJ</given-names></name>
<name><surname>Gavaghan</surname><given-names>DJ</given-names></name>
<name><surname>McQuay</surname><given-names>HJ</given-names></name>
</person-group>. <article-title>Assessing the quality of reports of randomized trials: Is blinding necessary?</article-title> <source>Control Clin Trials</source>, <year>1996</year>: <volume>17</volume>(<issue>1</issue>): <fpage>1</fpage>–<lpage>12</lpage>.</citation>
</ref>
<ref id="bibr20-0017896911419346">
<label>20.</label>
<citation citation-type="book">
<person-group person-group-type="editor">
<name><surname>Mulrow</surname><given-names>CD</given-names></name>
<name><surname>Oxman</surname><given-names>A</given-names></name>
</person-group> (eds). <source>How to Conduct a Cochrane Systematic Review</source> (<comment>San Antonio Cochrane Collaboration, version 3.0.2</comment>). <publisher-loc>Oxford</publisher-loc>: <publisher-name>The Cochrane Library, The Cochrane Collaboration</publisher-name>, <year>1997</year>.</citation>
</ref>
<ref id="bibr21-0017896911419346">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Stratford</surname><given-names>PW</given-names></name>
<name><surname>Binkley</surname><given-names>JM</given-names></name>
<name><surname>Solomon</surname><given-names>P</given-names></name>
<etal/></person-group>. <article-title>Defining the minimum level of detectable change for the Roland-Morris Questionnaire</article-title>. <source>Phys Ther</source>, <year>1996</year>: <volume>76</volume>: <fpage>359</fpage>–<lpage>368</lpage>.</citation>
</ref>
<ref id="bibr22-0017896911419346">
<label>22.</label>
<citation citation-type="journal">
<collab>The Philadelphia Panel</collab> (<collab>Ottawa Methods Group</collab>: <person-group person-group-type="author">
<name><surname>Brosseau</surname><given-names>L</given-names></name>
<name><surname>Tugwell</surname><given-names>P</given-names></name>
<name><surname>Wells</surname><given-names>G</given-names></name>
<etal/></person-group>.). <article-title>Philadelphia panel evidence-based clinical practice guidelines on selected rehabilitation interventions for knee pain</article-title>. <source>Phys Ther</source>, <year>2001</year>: <volume>81</volume>: <fpage>1676</fpage>–<lpage>1700</lpage>.</citation>
</ref>
<ref id="bibr23-0017896911419346">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Browman</surname><given-names>GP</given-names></name>
<name><surname>Newman</surname><given-names>TE</given-names></name>
<name><surname>Mohide</surname><given-names>EA</given-names></name>
<etal/></person-group>. <article-title>Progress of clinical oncology guidelines development using the Practice Guidelines Development Cycle: The role of practitioner feedback</article-title>. <source>J Clin Oncol</source>, <year>1998</year>: <volume>16</volume>: <fpage>1226</fpage>–<lpage>1231</lpage>.</citation>
</ref>
<ref id="bibr24-0017896911419346">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barlow</surname><given-names>JH</given-names></name>
<name><surname>Wright</surname><given-names>CC</given-names></name>
</person-group>. <article-title>Knowledge in patients with rheumatoid arthritis: A longer term follow-up of a randomized controlled study of patient education leaflets</article-title>. <source>Br J Rheumatol</source>, <year>1998</year>: <volume>37</volume>: <fpage>373</fpage>–<lpage>376</lpage>.</citation>
</ref>
<ref id="bibr25-0017896911419346">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bell</surname><given-names>MJ</given-names></name>
<name><surname>Lineker</surname><given-names>SC</given-names></name>
<name><surname>Wilkins</surname><given-names>AL</given-names></name>
<name><surname>Goldsmith</surname><given-names>CH</given-names></name>
<name><surname>Badley</surname><given-names>EM</given-names></name>
</person-group>. <article-title>A randomized controlled trial to evaluate the efficacy of community based physical therapy in the treatment of people with rheumatoid arthritis</article-title>. <source>J Rheumatol</source>, <year>1998</year>: <volume>25</volume>: <fpage>231</fpage>–<lpage>237</lpage>.</citation>
</ref>
<ref id="bibr26-0017896911419346">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brus</surname><given-names>HLM</given-names></name>
<name><surname>van de Laar</surname><given-names>MAFJ</given-names></name>
<name><surname>Taal</surname><given-names>E</given-names></name>
<name><surname>Rasker</surname><given-names>JJ</given-names></name>
<name><surname>Wiegman</surname><given-names>O</given-names></name>
</person-group>. <article-title>Effects of patient education on compliance with basic treatment regimens and health in recent onset active rheumatoid arthritis</article-title>. <source>Ann Rheum Dis</source>, <year>1998</year>: <volume>57</volume>: <fpage>146</fpage>–<lpage>151</lpage>.</citation>
</ref>
<ref id="bibr27-0017896911419346">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hammond</surname><given-names>A</given-names></name>
<name><surname>Lincoln</surname><given-names>N</given-names></name>
<name><surname>Sutcliffe</surname><given-names>L</given-names></name>
</person-group>. <article-title>A crossover trial evaluating an educational-behavioural programme for patients with RA</article-title>. <source>Patient Educ Couns</source>, <year>1999</year>: <volume>37</volume>: <fpage>19</fpage>–<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr28-0017896911419346">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hammond</surname><given-names>A</given-names></name>
<name><surname>Freeman</surname><given-names>K</given-names></name>
</person-group>. <article-title>One-year outcomes of a randomized controlled trial of an educational-behavioural joint protection programme for people with rheumatoid arthritis</article-title>. <source>Rheumatology (Oxford)</source>, <year>2001</year>: <volume>40</volume>(<issue>9</issue>): <fpage>1044</fpage>–<lpage>1051</lpage>.</citation>
</ref>
<ref id="bibr29-0017896911419346">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hammond</surname><given-names>A</given-names></name>
<name><surname>Freeman</surname><given-names>K</given-names></name>
</person-group>. <article-title>The long-term outcomes from a randomized controlled trial of an educational-behavioural joint protection programme for people with rheumatoid arthritis</article-title>. <source>Clin Rehabil</source>, <year>2004</year>: <volume>18</volume>(<issue>5</issue>): <fpage>520</fpage>–<lpage>528</lpage>.</citation>
</ref>
<ref id="bibr30-0017896911419346">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hammond</surname><given-names>A</given-names></name>
<name><surname>Young</surname><given-names>A</given-names></name>
<name><surname>Kidao</surname><given-names>R</given-names></name>
</person-group>. <article-title>A randomized controlled trial of occupational therapy for people with early rheumatoid arthritis</article-title>. <source>Ann Rheum Dis</source>, <year>2004</year>: <volume>63</volume>(<issue>1</issue>): <fpage>23</fpage>–<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr31-0017896911419346">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hammond</surname><given-names>A</given-names></name>
<name><surname>Bryan</surname><given-names>J</given-names></name>
<name><surname>Hardy</surname><given-names>A</given-names></name>
</person-group>. <article-title>Effects of a modular behavioral arthritis education programme: A pragmatic parallel group randomized control trial</article-title>. <source>Oxford Journal of Rheumatology</source>, <year>2008</year>: <volume>47</volume>: <fpage>1712</fpage>–<lpage>1718</lpage>.</citation>
</ref>
<ref id="bibr32-0017896911419346">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Helliwell</surname><given-names>PS</given-names></name>
<name><surname>O’Hara</surname><given-names>M</given-names></name>
<name><surname>Holdsworth</surname><given-names>J</given-names></name>
<name><surname>Hesselden</surname><given-names>A</given-names></name>
<name><surname>King</surname><given-names>T</given-names></name>
<name><surname>Evans</surname><given-names>P</given-names></name>
</person-group>. <article-title>A 12-month randomized controlled trial of patient education on radiographic changes and quality of life in early rheumatoid arthritis</article-title>. <source>Rheumatology (Oxford)</source>, <year>1999</year>: <volume>38</volume>(<issue>4</issue>): <fpage>303</fpage>–<lpage>308</lpage>.</citation>
</ref>
<ref id="bibr33-0017896911419346">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Knudson</surname><given-names>KG</given-names></name>
<name><surname>Spiegel</surname><given-names>TM</given-names></name>
<name><surname>Furst</surname><given-names>DE</given-names></name>
</person-group>. <article-title>Outpatient educational program for rheumatoid arthritis patients</article-title>. <source>Patient Counsell Health Educ</source>, <year>1981</year>: <volume>3</volume>(<issue>2</issue>): <fpage>77</fpage>–<lpage>82</lpage>.</citation>
</ref>
<ref id="bibr34-0017896911419346">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kraaimaat</surname><given-names>FW</given-names></name>
<name><surname>Brons</surname><given-names>MR</given-names></name>
<name><surname>Geenen</surname><given-names>R</given-names></name>
<name><surname>Bijlsma</surname><given-names>JWJ</given-names></name>
</person-group>. <article-title>The effect of cognitive behavior therapy in patients with rheumatoid arthritis</article-title>. <source>Behav. Res. Ther</source>, <year>1995</year>: <volume>33</volume>(<issue>3</issue>): <fpage>487</fpage>–<lpage>495</lpage>.</citation>
</ref>
<ref id="bibr35-0017896911419346">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lindroth</surname><given-names>Y</given-names></name>
<name><surname>Bauman</surname><given-names>A</given-names></name>
<name><surname>Barnes</surname><given-names>C</given-names></name>
<name><surname>McCredie</surname><given-names>M</given-names></name>
<name><surname>Brooks</surname><given-names>PM</given-names></name>
</person-group>. <article-title>A controlled evaluation of arthritis education</article-title>. <source>Br J Rheumatol</source>, <year>1989</year>: <volume>28</volume>(<issue>1</issue>): <fpage>7</fpage>–<lpage>12</lpage>.</citation>
</ref>
<ref id="bibr36-0017896911419346">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lindroth</surname><given-names>Y</given-names></name>
<name><surname>Brattstrom</surname><given-names>M</given-names></name>
<name><surname>Bellman</surname><given-names>I</given-names></name>
<name><surname>Ekestaf</surname><given-names>G</given-names></name>
<name><surname>Olofsson</surname><given-names>Y</given-names></name>
<name><surname>Strombeck</surname><given-names>B</given-names></name>
<name><surname>Stenshed</surname><given-names>B</given-names></name>
<name><surname>Wikstrom</surname><given-names>I</given-names></name>
<name><surname>Nilsson</surname><given-names>JA</given-names></name>
<name><surname>Wollheim</surname><given-names>FA</given-names></name>
</person-group>. <article-title>A problem-based education program for patients with rheumatoid arthritis: Evaluation after three and twelve months</article-title>. <source>Arthritis Care Res</source>, <year>1997</year>: <volume>10</volume>(<issue>5</issue>): <fpage>325</fpage>–<lpage>332</lpage>.</citation>
</ref>
<ref id="bibr37-0017896911419346">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Masiero</surname><given-names>S</given-names></name>
<name><surname>Boniolo</surname><given-names>A</given-names></name>
<name><surname>Wassermann</surname><given-names>L</given-names></name>
<name><surname>Machiedo</surname><given-names>H</given-names></name>
<name><surname>Volante</surname><given-names>D</given-names></name>
<name><surname>Punzi</surname><given-names>L</given-names></name>
</person-group>. <article-title>Effects of an educational-behavioral joint protection program on people with moderate to severe rheumatoid arthritis: A randomized controlled trial</article-title>. <source>Clinical Rheumatology</source>, <year>2007</year>: <volume>26</volume>: <fpage>2043</fpage>–<lpage>2050</lpage>.</citation>
</ref>
<ref id="bibr38-0017896911419346">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mathieux</surname><given-names>R</given-names></name>
<name><surname>Marotte</surname><given-names>H</given-names></name>
<name><surname>Battistini</surname><given-names>L</given-names></name>
<name><surname>Sarrazin</surname><given-names>A</given-names></name>
<name><surname>Berthier</surname><given-names>M</given-names></name>
<name><surname>Miossec</surname></name>
</person-group>. <article-title>Early occupational therapy programme increases hand grip strength at 3 months: Results from a randomized, blind, controlled study in early rheumatoid arthritis</article-title>. <source>Annals of the Rheumatic Disease, the Eular Journals</source>, <year>2009</year>: <volume>68</volume>: <fpage>400</fpage>–<lpage>403</lpage>.</citation>
</ref>
<ref id="bibr39-0017896911419346">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McAuley</surname><given-names>CA</given-names></name>
</person-group>. <article-title>Arthritis client education: A Feasibility study comparing 2 Instructional Styles</article-title>. <source>Can J Rehabil</source>, <year>1993</year>: <volume>7</volume>(<issue>1</issue>): <fpage>83</fpage>–<lpage>84</lpage>.</citation>
</ref>
<ref id="bibr40-0017896911419346">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Neuberger</surname><given-names>GB</given-names></name>
<name><surname>Smith</surname><given-names>KV</given-names></name>
<name><surname>Black</surname><given-names>SO</given-names></name>
<name><surname>Hassanein</surname><given-names>R</given-names></name>
</person-group>. <article-title>Promoting self-care in clients with arthritis</article-title>. <source>Arthritis Care Res</source>, <year>1993</year>: <volume>6</volume>(<issue>3</issue>): <fpage>141</fpage>–<lpage>148</lpage>.</citation>
</ref>
<ref id="bibr41-0017896911419346">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Niedermann</surname><given-names>K</given-names></name>
<name><surname>de Bie</surname><given-names>RA</given-names></name>
<name><surname>Kubli</surname><given-names>R</given-names></name>
<name><surname>Ciurea</surname><given-names>A</given-names></name>
<name><surname>Steurer-Stey</surname><given-names>C</given-names></name>
<name><surname>Villiger</surname><given-names>PM</given-names></name>
<etal/></person-group>. <article-title>Effectiveness of individual resource-oriented joint protection education in people with rheumatoid arthritis. A randomized controlled trial</article-title>. <source>Patient Education and Counseling</source>, <year>2011</year>: <volume>82</volume>(<issue>1</issue>): <fpage>42</fpage>–<lpage>48</lpage>.</citation>
</ref>
<ref id="bibr42-0017896911419346">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Parker</surname><given-names>JC</given-names></name>
<name><surname>Singsen</surname><given-names>BH</given-names></name>
<name><surname>Hewett</surname><given-names>JE</given-names></name>
<name><surname>Walker</surname><given-names>SE</given-names></name>
<name><surname>Hazelwood</surname><given-names>SE</given-names></name>
<name><surname>Hall</surname><given-names>PJ</given-names></name>
<name><surname>Holsten</surname><given-names>DJ</given-names></name>
<name><surname>Rodon</surname><given-names>CM</given-names></name>
</person-group>. <article-title>Educating patients with rheumatoid arthritis: A prospective analysis</article-title>. <source>Arch Phys Med Rehabil</source>, <year>1984</year>: <volume>65</volume>(<issue>12</issue>): <fpage>771</fpage>–<lpage>774</lpage>.</citation>
</ref>
<ref id="bibr43-0017896911419346">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Parker</surname><given-names>JC</given-names></name>
<name><surname>Frank</surname><given-names>RG</given-names></name>
<name><surname>Beck</surname><given-names>NC</given-names></name>
<name><surname>Smarr</surname><given-names>KL</given-names></name>
<name><surname>Buescher</surname><given-names>KL</given-names></name>
<name><surname>Phillips</surname><given-names>LR</given-names></name>
<name><surname>Smith</surname><given-names>EI</given-names></name>
<name><surname>Anderson</surname><given-names>SK</given-names></name>
<name><surname>Walker</surname><given-names>SE</given-names></name>
</person-group>. <article-title>Pain management in rheumatoid arthritis patients</article-title>. <source>Arthritis Rheum</source>, <year>1988</year>: <volume>31</volume>(<issue>5</issue>): <fpage>593</fpage>–<lpage>601</lpage>.</citation>
</ref>
<ref id="bibr44-0017896911419346">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Parker</surname><given-names>JC</given-names></name>
<name><surname>Smarr</surname><given-names>KL</given-names></name>
<name><surname>Buckelew</surname><given-names>SP</given-names></name>
<name><surname>Stucky-Ropp</surname><given-names>RC</given-names></name>
<name><surname>Hewett</surname><given-names>JE</given-names></name>
<name><surname>Johnson</surname><given-names>JC</given-names></name>
<name><surname>Wright</surname><given-names>GE</given-names></name>
<name><surname>Irvin</surname><given-names>WS</given-names></name>
<name><surname>Walker</surname><given-names>SE</given-names></name>
</person-group>. <article-title>Effects of stress management on clinical outcomes in rheumatoid arthritis</article-title>. <source>Arthritis Rheum</source>, <year>1995</year>: <volume>38</volume>(<issue>12</issue>): <fpage>1807</fpage>–<lpage>1818</lpage>.</citation>
</ref>
<ref id="bibr45-0017896911419346">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Platt Furst</surname><given-names>G</given-names></name>
<name><surname>Gerber</surname><given-names>LH</given-names></name>
<name><surname>Smith</surname><given-names>C</given-names></name>
<name><surname>Fisher</surname><given-names>S</given-names></name>
<name><surname>Shulman</surname><given-names>B</given-names></name>
</person-group>. <article-title>A program for improving energy conservation behaviors in adults with rheumatoid arthritis</article-title>. <source>Am J Occup Ther</source>, <year>1987</year>: <volume>41</volume>(<issue>2</issue>): <fpage>102</fpage>–<lpage>111</lpage>.</citation>
</ref>
<ref id="bibr46-0017896911419346">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Potts</surname><given-names>M</given-names></name>
<name><surname>Brandt</surname><given-names>KD</given-names></name>
</person-group>. <article-title>Analysis of education -support groups for patients with rheumatoid arthritis</article-title>. <source>Patient Couns Health Educ</source>, <year>1983</year>: <volume>4</volume>(<issue>3</issue>): <fpage>161</fpage>–<lpage>166</lpage>.</citation>
</ref>
<ref id="bibr47-0017896911419346">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Riemsma</surname><given-names>RP</given-names></name>
<name><surname>Taal</surname><given-names>E</given-names></name>
<name><surname>Brus</surname><given-names>HLM</given-names></name>
<name><surname>Rasker</surname><given-names>JJ</given-names></name>
<name><surname>Wiegman</surname><given-names>O</given-names></name>
</person-group>. <article-title>Coordinated individual education with an arthritis passport for patients with rheumatoid arthritis</article-title>. <source>Arthritis Care Res</source>, <year>1997</year>: <volume>10</volume>(<issue>4</issue>): <fpage>238</fpage>–<lpage>249</lpage>.</citation>
</ref>
<ref id="bibr48-0017896911419346">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Siu</surname><given-names>AM</given-names></name>
<name><surname>Chui</surname><given-names>DY</given-names></name>
</person-group>. <article-title>Evaluation of a community rehabilitation service for people with rheumatoid arthritis</article-title>. <source>Patient Educ Couns</source>, <year>2004</year>: <volume>55</volume>(<issue>1</issue>): <fpage>62</fpage>–<lpage>69</lpage>.</citation>
</ref>
<ref id="bibr49-0017896911419346">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Strauss</surname><given-names>GD</given-names></name>
<name><surname>Spiegel</surname><given-names>JS</given-names></name>
<name><surname>Daniles</surname><given-names>M</given-names></name>
<name><surname>Spiegel</surname><given-names>T</given-names></name>
<name><surname>Landsverk</surname><given-names>J</given-names></name>
<name><surname>Roy-Byrne</surname><given-names>P</given-names></name>
<name><surname>Edelstein</surname><given-names>C</given-names></name>
<name><surname>Ehlhardt</surname><given-names>J</given-names></name>
<name><surname>Falke</surname><given-names>R</given-names></name>
<name><surname>Hindin</surname><given-names>L</given-names></name>
<name><surname>Zackler</surname><given-names>L</given-names></name>
</person-group>. <article-title>Group therapies for rheumatoid arthritis. A controlled study of two approaches</article-title>. <source>Arthritis Rheum</source>, <year>1986</year>: <volume>29</volume>(<issue>10</issue>): <fpage>1203</fpage>–<lpage>1209</lpage>.</citation>
</ref>
<ref id="bibr50-0017896911419346">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Taal</surname><given-names>E</given-names></name>
<name><surname>Riemsma</surname><given-names>RP</given-names></name>
<name><surname>Brus</surname><given-names>HLM</given-names></name>
<name><surname>Seydel</surname><given-names>ER</given-names></name>
<name><surname>Rasker</surname><given-names>JJ</given-names></name>
<name><surname>Wiegman</surname><given-names>O</given-names></name>
</person-group>. <article-title>Group education for patients with RA</article-title>. <source>Patient Educ Couns</source>, <year>1993</year>: <volume>20</volume>: <fpage>127</fpage>–<lpage>187</lpage>.</citation>
</ref>
<ref id="bibr51-0017896911419346">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wetstone</surname><given-names>S</given-names></name>
<name><surname>Sheehan</surname><given-names>TJ</given-names></name>
<name><surname>Votaw</surname><given-names>RG</given-names></name>
<name><surname>Peterson</surname><given-names>MG</given-names></name>
<name><surname>Rothfield</surname><given-names>N</given-names></name>
</person-group>. <article-title>Evaluation of a computer based education lesson for patients with rheumatoid arthritis</article-title>. <source>J Rheumatol</source>, <year>1985</year>: <volume>12</volume>(<issue>5</issue>): <fpage>907</fpage>–<lpage>912</lpage>.</citation>
</ref>
<ref id="bibr52-0017896911419346">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Abourazzak</surname><given-names>F</given-names></name>
<name><surname>Mansouri</surname><given-names>LEL</given-names></name>
<name><surname>Huchet</surname><given-names>D</given-names></name>
<name><surname>Lozac’hmeur</surname><given-names>R</given-names></name>
<name><surname>Hajjaj-Hassouni</surname><given-names>N</given-names></name>
<name><surname>Ingels</surname><given-names>A</given-names></name>
<name><surname>Chalès</surname><given-names>G</given-names></name>
<name><surname>Perdriger</surname><given-names>A</given-names></name>
</person-group>. <article-title>Long-term effects of therapeutic education for patients with rheumatoid arthritis</article-title>. <source>Société Française de Rhumatologie</source>, <year>2009</year>: <volume>76</volume>: <fpage>648</fpage>–<lpage>653</lpage>.</citation>
</ref>
<ref id="bibr53-0017896911419346">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ahlmen</surname><given-names>M</given-names></name>
<name><surname>Sullivan</surname><given-names>M</given-names></name>
<name><surname>Bjelle</surname><given-names>A</given-names></name>
</person-group>. <article-title>Team versus non-team outpatient care in rheumatoid arthritis</article-title>. <source>Arthritis and Rheumatism</source>, <year>1988</year>: <volume>31</volume>(<issue>4</issue>): <fpage>471</fpage>–<lpage>479</lpage>.</citation>
</ref>
<ref id="bibr54-0017896911419346">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Anderson</surname><given-names>RB</given-names></name>
<name><surname>Needleman</surname><given-names>RD</given-names></name>
<name><surname>Gatter</surname><given-names>RA</given-names></name>
<name><surname>Andrews</surname><given-names>RP</given-names></name>
<name><surname>Scarola</surname><given-names>JA</given-names></name>
</person-group>. <article-title>Patient outcome following inpatient vs outpatient treatment of rheumatoid arthritis</article-title>. <source>Journal of Rheumatology</source>, <year>1988</year>: <volume>15</volume>(<issue>4</issue>): <fpage>556</fpage>–<lpage>560</lpage>.</citation>
</ref>
<ref id="bibr55-0017896911419346">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Appelbaum</surname><given-names>KA</given-names></name>
<name><surname>Blanchard</surname><given-names>EB</given-names></name>
<name><surname>Hickling</surname><given-names>EJ</given-names></name>
<name><surname>Alfonso</surname><given-names>M</given-names></name>
</person-group>. <article-title>Cognitive behavioral treatment of a veteran population with moderate to severe rheumatoid arthritis</article-title>. <source>Behavior Therapy</source>, <year>1988</year>: <volume>19</volume>: <fpage>489</fpage>–<lpage>502</lpage>.</citation>
</ref>
<ref id="bibr56-0017896911419346">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bagheri-Nesami</surname><given-names>M</given-names></name>
<name><surname>Mohseni-Bandpei</surname><given-names>M</given-names></name>
<name><surname>Shayesteh-Azar</surname><given-names>M</given-names></name>
</person-group>. <article-title>The effect of Benson Relaxation Technique on rheumatoid arthritis patients: Extended report</article-title>. <source>International Journal of Nursing Practice</source>, <year>2006</year>: <volume>12</volume>: <fpage>214</fpage>–<lpage>219</lpage>.</citation>
</ref>
<ref id="bibr57-0017896911419346">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Balmer</surname><given-names>DH</given-names></name>
</person-group>. <article-title>The CARE project: The evaluation of group counseling as a therapeutic intervention for patients with rheumatoid arthritis</article-title>. <source>British Journal of Guidance and Counselling</source>, <year>1989</year>: <volume>17</volume>(<issue>3</issue>): <fpage>304</fpage>–<lpage>316</lpage>.</citation>
</ref>
<ref id="bibr58-0017896911419346">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barlow</surname><given-names>JH</given-names></name>
<name><surname>Turner</surname><given-names>AP</given-names></name>
<name><surname>Wright</surname><given-names>CC</given-names></name>
</person-group>. <article-title>Sharing, caring and learning to take control: Self-management training for people with arthritis</article-title>. <source>Psychology, Health and Medicine</source>, <year>1998</year>: <volume>3</volume>(<issue>4</issue>): <fpage>387</fpage>–<lpage>393</lpage>.</citation>
</ref>
<ref id="bibr59-0017896911419346">
<label>59.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barlow</surname><given-names>JH</given-names></name>
<name><surname>Turner</surname><given-names>AP</given-names></name>
<name><surname>Wright</surname><given-names>CC</given-names></name>
</person-group>. <article-title>A randomized controlled study of the arthritis self-management program in the UK</article-title>. <source>Health Education Research</source>, <year>2000</year>: <volume>15</volume>(<issue>6</issue>): <fpage>665</fpage>–<lpage>680</lpage>.</citation>
</ref>
<ref id="bibr60-0017896911419346">
<label>60.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Belcon</surname><given-names>MC</given-names></name>
<name><surname>Haynes</surname><given-names>RB</given-names></name>
<name><surname>Tugwell</surname><given-names>P</given-names></name>
</person-group>. <article-title>A critical review of compliance studies in rheumatoid arthritis</article-title>. <source>Arthritis and Rheumatism</source>, <year>1984</year>: <volume>27</volume>(<issue>11</issue>): <fpage>1227</fpage>–<lpage>1233</lpage>.</citation>
</ref>
<ref id="bibr61-0017896911419346">
<label>61.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bradley</surname><given-names>LA</given-names></name>
<name><surname>Turner</surname><given-names>RA</given-names></name>
<name><surname>Young</surname><given-names>LD</given-names></name>
<name><surname>Agudelo</surname><given-names>CA</given-names></name>
<name><surname>Anderson</surname><given-names>KO</given-names></name>
<name><surname>McDaniel</surname><given-names>LK</given-names></name>
</person-group>. <article-title>Effects of cognitive-behavioral therapy on pain behavior of rheumatoid arthritis (RA) patients: Preliminary outcomes</article-title>. <source>Scandinavian Journal of Behavioural Therapy</source>, <year>1985</year>: <volume>14</volume>: <fpage>51</fpage>–<lpage>64</lpage>.</citation>
</ref>
<ref id="bibr62-0017896911419346">
<label>62.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Branch</surname><given-names>VK</given-names></name>
<name><surname>Lipsky</surname><given-names>K</given-names></name>
<name><surname>Nieman</surname><given-names>T</given-names></name>
<name><surname>Lipsky</surname><given-names>PE</given-names></name>
</person-group>. <article-title>Positive impact of an intervention by arthritis patient educators on knowledge and satisfaction of patients in a rheumatology practice</article-title>. <source>Arthritis Care and Research</source>, <year>1999</year>: <volume>12</volume>(<issue>6</issue>): <fpage>370</fpage>–<lpage>375</lpage>.</citation>
</ref>
<ref id="bibr63-0017896911419346">
<label>63.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brooks</surname><given-names>PM</given-names></name>
<name><surname>Lindroth</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Patient education in chronis arthritis</article-title>. <source>The Medical Journal of Australia</source>, <year>1985</year>: <volume>143</volume>: <fpage>486</fpage>–<lpage>487</lpage>.</citation>
</ref>
<ref id="bibr64-0017896911419346">
<label>64.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bruce</surname><given-names>JR</given-names></name>
<name><surname>Riggin</surname><given-names>CS</given-names></name>
<name><surname>Parker</surname><given-names>JC</given-names></name>
<name><surname>Walker</surname><given-names>SE</given-names></name>
<name><surname>Meyer</surname><given-names>AA</given-names></name>
<name><surname>Wellman</surname><given-names>FE</given-names></name>
<name><surname>Kunce</surname><given-names>J</given-names></name>
</person-group>. <article-title>Pain management in rheumatoid arthritis: Cognitive behavior modification and transcutaneous neural stimulation</article-title>. <source>Arthritis Care and Research June</source>, <year>1988</year>: <volume>1</volume>(<issue>2</issue>): <fpage>78</fpage>–<lpage>84</lpage>.</citation>
</ref>
<ref id="bibr65-0017896911419346">
<label>65.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Burckhardt</surname><given-names>CS</given-names></name>
</person-group>. <article-title>Arthritis and musculoskeletal patient education standards</article-title>. <source>Arthritis Care and Research</source>, <year>1994</year>: <volume>7</volume>: <fpage>1</fpage>–<lpage>4</lpage>.</citation>
</ref>
<ref id="bibr66-0017896911419346">
<label>66.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cohen</surname><given-names>JL</given-names></name>
<name><surname>van Houten Sauter</surname><given-names>S</given-names></name>
<name><surname>DeVellis</surname><given-names>RF</given-names></name>
<name><surname>McEvoy DeVellis</surname><given-names>B</given-names></name>
</person-group>. <article-title>Evaluation of arthritis self-management courses led by laypersons and by professionals</article-title>. <source>Arthritis and Rheumatism</source>, <year>1986</year>: <volume>29</volume>(<issue>3</issue>): <fpage>388</fpage>–<lpage>393</lpage>.</citation>
</ref>
<ref id="bibr67-0017896911419346">
<label>67.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cziske</surname><given-names>R</given-names></name>
<name><surname>Jaeckel</surname><given-names>W</given-names></name>
<name><surname>Jacobi</surname><given-names>E</given-names></name>
</person-group>. <article-title>Effekt eines Kurztrainingsprogramms zur Schmerzbewaltigung bei Rheumapatienten wahrend der Rehabilitation</article-title>. <source>Zeitschrift fur Klinische Psychologie</source>, <year>1987</year>: <volume>16</volume>(<issue>2</issue>): <fpage>115</fpage>–<lpage>123</lpage>.</citation>
</ref>
<ref id="bibr68-0017896911419346">
<label>68.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Daltroy</surname><given-names>LH</given-names></name>
<name><surname>Liang</surname><given-names>MH</given-names></name>
</person-group>. <article-title>Patient education in the rheumatic diseases: A research agenda</article-title>. <source>Arthritis Care and Research</source>, <year>1988</year>: <volume>1</volume>(<issue>3</issue>): <fpage>161</fpage>–<lpage>169</lpage>.</citation>
</ref>
<ref id="bibr69-0017896911419346">
<label>69.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Daltroy</surname><given-names>LH</given-names></name>
<name><surname>Liang</surname><given-names>MH</given-names></name>
</person-group>. <article-title>Arthritis Education: Opportunities and state of the art</article-title>. <source>Health Education Quarterly</source>, <year>1993</year>: <volume>20</volume>(<issue>1</issue>): <fpage>3</fpage>–<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr70-0017896911419346">
<label>70.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Daltroy</surname><given-names>LH</given-names></name>
</person-group>. <article-title>Arthritis patient education</article-title>. <source>Bulletin on the Rheumatic Diseases</source>, <year>1995</year>: <volume>41</volume>(<issue>7</issue>): <fpage>2</fpage>–<lpage>4</lpage>.</citation>
</ref>
<ref id="bibr71-0017896911419346">
<label>71.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Darmawan</surname><given-names>J</given-names></name>
<name><surname>Muirden</surname><given-names>KD</given-names></name>
<name><surname>Wigley</surname><given-names>RD</given-names></name>
<name><surname>Valkenburg</surname><given-names>HA</given-names></name>
</person-group>. <article-title>Arthritis community education by leather puppet (wayang kulit) shadow play in rural Indonesia (Java)</article-title>. <source>Rheumatol Int</source>, <year>1992</year>: <volume>12</volume>(<issue>3</issue>): <fpage>97</fpage>–<lpage>101</lpage>.</citation>
</ref>
<ref id="bibr72-0017896911419346">
<label>72.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Davis</surname><given-names>GC</given-names></name>
<name><surname>White</surname><given-names>TL</given-names></name>
</person-group>. <article-title>A goal attainment pain management program for older adults with arthritis</article-title>. <source>Pain Management Nursing</source>, <year>2008</year>: <volume>9</volume>(<issue>4</issue>): <fpage>171</fpage>–<lpage>179</lpage>.</citation>
</ref>
<ref id="bibr73-0017896911419346">
<label>73.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dial</surname><given-names>C</given-names></name>
<name><surname>Windsor</surname><given-names>RA</given-names></name>
</person-group>. <article-title>A formative evaluation of a health education – water exercise program for class I and II adult rheumatoid arthritis patients</article-title>. <source>Patient Education and Counseling</source>, <year>1985</year>: <volume>7</volume>: <fpage>33</fpage>–<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr74-0017896911419346">
<label>74.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ellard</surname><given-names>DR</given-names></name>
<name><surname>Barlow</surname><given-names>JH</given-names></name>
<name><surname>Paskins</surname><given-names>Z</given-names></name>
<name><surname>Stapley</surname><given-names>J</given-names></name>
<name><surname>Wild</surname><given-names>A</given-names></name>
<name><surname>Rowe</surname><given-names>IF</given-names></name>
</person-group>. <article-title>Research article: Piloting education days for patients with early rheumatoid arthritis and their partners: A multidisciplinary approach</article-title>. <source>Musculoskeletal care</source>, <year>2009</year>: <volume>7</volume>(<issue>1</issue>): <fpage>17</fpage>–<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr75-0017896911419346">
<label>75.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Feinberg</surname><given-names>J</given-names></name>
</person-group>. <article-title>Effect of the arthritis health professional on compliance with use of resting hand splints by patients with rheumatoid arthritis</article-title>. <source>Arthritis Care and Research</source>, <year>1992</year>: <volume>5</volume>(<issue>1</issue>): <fpage>17</fpage>–<lpage>23</lpage>.</citation>
</ref>
<ref id="bibr76-0017896911419346">
<label>76.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Friedrich</surname><given-names>M</given-names></name>
<name><surname>Cermark</surname><given-names>T</given-names></name>
<name><surname>Maderbacher</surname><given-names>P</given-names></name>
</person-group>. <article-title>The effect of brochure use versus therapist teaching on patients performing therapeutic exercise and on changes in impairment status</article-title>. <source>Physical Therapy</source>, <year>1996</year>: <volume>76</volume>(<issue>10</issue>): <fpage>1082</fpage>–<lpage>1088</lpage>.</citation>
</ref>
<ref id="bibr77-0017896911419346">
<label>77.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fries</surname><given-names>JF</given-names></name>
<name><surname>Carey</surname><given-names>C</given-names></name>
<name><surname>McShane</surname><given-names>Dennis</given-names></name>
</person-group>. <article-title>Patient education in arthritis: Randomized controlled trial of a mail-delivered program</article-title>. <source>The Journal of Rheumatology</source>, <year>1997</year>: <volume>24</volume>(<issue>7</issue>): <fpage>1378</fpage>–<lpage>1383</lpage>.</citation>
</ref>
<ref id="bibr78-0017896911419346">
<label>78.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Geissner</surname><given-names>E</given-names></name>
<name><surname>Jungnitsch</surname><given-names>G</given-names></name>
<name><surname>Schmitz</surname><given-names>J</given-names></name>
</person-group>. <article-title>Psychological treatment approaches in pain. A comparative study of therapies in patients with chronic polyarthritis</article-title>. <source>Z Klin Psychol Psychopathol Psychother</source>, <year>1994</year>: <volume>42</volume>(<issue>4</issue>): <fpage>319</fpage>–<lpage>338</lpage>.</citation>
</ref>
<ref id="bibr79-0017896911419346">
<label>79.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gerber</surname><given-names>L</given-names></name>
<name><surname>Furst</surname><given-names>G</given-names></name>
<name><surname>Shulman</surname><given-names>B</given-names></name>
<name><surname>Smith</surname><given-names>C</given-names></name>
<name><surname>Thornton</surname><given-names>B</given-names></name>
<name><surname>Liang</surname><given-names>M</given-names></name>
<name><surname>Cullen</surname><given-names>K</given-names></name>
<name><surname>Stevens</surname><given-names>MB</given-names></name>
<name><surname>Gillbert</surname><given-names>N</given-names></name>
</person-group>. <article-title>Patient education program to teach energy conservation behaviors to patients with rheumatoid arthritis: A pilot study</article-title>. <source>Archives of Physical Medicine and Rehabilitation</source>, <year>1987</year>: <volume>68</volume>: <fpage>442</fpage>–<lpage>445</lpage>.</citation>
</ref>
<ref id="bibr80-0017896911419346">
<label>80.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Goeppinger</surname><given-names>J</given-names></name>
<name><surname>Arthur</surname><given-names>MW</given-names></name>
<name><surname>Baglioni</surname><given-names>AJ</given-names></name>
<name><surname>Brunk</surname><given-names>SE</given-names></name>
<name><surname>Brunner</surname><given-names>CM</given-names></name>
</person-group>. <article-title>A Reexamination or the effectiveness of self-care education for persons with arthritis</article-title>. <source>Arthritis Care and Research</source>, <year>1989</year>: <volume>32</volume>(<issue>6</issue>): <fpage>706</fpage>–<lpage>716</lpage>.</citation>
</ref>
<ref id="bibr81-0017896911419346">
<label>81.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Goff</surname><given-names>S</given-names></name>
</person-group>. <article-title>Continuing education – Autoimmune diseases – Patients benefit from arthritis education</article-title>. <source>World of Irish Nursing &amp; Midwifery</source>, <year>2009</year>: <volume>17</volume>(<issue>3</issue>): <fpage>39</fpage>–<lpage>40</lpage>.</citation>
</ref>
<ref id="bibr82-0017896911419346">
<label>82.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hammond</surname><given-names>A</given-names></name>
</person-group>. <article-title>The effect of a joint protection education programme for people with rheumatoid arthritis</article-title>. <source>Clinical Rehabilitation</source>, <year>1999</year>: <volume>13</volume>: <fpage>392</fpage>–<lpage>400</lpage>.</citation>
</ref>
<ref id="bibr83-0017896911419346">
<label>83.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harvey</surname><given-names>PW</given-names></name>
<name><surname>Petkov</surname><given-names>JN</given-names></name>
<name><surname>Misan</surname><given-names>G</given-names></name>
<name><surname>Fuller</surname><given-names>J</given-names></name>
<name><surname>Battersby</surname><given-names>MW</given-names></name>
<name><surname>Cayetano</surname><given-names>TN</given-names></name>
<name><surname>Warren</surname><given-names>K</given-names></name>
<name><surname>Holmes</surname><given-names>P</given-names></name>
</person-group>. <article-title>Self-management support and training for patients with chronic and complex conditions improves health-related behaviour and health outcomes</article-title>. <source>Australian Health Review</source>, <year>2008</year>: <volume>32</volume>(<issue>2</issue>): <fpage>330</fpage>–<lpage>338</lpage>.</citation>
</ref>
<ref id="bibr84-0017896911419346">
<label>84.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Helewa</surname><given-names>A</given-names></name>
<name><surname>Smythe</surname><given-names>HA</given-names></name>
<name><surname>Goldsmith</surname><given-names>CH</given-names></name>
</person-group>. <article-title>Can specially trained physiotherapists improve the care of patients with rheumatoid arthritis? A randomized health care trial</article-title>. <source>The Journal of Rheumatology</source>, <year>1993</year>: <volume>21</volume>: <fpage>70</fpage>–<lpage>79</lpage>.</citation>
</ref>
<ref id="bibr85-0017896911419346">
<label>85.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hendry</surname><given-names>GD</given-names></name>
<name><surname>Schrieber</surname><given-names>L</given-names></name>
<name><surname>Bryce</surname><given-names>D</given-names></name>
</person-group>. <article-title>Patients teach students: Partners in arthritis education</article-title>. <source>Medical Education</source>, <year>1999</year>: <volume>33</volume>: <fpage>674</fpage>–<lpage>677</lpage>.</citation>
</ref>
<ref id="bibr86-0017896911419346">
<label>86.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hirano</surname><given-names>PC</given-names></name>
<name><surname>Laurent</surname><given-names>DD</given-names></name>
<name><surname>Lorig</surname><given-names>K</given-names></name>
</person-group>. <article-title>Arthritis patient education studies, 1987–1991: A review of the literature</article-title>. <source>Patient Education and Counselling</source>, <year>1994</year>: <volume>24</volume>: <fpage>9</fpage>–<lpage>54</lpage>.</citation>
</ref>
<ref id="bibr87-0017896911419346">
<label>87.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Holman</surname><given-names>H</given-names></name>
<name><surname>Lorig</surname><given-names>K</given-names></name>
</person-group>. <article-title>Patient education in the rheumatic diseases – pros and cons</article-title>. <source>Arthritis Foundation/Bulletin on the Rheumatic Diseases</source>, <year>1987</year>: <volume>37</volume>(<issue>5</issue>): <fpage>1</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr88-0017896911419346">
<label>88.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Holman</surname><given-names>HR</given-names></name>
<name><surname>Lorig</surname><given-names>KR</given-names></name>
</person-group>. <article-title>Patient education: Essential to good health care for patients with chronic arthritis</article-title>. <source>Arthritis and Rheumatism</source>, <year>1997</year>: <volume>40</volume>(<issue>8</issue>): <fpage>1371</fpage>–<lpage>1373</lpage>.</citation>
</ref>
<ref id="bibr89-0017896911419346">
<label>89.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huffstutter</surname><given-names>J</given-names></name>
<name><surname>Craig</surname><given-names>DW</given-names></name>
<name><surname>Schimizzi</surname><given-names>G</given-names></name>
<name><surname>Harshbarger</surname><given-names>J</given-names></name>
<name><surname>Lisse</surname><given-names>J</given-names></name>
<name><surname>Kasle</surname><given-names>S</given-names></name>
<name><surname>Hymson</surname><given-names>L</given-names></name>
<name><surname>Yocum</surname><given-names>D</given-names></name>
<name><surname>Castro</surname><given-names>L</given-names></name>
<name><surname>Hegedus</surname><given-names>R</given-names></name>
<name><surname>Calleri</surname><given-names>P</given-names></name>
<name><surname>Yeilding</surname><given-names>N</given-names></name>
<name><surname>Gilmer</surname><given-names>K</given-names></name>
</person-group>. <article-title>A multicenter, randomized, open study to evaluate the impact of an electronic data capture system on the care of patients with rheumatoid arthritis</article-title>. <source>Current Medical Research and Opinon</source>, <year>2007</year>: <volume>23</volume>(<issue>8</issue>): <fpage>1967</fpage>–<lpage>1979</lpage>.</citation>
</ref>
<ref id="bibr90-0017896911419346">
<label>90.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Huiskes</surname><given-names>CJAE</given-names></name>
<name><surname>Kraaimaat</surname><given-names>FW</given-names></name>
<name><surname>Brons</surname><given-names>MR</given-names></name>
<name><surname>Bijlsma</surname><given-names>JWJ</given-names></name>
</person-group>. <article-title>The effect of behaviour therapy and occupation therapy in patients with rheumatoid arthritis</article-title>. <source>Gedragstherapie</source>, <year>1991</year>: <volume>24</volume>(<issue>4</issue>): <fpage>253</fpage>–<lpage>268</lpage>.</citation>
</ref>
<ref id="bibr91-0017896911419346">
<label>91.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaplan</surname><given-names>S</given-names></name>
<name><surname>Kozin</surname><given-names>F</given-names></name>
</person-group>. <article-title>A controlled study of group counseling in rheumatoid arthritis</article-title>. <source>The Journal of Rheumatology</source>, <year>1981</year>: <volume>8</volume>(<issue>1</issue>): <fpage>91</fpage>–<lpage>99</lpage>.</citation>
</ref>
<ref id="bibr92-0017896911419346">
<label>92.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kaye</surname><given-names>RL</given-names></name>
<name><surname>Hammond</surname><given-names>AH</given-names></name>
</person-group>. <article-title>Understanding rheumatoid arthritis – evaluation of a patient education program</article-title>. <source>Journal of the American Medical Association</source>, <year>1978</year>: <volume>239</volume>(<issue>23</issue>): <fpage>2466</fpage>–<lpage>2467</lpage>.</citation>
</ref>
<ref id="bibr93-0017896911419346">
<label>93.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>LeFort</surname><given-names>SM</given-names></name>
<name><surname>Gray-Donald</surname><given-names>K</given-names></name>
<name><surname>Rowat</surname><given-names>KM</given-names></name>
<name><surname>Jeans</surname><given-names>ME</given-names></name>
</person-group>. <article-title>Randomized controlled trial of a community-based psychoeducation program for the self-management of chronic pain</article-title>. <source>Pain</source>, <year>1998</year>: <volume>74</volume>: <fpage>297</fpage>–<lpage>306</lpage>.</citation>
</ref>
<ref id="bibr94-0017896911419346">
<label>94.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Li</surname><given-names>LC</given-names></name>
<name><surname>Davis</surname><given-names>AM</given-names></name>
<name><surname>Lineker</surname><given-names>SC</given-names></name>
<name><surname>Coyte</surname><given-names>PC</given-names></name>
<name><surname>Bombardier</surname><given-names>C</given-names></name>
</person-group>. <article-title>Effectiveness of the primary therapist model for rheumatoid arthritis rehabilitation: A randomized controlled trial</article-title>. <source>Arthritis &amp; Rheumatism (Arthritis Care &amp; Research)</source>, <year>2006</year>: <volume>55</volume>(<issue>1</issue>): <fpage>42</fpage>–<lpage>52</lpage>.</citation>
</ref>
<ref id="bibr95-0017896911419346">
<label>95.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Liang</surname><given-names>MH</given-names></name>
<name><surname>Partridge</surname><given-names>AJ</given-names></name>
<name><surname>Larson</surname><given-names>MG</given-names></name>
<name><surname>Gall</surname><given-names>V</given-names></name>
<name><surname>Taylor</surname><given-names>J</given-names></name>
<name><surname>Berkman</surname><given-names>C</given-names></name>
<name><surname>Master</surname><given-names>R</given-names></name>
<name><surname>Feltin</surname><given-names>M</given-names></name>
<name><surname>Taylor</surname><given-names>J</given-names></name>
</person-group>. <article-title>Evaluation of a comprehensive rehabilitation services for elderly homebound patients with arthritis and orthopedic disability</article-title>. <source>Arthritis and Rheumatism</source>, <year>1984</year>: <volume>27</volume>(<issue>3</issue>): <fpage>258</fpage>–<lpage>266</lpage>.</citation>
</ref>
<ref id="bibr96-0017896911419346">
<label>96.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lineker</surname><given-names>SC</given-names></name>
<name><surname>Bell</surname><given-names>MJ</given-names></name>
<name><surname>Wilkins</surname><given-names>AL</given-names></name>
<name><surname>Badley</surname><given-names>EM</given-names></name>
</person-group>. <article-title>Improvements following short term home based physical therapy are maintained at one year in people with moderate to severe rheumatoid arthritis</article-title>. <source>The Journal of Rheumatology</source>, <year>2001</year>: <volume>28</volume>(<issue>1</issue>): <fpage>165</fpage>–<lpage>168</lpage>.</citation>
</ref>
<ref id="bibr97-0017896911419346">
<label>97.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lorig</surname><given-names>K</given-names></name>
<name><surname>Laurin</surname><given-names>J</given-names></name>
<name><surname>Holman</surname><given-names>HR</given-names></name>
</person-group>. <article-title>Arthritis self-management: A study of the effectiveness of patient education for the elderly</article-title>. <source>The Gerontologist</source>, <year>1984</year>: <volume>24</volume>(<issue>5</issue>): <fpage>455</fpage>–<lpage>457</lpage>.</citation>
</ref>
<ref id="bibr98-0017896911419346">
<label>98.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lorig</surname><given-names>K</given-names></name>
</person-group>. <article-title>Development and dissemination of an arthritis patient education course</article-title>. <source>Family and Community</source>, <year>1986</year>: <volume>9</volume>(<issue>1</issue>): <fpage>23</fpage>–<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr99-0017896911419346">
<label>99.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lorig</surname><given-names>K</given-names></name>
<name><surname>Laurin</surname><given-names>J</given-names></name>
<name><surname>Gines</surname><given-names>GES</given-names></name>
</person-group>. <article-title>Arthritis self-management: A five-year history of a patient education program</article-title>. <source>Nursing Clinics of North America</source>, <year>1984</year>: <volume>19</volume>(<issue>4</issue>): <fpage>637</fpage>–<lpage>645</lpage>.</citation>
</ref>
<ref id="bibr100-0017896911419346">
<label>100.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lorig</surname><given-names>K</given-names></name>
<name><surname>Lubeck</surname><given-names>D</given-names></name>
<name><surname>Kraines</surname><given-names>RG</given-names></name>
<name><surname>Seleznick</surname><given-names>M</given-names></name>
<name><surname>Holman</surname><given-names>HR</given-names></name>
</person-group>. <article-title>Outcomes of self-help education for patients with arthritis</article-title>. <source>Arthritis and Rheumatism</source>, <year>1985</year>: <volume>28</volume>(<issue>6</issue>): <fpage>680</fpage>–<lpage>685</lpage>.</citation>
</ref>
<ref id="bibr101-0017896911419346">
<label>101.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lorig</surname><given-names>K</given-names></name>
<name><surname>Feigenbaum</surname><given-names>P</given-names></name>
<name><surname>Regan</surname><given-names>C</given-names></name>
<name><surname>Ung</surname><given-names>E</given-names></name>
<name><surname>Chastain</surname><given-names>RL</given-names></name>
<name><surname>Holman</surname><given-names>HR</given-names></name>
</person-group>. <article-title>A comparison of lay-taught and professional-taught arthritis self-management courses</article-title>. <source>Journal of Rheumatology</source>, <year>1986</year>: <volume>13</volume>: <fpage>763</fpage>–<lpage>767</lpage>.</citation>
</ref>
<ref id="bibr102-0017896911419346">
<label>102.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lorig</surname><given-names>K</given-names></name>
<name><surname>Holman</surname><given-names>HR</given-names></name>
</person-group>. <article-title>Long-term outcomes of an arthritis self-management study: effects of reinforcement efforts</article-title>. <source>Soc. Sci. Med</source>, <year>1989</year>: <volume>29</volume>(<issue>2</issue>): <fpage>221</fpage>–<lpage>224</lpage>.</citation>
</ref>
<ref id="bibr103-0017896911419346">
<label>103.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lorig</surname><given-names>K</given-names></name>
<name><surname>Holman</surname><given-names>H</given-names></name>
</person-group>. <article-title>Arthritis self-management studies: A twelve-year review</article-title>. <source>Health Education Quarterly</source>, <year>1993</year>: <volume>20</volume>(<issue>1</issue>): <fpage>17</fpage>–<lpage>28</lpage>.</citation>
</ref>
<ref id="bibr104-0017896911419346">
<label>104.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lorig</surname><given-names>K</given-names></name>
<name><surname>Gonzalez</surname><given-names>VM</given-names></name>
<name><surname>Ritter</surname><given-names>P</given-names></name>
</person-group>. <article-title>Community-based Spanish language arthritis education program</article-title>. <source>Medical Care</source>, <year>1999</year>: <volume>37</volume>(<issue>9</issue>): <fpage>957</fpage>–<lpage>963</lpage>.</citation>
</ref>
<ref id="bibr105-0017896911419346">
<label>105.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lorig</surname><given-names>KR</given-names></name>
<name><surname>Mazonson</surname><given-names>PD</given-names></name>
<name><surname>Holman</surname><given-names>HR</given-names></name>
</person-group>. <article-title>Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs</article-title>. <source>Arthritis and Rheumatism</source>, <year>1993</year>: <volume>36</volume>(<issue>4</issue>): <fpage>439</fpage>–<lpage>446</lpage>.</citation>
</ref>
<ref id="bibr106-0017896911419346">
<label>106.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lorish</surname><given-names>CD</given-names></name>
<name><surname>Parker</surname><given-names>J</given-names></name>
<name><surname>Brown</surname><given-names>S</given-names></name>
</person-group>. <article-title>Effective patient education</article-title>. <source>Arthritis and Rheumatism</source>, <year>1985</year>: <volume>28</volume>(<issue>11</issue>): <fpage>1289</fpage>–<lpage>1297</lpage>.</citation>
</ref>
<ref id="bibr107-0017896911419346">
<label>107.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Maggs</surname><given-names>FM</given-names></name>
<name><surname>Jubb</surname><given-names>RW</given-names></name>
<name><surname>Kemm</surname><given-names>JR</given-names></name>
</person-group>. <article-title>Single-blind randomized controlled trial of an educational booklet for patients with chronic arthritis</article-title>. <source>Br J Rheumatol</source>, <year>1996</year>: <volume>35</volume>(<issue>8</issue>): <fpage>775</fpage>–<lpage>777</lpage>.</citation>
</ref>
<ref id="bibr108-0017896911419346">
<label>108.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mahowald</surname><given-names>ML</given-names></name>
<name><surname>Steveken</surname><given-names>ME</given-names></name>
<name><surname>Young</surname><given-names>M</given-names></name>
<name><surname>Ytterberg</surname><given-names>SR</given-names></name>
</person-group>. <article-title>The Minnesota arthritis training program: Emphasis on self-management, not compliance</article-title>. <source>Patient Education and Counseling</source>, <year>1988</year>: <volume>11</volume>: <fpage>235</fpage>–<lpage>241</lpage>.</citation>
</ref>
<ref id="bibr109-0017896911419346">
<label>109.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Maisiak</surname><given-names>R</given-names></name>
<name><surname>Austin</surname><given-names>J</given-names></name>
<name><surname>Heck</surname><given-names>L</given-names></name>
</person-group>. <article-title>Health outcomes of two telephone interventions for patients with rheumatoid arthritis or osteoarthritis</article-title>. <source>Arthritis Rheum</source>, <year>1996</year>: <volume>39</volume>(<issue>8</issue>): <fpage>1391</fpage>–<lpage>1399</lpage>.</citation>
</ref>
<ref id="bibr110-0017896911419346">
<label>110.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Maisiak</surname><given-names>R</given-names></name>
<name><surname>Austin</surname><given-names>JS</given-names></name>
<name><surname>West</surname><given-names>SG</given-names></name>
<name><surname>Heck</surname><given-names>L</given-names></name>
</person-group>. <article-title>The effect of person-centered counseling on the psychological status of persons with systemic lupus erythematosus or rheumatoid arthritis: a randomized, controlled trial</article-title>. <source>Arthritis Care Res</source>, <year>1996</year>: <volume>9</volume>(<issue>1</issue>): <fpage>60</fpage>–<lpage>66</lpage>.</citation>
</ref>
<ref id="bibr111-0017896911419346">
<label>111.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mäkeläinen</surname><given-names>P</given-names></name>
<name><surname>Vehvilainen-Julkunen</surname><given-names>K</given-names></name>
<name><surname>Pietila</surname><given-names>A-M</given-names></name>
</person-group>. <article-title>Research article: Rheumatoid arthritis patients’ knowledge of the disease and its treatments: A descriptive study</article-title>. <source>Musculoskeletal Care</source>, <year>2009</year>: <volume>7</volume>(<issue>1</issue>): <fpage>31</fpage>–<lpage>44</lpage>.</citation>
</ref>
<ref id="bibr112-0017896911419346">
<label>112.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mäkeläinen</surname><given-names>P</given-names></name>
<name><surname>Vehviläinen-Julkunen</surname><given-names>K</given-names></name>
<name><surname>Pietilä</surname><given-names>A-M</given-names></name>
</person-group>. <article-title>Change in knowledge and self-efficacy of patients with rheumatoid arthritis: A six month follow up</article-title>. <source>International Journal of Nursing Practice</source>, <year>2009</year>: <volume>15</volume>: <fpage>368</fpage>–<lpage>375</lpage>.</citation>
</ref>
<ref id="bibr113-0017896911419346">
<label>113.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mäkeläinen</surname><given-names>P</given-names></name>
<name><surname>Vehviläinen-Julkunen</surname><given-names>K</given-names></name>
<name><surname>Pietilä</surname><given-names>A-M</given-names></name>
</person-group>. <article-title>Rheumatoid arthritis patient education: RA patient’s experience</article-title>. <source>Journal of Clinical Nursing</source>, <year>2009</year>: <volume>18</volume>: <fpage>2058</fpage>–<lpage>2065</lpage>.</citation>
</ref>
<ref id="bibr114-0017896911419346">
<label>114.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mayoux-Benhamou</surname><given-names>A</given-names></name>
<name><surname>Giraudet-le Quintrec</surname><given-names>J-S</given-names></name>
<name><surname>Ravaud</surname><given-names>P</given-names></name>
<name><surname>Champion</surname><given-names>K</given-names></name>
<name><surname>Dernis</surname><given-names>E</given-names></name>
<name><surname>Zerkak</surname><given-names>D</given-names></name>
<name><surname>Roy</surname><given-names>R</given-names></name>
<name><surname>Kahan</surname><given-names>A</given-names></name>
<name><surname>Revel</surname><given-names>M</given-names></name>
<name><surname>Dougados</surname><given-names>M</given-names></name>
</person-group>. <article-title>Influence of patient education on exercise compliance in rheumatoid arthritis: A prospective 12-month randomized control trial</article-title>. <source>Journal of Rheumatology</source>, <year>2008</year>: <volume>35</volume>: <fpage>216</fpage>–<lpage>223</lpage>.</citation>
</ref>
<ref id="bibr115-0017896911419346">
<label>115.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McEvoy-DeVellis</surname><given-names>B</given-names></name>
<name><surname>Blalock</surname><given-names>SJ</given-names></name>
<name><surname>Hahn</surname><given-names>PM</given-names></name>
<name><surname>DeVellis</surname><given-names>RF</given-names></name>
<name><surname>Hochbaum</surname><given-names>GM</given-names></name>
</person-group>. <article-title>Evaluation of a problem-solving intervention for patients with arthritis</article-title>. <source>Patient Education and Counseling</source>, <year>1988</year>: <volume>11</volume>: <fpage>29</fpage>–<lpage>42</lpage>.</citation>
</ref>
<ref id="bibr116-0017896911419346">
<label>116.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nordmark</surname><given-names>B</given-names></name>
<name><surname>Blomqvist</surname><given-names>P</given-names></name>
<name><surname>Andersson</surname><given-names>B</given-names></name>
<name><surname>Hagerstrom</surname><given-names>M</given-names></name>
<name><surname>Nordh-Grate</surname><given-names>K</given-names></name>
<name><surname>Ronnqvist</surname><given-names>R</given-names></name>
<name><surname>Svensson</surname><given-names>H</given-names></name>
<name><surname>Klareskog</surname><given-names>L</given-names></name>
</person-group>. <source>Scandinavian Journal of Rheumatology</source>, <year>2006</year>: <volume>35</volume>: <fpage>7</fpage>–<lpage>14</lpage>.</citation>
</ref>
<ref id="bibr117-0017896911419346">
<label>117.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nordstrom</surname><given-names>DCE</given-names></name>
<name><surname>Konttinen</surname><given-names>YT</given-names></name>
<name><surname>Solovieva</surname><given-names>S</given-names></name>
<name><surname>Friman</surname><given-names>C</given-names></name>
<name><surname>Santavirta</surname><given-names>S</given-names></name>
</person-group>. <article-title>In- and out-patient rehabilitation in rheumatoid arthritis</article-title>. <source>Scandinavian Journal of Rheumatology</source>, <year>1996</year>: <volume>25</volume>: <fpage>200</fpage>–<lpage>206</lpage>.</citation>
</ref>
<ref id="bibr118-0017896911419346">
<label>118.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>O’Leary</surname><given-names>A</given-names></name>
<name><surname>Shoor</surname><given-names>S</given-names></name>
<name><surname>Lorig</surname><given-names>K</given-names></name>
<name><surname>Holman</surname><given-names>HR</given-names></name>
</person-group>. <article-title>A cognitive-behavioral treatment for rheumatoid arthritis</article-title>. <source>Health Psychology</source>, <year>1988</year>: <volume>7</volume>(<issue>6</issue>): <fpage>527</fpage>–<lpage>544</lpage>.</citation>
</ref>
<ref id="bibr119-0017896911419346">
<label>119.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Oermann</surname><given-names>MH</given-names></name>
<name><surname>Doyle</surname><given-names>TH</given-names></name>
<name><surname>Clark</surname><given-names>LR</given-names></name>
<name><surname>Rivers</surname><given-names>CL</given-names></name>
<name><surname>Rose</surname><given-names>VY</given-names></name>
</person-group>. <article-title>Effectiveness of self-instruction for arthritis patient education</article-title>. <source>Patient Education and Counseling</source>, <year>1986</year>: <volume>8</volume>: <fpage>245</fpage>–<lpage>254</lpage>.</citation>
</ref>
<ref id="bibr120-0017896911419346">
<label>120.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Palchik</surname><given-names>NS</given-names></name>
<name><surname>Laing</surname><given-names>TJ</given-names></name>
<name><surname>Connell</surname><given-names>KJ</given-names></name>
<name><surname>Daltroy</surname><given-names>LH</given-names></name>
<name><surname>Friedman</surname><given-names>CP</given-names></name>
<name><surname>Hull</surname><given-names>AL</given-names></name>
<name><surname>Mazzuca</surname><given-names>SA</given-names></name>
</person-group>. <article-title>Research priorities for arthritis professional education</article-title>. <source>Arthritis and Rheumatism</source>, <year>1991</year>: <volume>34</volume>(<issue>2</issue>): <fpage>234</fpage>–<lpage>240</lpage>.</citation>
</ref>
<ref id="bibr121-0017896911419346">
<label>121.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Platto</surname><given-names>MJ</given-names></name>
<name><surname>O’Connell</surname><given-names>PG</given-names></name>
<name><surname>HIcks</surname><given-names>JE</given-names></name>
<name><surname>Gerber</surname><given-names>LH</given-names></name>
</person-group>. <article-title>The relationship of pain and deformity of the rheumatic foot to gait and an index of functional ambulation</article-title>. <source>The Journal of Rheumatology</source>, <year>1991</year>: <volume>18</volume>(<issue>1</issue>): <fpage>38</fpage>–<lpage>43</lpage>.</citation>
</ref>
<ref id="bibr122-0017896911419346">
<label>122.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Radojevic</surname><given-names>V</given-names></name>
<name><surname>Nicassio</surname><given-names>PM</given-names></name>
<name><surname>Weisman</surname><given-names>MH</given-names></name>
</person-group>. <article-title>Behavioral intervention with and without family support for rheumatoid arthritis</article-title>. <source>Behavior Therapy</source>, <year>1992</year>: <volume>23</volume>: <fpage>13</fpage>–<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr123-0017896911419346">
<label>123.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rodriguez-Lozano</surname><given-names>C</given-names></name>
<name><surname>Bilbao</surname><given-names>A</given-names></name>
<name><surname>Naranjo</surname><given-names>A</given-names></name>
<name><surname>Ojeda</surname><given-names>S</given-names></name>
<name><surname>Francisco</surname><given-names>F</given-names></name>
</person-group>. <article-title>Educacion del paciente con artritis reumatoide: su influencia en la evolucion de la enfermedad</article-title> [<trans-title xml:lang="en">Patient education in rheumatoid arthritis: its influence in the disease outcome</trans-title>]. <source>Revista Espanola Reumatologia</source>, <year>1996</year>: <volume>23</volume>: <fpage>40</fpage>–<lpage>48</lpage>.</citation>
</ref>
<ref id="bibr124-0017896911419346">
<label>124.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ryan</surname><given-names>S</given-names></name>
<name><surname>Hassell</surname><given-names>AB</given-names></name>
<name><surname>Lewis</surname><given-names>M</given-names></name>
<name><surname>Farrell</surname><given-names>A</given-names></name>
</person-group>. <article-title>Impact of a rheumatology expert neurse on the wellbeig of attending a drug monitoring clinic</article-title>. <source>Journal of Advanced Nursing</source>, <year>2006</year>: <volume>53</volume>(<issue>3</issue>): <fpage>277</fpage>–<lpage>286</lpage>.</citation>
</ref>
<ref id="bibr125-0017896911419346">
<label>125.</label>
<citation citation-type="other">
<person-group person-group-type="author">
<name><surname>Savelkoul</surname><given-names>M</given-names></name>
<name><surname>De Witte</surname><given-names>LP</given-names></name>
<name><surname>Van der Borne</surname><given-names>BHW</given-names></name>
<name><surname>Van der Tempel</surname><given-names>H</given-names></name>
</person-group>. <article-title>Effects of a coping intervention on patients with rheumatic diseases: Results of a randomized controlled trial: Arthritis Rhuem</article-title>, <year>2000</year>: <volume>45</volume> (<issue>1</issue>): <fpage>69</fpage>–<lpage>76</lpage>.</citation>
</ref>
<ref id="bibr126-0017896911419346">
<label>126.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schwartz</surname><given-names>LH</given-names></name>
<name><surname>Marcus</surname><given-names>R</given-names></name>
<name><surname>Condon</surname><given-names>R</given-names></name>
</person-group>. <article-title>Multidisciplinary group therapy for rheumatoid arthritis</article-title>. <source>Pscychosomatics</source>, <year>1978</year>: <volume>19</volume>(<issue>5</issue>): <fpage>289</fpage>–<lpage>293</lpage>.</citation>
</ref>
<ref id="bibr127-0017896911419346">
<label>127.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sebro</surname><given-names>B</given-names></name>
<name><surname>Dubravica</surname><given-names>M</given-names></name>
<name><surname>Jajicz</surname></name>
</person-group>. <article-title>Spontaneous use of active and passive coping strategies for pain in patients with rheumatoid arthritis</article-title>. <source>Reumatizam</source>, <year>1993</year>: <volume>40</volume>(<issue>1</issue>): <fpage>1</fpage>–<lpage>4</lpage>.</citation>
</ref>
<ref id="bibr128-0017896911419346">
<label>128.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sharpe</surname><given-names>L</given-names></name>
<name><surname>Allard</surname><given-names>S</given-names></name>
<name><surname>Sensky</surname><given-names>T</given-names></name>
</person-group>. <article-title>Five-year followup of a cognitive-behavioral intervention for patients with recently-diagnosed rheumatoid arthritis: Effects on health care utilization</article-title>. <source>Arthritis &amp; Rheumatism (Arthritis Care &amp; Research)</source>, <year>2008</year>: <volume>59</volume>(<issue>3</issue>): <fpage>311</fpage>–<lpage>316</lpage>.</citation>
</ref>
<ref id="bibr129-0017896911419346">
<label>129.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shearn</surname><given-names>MA</given-names></name>
<name><surname>Fireman</surname><given-names>BH</given-names></name>
</person-group>. <article-title>Stress management and mutual support groups in rheumatoid arthritis</article-title>. <source>Am J Med</source>, <year>1985</year>: <volume>78</volume>(<issue>5</issue>): <fpage>771</fpage>–<lpage>775</lpage>.</citation>
</ref>
<ref id="bibr130-0017896911419346">
<label>130.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shigaki</surname><given-names>CL</given-names></name>
<name><surname>Smarr</surname><given-names>KL</given-names></name>
<name><surname>Gong</surname><given-names>Y</given-names></name>
<name><surname>Donovan-Hanson</surname><given-names>K</given-names></name>
<name><surname>Siva</surname><given-names>C</given-names></name>
<name><surname>Johnson</surname><given-names>RA</given-names></name>
<name><surname>Ge</surname><given-names>B</given-names></name>
<name><surname>Musser</surname><given-names>DR</given-names></name>
</person-group>. <article-title>Social interactions in an online self-management program for rheumatoid arthritis</article-title>. <source>Chronic Illness</source>, <year>2008</year>: <volume>4</volume>: <fpage>239</fpage>–<lpage>246</lpage>.</citation>
</ref>
<ref id="bibr131-0017896911419346">
<label>131.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Simeoni</surname><given-names>E</given-names></name>
<name><surname>Bauman</surname><given-names>A</given-names></name>
<name><surname>Stenmark</surname><given-names>J</given-names></name>
<name><surname>O’Brien</surname><given-names>J</given-names></name>
</person-group>. <article-title>Evaluation of a community arthritis program in Australia: Dissemination of a developed program</article-title>. <source>Arthritis Care and Research</source>, <year>1995</year>: <volume>8</volume>(<issue>2</issue>): <fpage>102</fpage>–<lpage>107</lpage>.</citation>
</ref>
<ref id="bibr132-0017896911419346">
<label>132.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Smarr</surname><given-names>KL</given-names></name>
<name><surname>Parker</surname><given-names>JC</given-names></name>
<name><surname>Wright</surname><given-names>GE</given-names></name>
<name><surname>Stucky-Ropp</surname><given-names>RC</given-names></name>
<name><surname>Buckelew</surname><given-names>SP</given-names></name>
<name><surname>Hoffman</surname><given-names>RW</given-names></name>
<name><surname>O’Sullivan</surname><given-names>FX</given-names></name>
<name><surname>Hewett</surname><given-names>JE</given-names></name>
</person-group>. <article-title>The importance of enahncing self-efficacy in rheumatoid arthritis</article-title>. <source>Arthritis Care and Research</source>, <year>1997</year>: <volume>10</volume>(<issue>1</issue>): <fpage>18</fpage>–<lpage>26</lpage>.</citation>
</ref>
<ref id="bibr133-0017896911419346">
<label>133.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Taal</surname><given-names>E</given-names></name>
<name><surname>Rasker</surname><given-names>JJ</given-names></name>
<name><surname>Seydel</surname><given-names>ER</given-names></name>
<name><surname>Wiegman</surname><given-names>O</given-names></name>
</person-group>. <article-title>Health status, adherence with health recommendations, self-efficacy and social support in patients with rheumatoid arthritis</article-title>. <source>Patient Education and Counselling</source>, <year>1993</year>: <volume>20</volume>: <fpage>63</fpage>–<lpage>76</lpage>.</citation>
</ref>
<ref id="bibr134-0017896911419346">
<label>134.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Taal</surname><given-names>E</given-names></name>
<name><surname>Rasker</surname><given-names>JJ</given-names></name>
<name><surname>Wiegman</surname><given-names>O</given-names></name>
</person-group>. <article-title>Patient education and self-management in the rheumatic diseases: A self-efficacy approach</article-title>. <source>Arthritis Care and Research</source>, <year>1996</year>: <volume>9</volume>(<issue>3</issue>): <fpage>229</fpage>–<lpage>238</lpage>.</citation>
</ref>
<ref id="bibr135-0017896911419346">
<label>135.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tucker</surname><given-names>M</given-names></name>
<name><surname>Kirwan</surname><given-names>JR</given-names></name>
</person-group>. <article-title>Does patient education in rheumatoid arthritis have therapeutic potential?</article-title> <source>Annals of the Rheumatic Diseases</source>, <year>1991</year>: <volume>50</volume>: <fpage>422</fpage>–<lpage>428</lpage>.</citation>
</ref>
<ref id="bibr136-0017896911419346">
<label>136.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Udelman</surname><given-names>HR</given-names></name>
<name><surname>Udelman</surname><given-names>DL</given-names></name>
</person-group>. <article-title>Group therapy with rheumatoid arthritic patients</article-title>. <source>American Journal of Psychotherapy</source>, <year>1978</year>: <volume>32</volume>: <fpage>288</fpage>–<lpage>299</lpage>.</citation>
</ref>
<ref id="bibr137-0017896911419346">
<label>137.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Van den Berg</surname><given-names>MH</given-names></name>
<name><surname>Ronday</surname><given-names>HK</given-names></name>
<name><surname>Peeters</surname><given-names>AJ</given-names></name>
<name><surname>Voogt-van der Harst</surname><given-names>EM</given-names></name>
<name><surname>Munneke</surname><given-names>M</given-names></name>
<name><surname>Breedveld</surname><given-names>FC</given-names></name>
<name><surname>Vliet Vlieland</surname><given-names>TPM</given-names></name>
</person-group>. <article-title>Engagement and satisfaction with an Internet-based physical activity intervention in patients with rheumatoid arthritis</article-title>. <source>Rheumatology</source>, <year>2007</year>: <volume>46</volume>: <fpage>545</fpage>–<lpage>552</lpage>.</citation>
</ref>
<ref id="bibr138-0017896911419346">
<label>138.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Van den Berg</surname><given-names>MH</given-names></name>
<name><surname>Ronday</surname><given-names>HK</given-names></name>
<name><surname>Peeters</surname><given-names>AJ</given-names></name>
<name><surname>Le Cessie</surname><given-names>S</given-names></name>
<name><surname>van der Giesen</surname><given-names>FJ</given-names></name>
<name><surname>Breedveld</surname><given-names>F</given-names></name>
<name><surname>Vliet Vlieland</surname><given-names>TPM</given-names></name>
</person-group>. <article-title>Using internet technology to deliver a home-based physical activity intervention for patients with rheumatoid arthritis: A randomized controlled trial</article-title>. <source>Arthritis &amp; Rheumatism (Arthritis Care &amp; Research)</source>, <year>2006</year>: <volume>55</volume>(<issue>6</issue>): <fpage>935</fpage>–<lpage>945</lpage>.</citation>
</ref>
<ref id="bibr139-0017896911419346">
<label>139.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Van Deusen</surname><given-names>J</given-names></name>
<name><surname>Harlowe</surname><given-names>D</given-names></name>
</person-group>. <article-title>The efficacy of the ROM dance program for adults with rheumatoid arthritis</article-title>. <source>Am J Occup Ther</source>, <year>1987</year>: <volume>41</volume>(<issue>2</issue>): <fpage>90</fpage>–<lpage>95</lpage>.</citation>
</ref>
<ref id="bibr140-0017896911419346">
<label>140.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vignos</surname><given-names>PJ</given-names></name>
<name><surname>Parker</surname><given-names>WT</given-names></name>
<name><surname>Thompson</surname><given-names>HM</given-names></name>
</person-group>. <article-title>Evaluation of a clinic education program for patients with rheumatoid arthritis</article-title>. <source>The Journal of Rheumatology</source>, <year>1976</year>: <volume>3</volume>(<issue>2</issue>): <fpage>155</fpage>–<lpage>165</lpage>.</citation>
</ref>
<ref id="bibr141-0017896911419346">
<label>141.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Young</surname><given-names>LD</given-names></name>
<name><surname>Bradley</surname><given-names>LA</given-names></name>
<name><surname>Turner</surname><given-names>RA</given-names></name>
</person-group>. <article-title>Decreases in health care resource utilization in patients with rheumatoid arthritis following a cognitive behavioral intervention</article-title>. <source>Biofeedback Self Regul</source>, <year>1995</year>: <volume>20</volume>(<issue>3</issue>): <fpage>259</fpage>–<lpage>268</lpage>.</citation>
</ref>
<ref id="bibr142-0017896911419346">
<label>142.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hammond</surname><given-names>A</given-names></name>
<name><surname>Klompenhouwer</surname><given-names>P</given-names></name>
</person-group>. <article-title>Getting evidence into practice: Implementing a behavioural joint protection education programme for people with rheumatoid arthritis</article-title>. <source>British Journal of Occupational Therapy</source>, <year>2005</year>: <volume>68</volume>: <fpage>25</fpage>–<lpage>31</lpage>.</citation>
</ref>
<ref id="bibr143-0017896911419346">
<label>143.</label>
<citation citation-type="other">
<person-group person-group-type="author">
<name><surname>Riemsma</surname><given-names>RP</given-names></name>
<name><surname>Kirwan</surname><given-names>JR</given-names></name>
<name><surname>Taal</surname><given-names>E</given-names></name>
<name><surname>Rasker</surname><given-names>HJJ</given-names></name>
</person-group>. <article-title>Patient education for adults with rheumatoid arthritis</article-title>. <source>Cochrane Database of Systematic Reviews</source>, <year>2003</year>: (<issue>2</issue>): <fpage>CD003688</fpage>.</citation>
</ref>
<ref id="bibr144-0017896911419346">
<label>144.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Riemsma</surname><given-names>RP</given-names></name>
<name><surname>Kirwan</surname><given-names>JR</given-names></name>
<name><surname>Taal</surname><given-names>E</given-names></name>
<name><surname>Rasker</surname><given-names>HJJ</given-names></name>
</person-group>. <article-title>Systematic review of rheumatoid arthritis patient education</article-title>. <source>Arthritis &amp; Rheumatism</source>, <year>2004</year>: <volume>51</volume>: <fpage>1045</fpage>–<lpage>1059</lpage>.</citation>
</ref>
<ref id="bibr145-0017896911419346">
<label>145.</label>
<citation citation-type="journal">
<collab>ACR American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines</collab>. <article-title>Guidelines for the management of rheumatoid arthritis: 2002 update</article-title>. <source>Arthritis &amp; Rheumatism</source>, <year>2002</year>: <volume>46</volume>: <fpage>328</fpage>–<lpage>346</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>